2. Cell Cycle/DNA Damage Autophagy Anti-infection Apoptosis
  3. Topoisomerase Autophagy Mitophagy Bacterial Apoptosis Antibiotic
  4. Etoposide

Etoposide  (Synonyms: VP-16; VP-16-213)

Cat. No.: HY-13629 Purity: 99.93%
COA
SDS
Handling Instructions Technical Support

Etoposide (VP-16; VP-16-213) est un agent de chimiothérapie anticancéreuse. Etoposide inhibe la topoisomérase II, il peut arrêter ainsi la réplication de l'ADN. Etoposide induit un arrêt du cycle cellulaire, l'apoptose et l'autophagie.

Etoposid (VP-16; VP-16-213) ist ein Anti-Krebs-Chemotherapeutikum. Etoposid hemmt die topoisomerase II und stoppt so die DNA-Replikation. Etoposid induziert Zellzyklus-Arrest, apoptosis und autophagy.

Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy.

For research use only. We do not sell to patients.

CAS No. : 33419-42-0

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
100 mg In-stock
200 mg In-stock
500 mg In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 174 publication(s) in Google Scholar

Other Forms of Etoposide:

Etoposide Related Antibodies

Top Publications Citing Use of Products

174 Publications Citing Use of MCE Etoposide

RT-PCR
WB
Cell Proliferation/Viability Assay
IF

    Etoposide purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Mar 7;134(10):e172716.  [Abstract]

    The given cell lines were treated with 250 nM osimertinib (Osim), 1.25 μM Etoposide (VP-16), 125 nM Doxorubicin (DXR), 5 nM Paclitaxel, 10 μM Cisplatin, 25 μM Carboplatin, 25 nM Gemcitabine, 20 nM 5-Fluorouracil (5-FU), 25 μM Cyclophosphamide, 25 μM Capecitabine, or 10 nM Vincristine alone or in combination for 3 days. Cell numbers were then measured using the SRB assay.

    Etoposide purchased from MedChemExpress. Usage Cited in: Cell Host Microbe. 2023 Nov 8;31(11):1820-1836.e10.  [Abstract]

    Immunoblot and immunoprecipitation of lysates of HEK293T cells transfected with plasmids encoding Flag-UreC and exposed to etoposide (100 μg/ml) for 4 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Oncogene. 2023 Mar;42(13):967-979.  [Abstract]

    Etoposide (VP16; 5 mg/kg; s.c.; every two days for 8 days) strongly suppresses tumor growth in mice.

    Etoposide purchased from MedChemExpress. Usage Cited in: J Pharm Pharmacol. 2023 Apr 7;75(4):523-532.  [Abstract]

    Irinotecan (CPT11; 20 μM; 48 h) or Etoposide (VP16; 20 μM; 48 h) induces MDA-MB-231 cells cycle arrest significantly.

    Etoposide purchased from MedChemExpress. Usage Cited in: Elife. 2022 May 3;11:e69255.  [Abstract]

    Cell sensitivity to Etoposide (ETO). Cancer cells are treated with etoposide at gradient concentrations for 48 hr.

    Etoposide purchased from MedChemExpress. Usage Cited in: Elife. 2022 May 3;11:e69255.  [Abstract]

    BCL6 mRNA expression in Etoposide (ETO)-resistant and -sensitive cells. Cells are treated with Etoposide at their respective 1/2 IC50s for 24 hr.

    Etoposide purchased from MedChemExpress. Usage Cited in: Elife. 2022 May 3;11:e69255.  [Abstract]

    Etoposide induced BCL6 protein expression in a time-dependent manner. ETO-resistant or -sensitive cells are treated with etoposide at their respective 1/4 IC50s for 2, 4, or 6 days.

    Etoposide purchased from MedChemExpress. Usage Cited in: Elife. 2022 May 3;11:e69255.  [Abstract]

    STAT1 protein and its phosphorylation levels by immunoblotting analysis. Etoposide (ETO)-resistant and -sensitive cells are treated with Etoposide at their respective 1/2 IC50s for indicated time points.

    Etoposide purchased from MedChemExpress. Usage Cited in: Elife. 2022 May 3;11:e69255.  [Abstract]

    Etoposide activated mTOR signaling components in Etoposide-resistant Capan-2 and PANC28 cells. Cells were treated with etoposide at their respective 1/2 IC50s for 6 or 12 hr. A long-term treatment with Etoposide activated mTOR signaling components in ETO-resistant cells. Capan-2 and PANC28 cells are treated with 10 μM Etoposide for 2 or 4 days.

    Etoposide purchased from MedChemExpress. Usage Cited in: Protein Cell. 2022 Jan;13(1):47-64.  [Abstract]

    FISH of telomeres on metaphase spreads to detect chromosome end-to-end fusions in 6 kb-HeLa treated with VP-16. Control (Scr) or cGAS-depleted cells (gcGAS-1, gcGAS-2) are either harvested immediately following treatment (VP-16, 2 μM, 1 h) or released for 4 h (Release 4 h) during mitosis.

    Etoposide purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2021 Mar 12;12(3):265.  [Abstract]

    Inhibition of PRDX1 increased the sensitivity of HCT116 cells to Etoposide-induced apoptosis: HCT116 cells infected with lentivirus expressing the indicated shRNAs were treated with 50 μM Etoposide for 0-6 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Hepatology. 2020 May;71(5):1660-1677.  [Abstract]

    Exposure to Etoposide (Eto), another DNA-damaging agent, induces PDIA3P1 expression, suggesting that PDIA3P1 may be up-regulated by DNA-damaging agents.

    Etoposide purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2020 Sep 28;7(21):2001364.  [Abstract]

    Lnc‐Ip53 attenuated the DNA damage- and oxidation stress-induced p53 acetylation at K382. Cells are incubated with 50 µM Etoposide (Eto) for 5 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2020 Sep 28;7(21):2001364.  [Abstract]

    Lnc‐Ip53 attenuated the DNA damage‐ and oxidation stress‐triggered increase of CDKN1A and PUMA. Cells are incubated with 50 µM Etoposide (Eto) for 6 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Theranostics. 2020 Jul 25;10(21):9477-9494.  [Abstract]

    Fibroblasts and HT-1080 cells are treated with 20 µM Etoposide or DMSO (vehicle group) for 2, 4, 8, 16, 24 and 36 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Theranostics. 2020 Jul 25;10(21):9477-9494.  [Abstract]

    When cells are treated with 20 µM Etoposide or DMSO (vehicle group) for 4 h, western blots (WB) shows elevated expression of γH2AX, a marker of double-strand breaks (DSBs), in the Etoposide group.

    Etoposide purchased from MedChemExpress. Usage Cited in: Theranostics. 2020 Jul 25;10(21):9477-9494.  [Abstract]

    When cells are treated with 20 µM Etoposide, an obvious increased green focus of RAD51 is observed in the treated fibroblasts using immunofluorescence (IF) staining.

    Etoposide purchased from MedChemExpress. Usage Cited in: EMBO Mol Med. 2020 Nov 6;12(11):e12525.  [Abstract]

    Immunoblot of PARP1 cleavage of PeTa cells after 6 days of indicated treatment. Etoposide (10 μM; for 24 h) serves as positive control for apoptosis, and H3 serves as loading control.

    Etoposide purchased from MedChemExpress. Usage Cited in: Aging Cell. 2020 Jul;19(7):e13171.  [Abstract]

    RPE p16‐mCherry cells were treated with DMSO, Etoposide (20 μM), H2O2 (200 μM), or serum starved for 24 hr.

    Etoposide purchased from MedChemExpress. Usage Cited in: Leuk Lymphoma. 2018 Jan;59(1):162-170.  [Abstract]

    WT1 and caspase-3 protein levels are detected in two primary AML blasts treated with 100 μM Eto for 24 h.

    Etoposide purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2017 Nov 1:408:43-54.  [Abstract]

    Western blot analysis of p-p70S6k, p70S6k, p-AKT and AKT after 6 h of treatment with 20 μM RAD001. Levels of p-p70S6k and p-AKT are quantified by densitometric analysis and a corresponding histogram is constructed as relative to p70S6k or AKT and α-tubulin. The lower panel shows a representative Western blot.

    View All Topoisomerase Isoform Specific Products:

    View All Isoforms
    Topoisomerase Topo I Topo II DNA gyrase

    View All Antibiotic Isoform Specific Products:

    View All Isoforms
    Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy[1].

    IC50 & Target[1]

    Topoisomerase II

     

    Cellular Effect
    Cell Line Type Value Description References
    1A9 ED50
    0.15 3
    Compound: 1
    Dose required to cause reduction in human ovarian 1A9 cancer cells after 3 days incubation
    Dose required to cause reduction in human ovarian 1A9 cancer cells after 3 days incubation
    		[PMID: 15456257]
    1A9 ED50
    0.15 3
    Compound: 1
    Dose required to cause reduction in human ovarian 1A9 cancer cells after 3 days incubation
    Dose required to cause reduction in human ovarian 1A9 cancer cells after 3 days incubation
    		[PMID: 15456257]
    1A9/ptx-10 ED50
    > 5 3
    Compound: 1
    Dose required for reduction in paclitaxel resistant human ovarian 1A9-PTX10 cancer cells after 3 days incubation
    Dose required for reduction in paclitaxel resistant human ovarian 1A9-PTX10 cancer cells after 3 days incubation
    		[PMID: 15456257]
    1A9/ptx-10 ED50
    > 5 3
    Compound: 1
    Dose required for reduction in paclitaxel resistant human ovarian 1A9-PTX10 cancer cells after 3 days incubation
    Dose required for reduction in paclitaxel resistant human ovarian 1A9-PTX10 cancer cells after 3 days incubation
    		[PMID: 15456257]
    4T1 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of mouse 4T1 cells after 72 hrs by MTT assay
    Growth inhibition of mouse 4T1 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    3LL cell line IC50
    4 3
    Compound: Etoposide
    Cytotoxicity against mouse 3LL CRL 1642 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse 3LL CRL 1642 cells after 48 hrs by MTT assay
    		[PMID: 18558490]
    5637 IC50
    0.53 3
    Compound: Etoposide
    Growth inhibition against human 5637 cell lines
    Growth inhibition against human 5637 cell lines
    		[PMID: 15189040]
    4T1 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of mouse 4T1 cells after 72 hrs by MTT assay
    Growth inhibition of mouse 4T1 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    5637 IC50
    0.54 3
    Compound: Etoposide
    Antiproliferative activity against human 5637 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human 5637 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    5637 IC50
    0.54 3
    Compound: Etoposide
    Antiproliferative activity against human 5637 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human 5637 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    A2058 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    A2780 IC50
    0.07 3
    Compound: EP
    Growth inhibition human A2780 cells after 72 hrs by MTS assay
    Growth inhibition human A2780 cells after 72 hrs by MTS assay
    		[PMID: 30633861]
    A2780 GI50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    A-375 IC50
    0.24 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human A375 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    A2780 GI50
    1.3 3
    Compound: 2, VP-16
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    A-375 IC50
    0.24 3
    Compound: Etoposide
    Antiproliferative activity against human A375 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human A375 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    A2780 GI50
    1.3 3
    Compound: 2
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    A-375 IC50
    0.28 3
    Compound: VP-16
    Cytotoxicity against human A-375 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human A-375 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    A2780 GI50
    1.31 3
    Compound: 2, Eto
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    A-375 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferation activity against human A375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human A375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    A2780 GI50
    1.31 3
    Compound: 2, Eto
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    A-375 IC50
    1.39 3
    Compound: 2, Etop
    Anticancer activity against human A375 cells after 48 hrs by MTT assay
    Anticancer activity against human A375 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    A-375 IC50
    0.24 3
    Compound: Etoposide
    Antiproliferative activity against human A375 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human A375 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    A-375 IC50
    12 3
    Compound: Etoposide
    Cytotoxicity activity against human A375 cells after 48 hrs by NRU assay
    Cytotoxicity activity against human A375 cells after 48 hrs by NRU assay
    		[PMID: 20570625]
    A-375 IC50
    0.24 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human A375 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    A-375 IC50
    19 3
    Compound: Etoposide
    Cytotoxicity activity against human A375 cells after 24 hrs by NRU assay
    Cytotoxicity activity against human A375 cells after 24 hrs by NRU assay
    		[PMID: 20570625]
    A-375 IC50
    0.28 3
    Compound: VP-16
    Cytotoxicity against human A-375 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human A-375 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    A-375 IC50
    2.31 6
    Compound: Etoposide
    Antiproliferative activity against human A375 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A375 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    A-375 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferation activity against human A375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human A375 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    A-375 IC50
    24.46 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    A-375 IC50
    1.39 3
    Compound: 2, Etop
    Anticancer activity against human A375 cells after 48 hrs by MTT assay
    Anticancer activity against human A375 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    A-375 IC50
    12 3
    Compound: Etoposide
    Cytotoxicity activity against human A375 cells after 48 hrs by NRU assay
    Cytotoxicity activity against human A375 cells after 48 hrs by NRU assay
    		[PMID: 20570625]
    A-375 IC50
    3.92 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells by MTT assay
    Cytotoxicity against human A375 cells by MTT assay
    		[PMID: 19036584]
    A-375 IC50
    3.92 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells by MTT assay
    Cytotoxicity against human A375 cells by MTT assay
    		[PMID: 19782567]
    A-375 IC50
    19 3
    Compound: Etoposide
    Cytotoxicity activity against human A375 cells after 24 hrs by NRU assay
    Cytotoxicity activity against human A375 cells after 24 hrs by NRU assay
    		[PMID: 20570625]
    A-375 IC50
    2.31 6
    Compound: Etoposide
    Antiproliferative activity against human A375 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A375 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    A-375 IC50
    24.46 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    A-427 IC50
    0.095 6
    Compound: Etoposide
    Cytotoxic activity of compound against A-427 lung human tumor cell line
    Cytotoxic activity of compound against A-427 lung human tumor cell line
    		[PMID: 12459024]
    A-375 IC50
    3.92 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells by MTT assay
    Cytotoxicity against human A375 cells by MTT assay
    		[PMID: 19782567]
    A-427 IC50
    0.095 6
    Compound: Etoposide
    Cytotoxic activity against human A-427 lung tumor cell line
    Cytotoxic activity against human A-427 lung tumor cell line
    		[PMID: 15149673]
    A-375 IC50
    3.92 3
    Compound: Etoposide
    Cytotoxicity against human A375 cells by MTT assay
    Cytotoxicity against human A375 cells by MTT assay
    		[PMID: 19036584]
    A-427 IC50
    0.13 3
    Compound: Etoposide
    Antiproliferative activity against human A427 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human A427 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    A-427 IC50
    0.13 3
    Compound: Etoposide
    Antiproliferative activity against human A427 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human A427 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    A-431 IC50
    591 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against A431 cell line
    In vivo antiproliferative activity against A431 cell line
    		[PMID: 15084135]
    A498 IC50
    0.23 3
    Compound: Etoposide
    Antiproliferative activity against human A498 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human A498 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    A549 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 30543429]
    A2058 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human A2058 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    A549 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 29072457]
    A549 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    A2780 GI50
    1.3 3
    Compound: 2
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    A549 IC50
    > 30 3
    Compound: ETP
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    A2780 GI50
    1.3 3
    Compound: 2, VP-16
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    A2780 GI50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    A549 IC50
    > 50 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 31404864]
    A2780 GI50
    1.31 3
    Compound: 2, Eto
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    A549 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human A549 cells after 48 hrs by SRB assay
    Anticancer activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    A2780 GI50
    1.31 3
    Compound: 2, Eto
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    A549 IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by SRB assay
    Antiproliferative activity against human A549 cells by SRB assay
    		[PMID: 31546197]
    A549 IC50
    0.1 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    A2780 IC50
    0.07 3
    Compound: EP
    Growth inhibition human A2780 cells after 72 hrs by MTS assay
    Growth inhibition human A2780 cells after 72 hrs by MTS assay
    		[PMID: 30633861]
    A2780 IC50
    65 3
    Compound: 1
    Tested for cytotoxicity against Ovarian carcinoma parental type A2780 cell line expressing MDR-1 (-) gene
    Tested for cytotoxicity against Ovarian carcinoma parental type A2780 cell line expressing MDR-1 (-) gene
    		[PMID: 11844671]
    A549 IC50
    0.16 3
    Compound: Etoposide
    Inhibitory activity against A549 cell line using MTT assay(Wild type p53)
    Inhibitory activity against A549 cell line using MTT assay(Wild type p53)
    		[PMID: 10780913]
    A498 GI50
    8 3
    Compound: 2
    In vitro cytotoxic activity against renal (A 498) cancer cell line.
    In vitro cytotoxic activity against renal (A 498) cancer cell line.
    		[PMID: 10465531]
    A549 IC50
    0.24 3
    Compound: Etoposide
    Cytotoxicity in human A549 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human A549 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    A498 IC50
    0.23 3
    Compound: Etoposide
    Antiproliferative activity against human A498 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human A498 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    A549 IC50
    0.29 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs
    Cytotoxicity against human A549 cells after 48 hrs
    		[PMID: 20053564]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Growth inhibition of human A549 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    A549 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    A549 IC50
    0.32 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    A549 EC50
    0.4 6
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    A549 IC50
    0.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    A549 IC50
    0.44 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    		[PMID: 21936523]
    A549 IC50
    0.47 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    A549 IC50
    0.48 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    		[PMID: 26225905]
    A549 IC50
    0.48 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    A549 IC50
    0.5 3
    Compound: VP-16
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 11473438]
    A549 IC50
    0.59 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    A549 IC50
    0.59 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    A549 IC50
    0.6 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 3 days by MTT assay
    Cytotoxicity against human A549 cells after 3 days by MTT assay
    		[PMID: 21216051]
    A549 IC50
    0.6 3
    Compound: VP-16
    Cytotoxicity against human A549 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    A549 IC50
    0.6 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    A549 IC50
    0.63 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19685913]
    A549 IC50
    0.63 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 24 hrs by SRB assay
    Cytotoxicity against human A549 cells after 24 hrs by SRB assay
    		[PMID: 19769341]
    A549 IC50
    0.63 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 20415462]
    A549 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    A549 GI50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    A549 IC50
    0.71 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    A549 IC50
    0.72 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    A549 EC50
    0.8 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 2 days
    Cytotoxicity against human A549 cells after 2 days
    		[PMID: 17629328]
    A549 IC50
    0.8 3
    Compound: etoposide
    Antiproliferative activity at human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity at human A549 cells after 72 hrs by MTT assay
    		[PMID: 22861499]
    A549 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    A549 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    A549 IC50
    0.8 3
    Compound: etoposide
    Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    A549 IC50
    0.8 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    A549 IC50
    0.83 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 20071056]
    A549 IC50
    0.92 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    A549 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    1.06 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human lung tumor cell line A549 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human lung tumor cell line A549 after 72 hr of incubation was determined
    		[PMID: 15482917]
    A549 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    A549 IC50
    1.16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    		[PMID: 18321715]
    A549 IC50
    1.16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 17194596]
    A549 EC50
    0.4 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells
    Cytotoxicity against human A549 cells
    		[PMID: 23043462]
    A549 EC50
    0.4 6
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    A549 IC50
    1.2 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs
    Cytotoxicity against human A549 cells after 48 hrs
    		[PMID: 19115839]
    A549 EC50
    0.8 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 2 days
    Cytotoxicity against human A549 cells after 2 days
    		[PMID: 17629328]
    A549 IC50
    1.3 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    A549 EC50
    0.8 6
    Compound: etoposide
    Cytotoxicity against human A549 cells
    Cytotoxicity against human A549 cells
    		[PMID: 17672504]
    A549 IC50
    1.3 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 32196342]
    A549 IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity in human A549 cells by SRB assay
    Cytotoxicity in human A549 cells by SRB assay
    		[PMID: 26812172]
    A549 ED50
    1.5 6
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB method
    Cytotoxicity against human A549 cells by SRB method
    		[PMID: 16252909]
    A549 ED50
    1.95 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human lung carcinoma (A549) cell line.
    The compound was tested for tumor cell growth inhibitory activity against human lung carcinoma (A549) cell line.
    		[PMID: 10395485]
    A549 IC50
    1.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB microtiter plate assay
    Cytotoxicity against human A549 cells by SRB microtiter plate assay
    		[PMID: 17585747]
    A549 ED50
    10.6 3
    Compound: 1
    Dose required for reduction in human lung A549 cancer cells after 3 days incubation
    Dose required for reduction in human lung A549 cancer cells after 3 days incubation
    		[PMID: 15456257]
    A549 ED50
    1.5 6
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB method
    Cytotoxicity against human A549 cells by SRB method
    		[PMID: 16252909]
    A549 ED50
    1900 1
    Compound: Etoposide
    In vitro cytotoxicity against A549 (human lung carcinoma) cell line.
    In vitro cytotoxicity against A549 (human lung carcinoma) cell line.
    		[PMID: 12419378]
    A549 GI50
    1.5 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    A549 ED50
    2.9 6
    Compound: VP-16
    Inhibition of growth of lung non-small cell carcinoma A-549 cell line
    Inhibition of growth of lung non-small cell carcinoma A-549 cell line
    		[PMID: 8389875]
    A549 GI50
    1.5 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    A549 ED50
    3.39 3
    Compound: Etoposide
    Effective dose on human lung carcinoma (A549) cells
    Effective dose on human lung carcinoma (A549) cells
    		[PMID: 15914002]
    A549 GI50
    1.7 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    A549 ED50
    3.76 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 16441087]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by resazurin assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by resazurin assay
    		[PMID: 26592897]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human A549 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    A549 IC50
    1.71 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24095018]
    A549 GI50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    A549 IC50
    1.74 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    A549 GI50
    1.5 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 26988298]
    A549 GI50
    1.5 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    		[PMID: 37531922]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Anticancer activity against human A549 cells by SRB assay
    Anticancer activity against human A549 cells by SRB assay
    		[PMID: 21420296]
    A549 GI50
    1.5 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 21182258]
    A549 GI50
    1.7 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    A549 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    A549 GI50
    10 3
    Compound: ETP
    Cytotoxicity against human A549 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    		[PMID: 35580424]
    A549 IC50
    1.97 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    A549 GI50
    2.2 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by SRB assay
    Growth inhibition of human A549 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    A549 GI50
    10 3
    Compound: ETP
    Cytotoxicity against human A549 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    		[PMID: 35580424]
    A549 GI50
    3.08 3
    Compound: 2
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    A549 IC50
    10.12 3
    Compound: Etoposideg
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    A549 GI50
    3.08 3
    Compound: 2, Eto
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    A549 IC50
    10.12 3
    Compound: 2
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    A549 GI50
    3.08 3
    Compound: 2, Eto
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    A549 IC50
    10.44 3
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    A549 GI50
    3.08 3
    Compound: 2, VP-16
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    A549 ED50
    10.6 3
    Compound: 1
    Dose required for reduction in human lung A549 cancer cells after 3 days incubation
    Dose required for reduction in human lung A549 cancer cells after 3 days incubation
    		[PMID: 15456257]
    A549 GI50
    3.08 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    A549 IC50
    10.71 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    A549 IC50
    100 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    A549 GI50
    4.46 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    A549 IC50
    11 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 21397370]
    A549 IC50
    0.1 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    A549 IC50
    11.92 3
    Compound: 2
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    A549 IC50
    0.16 3
    Compound: Etoposide
    Inhibitory activity against A549 cell line using MTT assay(Wild type p53)
    Inhibitory activity against A549 cell line using MTT assay(Wild type p53)
    		[PMID: 10780913]
    A549 IC50
    13.71 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    A549 IC50
    0.24 3
    Compound: Etoposide
    Cytotoxicity in human A549 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human A549 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    A549 IC50
    13.78 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    A549 IC50
    0.29 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs
    Cytotoxicity against human A549 cells after 48 hrs
    		[PMID: 20053564]
    A549 IC50
    14.3 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Growth inhibition of human A549 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    A549 IC50
    14.3 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    A549 IC50
    14.7 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    A549 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    A549 IC50
    14.8 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    A549 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    A549 IC50
    14.9 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    A549 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    0.32 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    A549 IC50
    16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
    Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
    		[PMID: 20413315]
    A549 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    A549 IC50
    0.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    A549 IC50
    16.6 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    A549 IC50
    0.44 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    		[PMID: 21936523]
    A549 IC50
    18.2 3
    Compound: Etop
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 26216018]
    A549 IC50
    0.47 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    A549 IC50
    19.83 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    A549 IC50
    0.48 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    A549 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    A549 IC50
    0.48 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    		[PMID: 26225905]
    A549 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    A549 IC50
    0.5 3
    Compound: VP-16
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 11473438]
    A549 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human lung adenocarcinoma cell line A549 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human lung adenocarcinoma cell line A549 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    A549 IC50
    0.59 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    A549 IC50
    2.17 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    A549 IC50
    0.59 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    A549 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    A549 IC50
    0.6 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    A549 GI50
    2.2 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by SRB assay
    Growth inhibition of human A549 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    A549 IC50
    0.6 3
    Compound: VP-16
    Cytotoxicity against human A549 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    A549 IC50
    2.27 3
    Compound: V
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    A549 IC50
    0.63 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 24 hrs by SRB assay
    Cytotoxicity against human A549 cells after 24 hrs by SRB assay
    		[PMID: 19769341]
    A549 IC50
    2.34 3
    Compound: 2, Etop
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    A549 IC50
    0.63 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 20415462]
    A549 IC50
    2.4 3
    Compound: Etoposide
    Antiproliferation activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    A549 IC50
    0.63 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19685913]
    A549 IC50
    2.45 3
    Compound: 2
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    A549 IC50
    0.6 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 3 days by MTT assay
    Cytotoxicity against human A549 cells after 3 days by MTT assay
    		[PMID: 21216051]
    A549 IC50
    2.46 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    A549 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    A549 IC50
    2.56 1
    Compound: 1, VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 21145139]
    A549 IC50
    0.71 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    A549 IC50
    2.58 3
    Compound: 2
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    A549 IC50
    0.72 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    A549 IC50
    2.58 3
    Compound: 3
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    A549 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    A549 IC50
    2.58 3
    Compound: 3
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    A549 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human A549 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    A549 IC50
    2.675 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    A549 IC50
    0.8 3
    Compound: etoposide
    Antiproliferative activity at human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity at human A549 cells after 72 hrs by MTT assay
    		[PMID: 22861499]
    A549 IC50
    2.8 3
    Compound: 2a, VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    A549 IC50
    0.8 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    A549 IC50
    2.87 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by Alamar Blue assay
    Cytotoxicity against human A549 cells after 48 hrs by Alamar Blue assay
    		[PMID: 25466187]
    A549 IC50
    0.8 3
    Compound: etoposide
    Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    A549 IC50
    20.9 3
    Compound: etoposide
    Cytotoxicity against human A549 cell line by MTT assay
    Cytotoxicity against human A549 cell line by MTT assay
    		[PMID: 17243725]
    A549 IC50
    21.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    A549 IC50
    0.83 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 20071056]
    A549 IC50
    0.92 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    A549 IC50
    22.5 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    A549 IC50
    1.03 6
    Compound: 1
    Growth inhibition of A549 (human lung carcinoma) cell line.
    Growth inhibition of A549 (human lung carcinoma) cell line.
    		[PMID: 2002477]
    A549 IC50
    23.8 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    A549 IC50
    1.06 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human lung tumor cell line A549 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human lung tumor cell line A549 after 72 hr of incubation was determined
    		[PMID: 15482917]
    A549 IC50
    23.94 3
    Compound: VP16; 2
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    A549 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    24.31 3
    Compound: vp16
    Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    A549 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    A549 IC50
    24.9 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 22244588]
    A549 IC50
    24.9 3
    Compound: 5, VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 22041063]
    A549 IC50
    1.16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 17194596]
    A549 IC50
    1.16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    Cytotoxicity against human A549 cells after 3 days by SRB assay
    		[PMID: 18321715]
    A549 IC50
    241.9 3
    Compound: Etoposide
    Antiproliferative against human A549 cells after 48 hrs by MTT assay
    Antiproliferative against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    A549 IC50
    25.6 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    A549 IC50
    1.2 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs
    Cytotoxicity against human A549 cells after 48 hrs
    		[PMID: 19115839]
    A549 IC50
    1.3 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    A549 IC50
    29.7 3
    Compound: VP16
    Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    A549 IC50
    1.3 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 32196342]
    A549 IC50
    3.01 3
    Compound: Etoposide
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    A549 IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity in human A549 cells by SRB assay
    Cytotoxicity in human A549 cells by SRB assay
    		[PMID: 26812172]
    A549 IC50
    3.08 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    A549 IC50
    1.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells by SRB microtiter plate assay
    Cytotoxicity against human A549 cells by SRB microtiter plate assay
    		[PMID: 17585747]
    A549 IC50
    3.08 3
    Compound: Etoposide
    Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human A549 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    A549 GI50
    3.08 3
    Compound: 2, Eto
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    Cytotoxicity against human A549 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    A549 GI50
    3.08 3
    Compound: 2, Eto
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    A549 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by resazurin assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by resazurin assay
    		[PMID: 26592897]
    A549 GI50
    3.08 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    A549 IC50
    1.71 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24095018]
    A549 GI50
    3.08 3
    Compound: 2, VP-16
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    A549 IC50
    1.74 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    Cytotoxicity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    A549 GI50
    3.08 3
    Compound: 2
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 21182258]
    A549 IC50
    3.2 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Anticancer activity against human A549 cells by SRB assay
    Anticancer activity against human A549 cells by SRB assay
    		[PMID: 21420296]
    A549 IC50
    3.2 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    A549 IC50
    1.85 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by SRB assay
    Cytotoxicity against human A549 cells by SRB assay
    		[PMID: 26988298]
    A549 IC50
    3.25 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    A549 ED50
    3.76 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 16441087]
    A549 IC50
    1.9 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 48 hrs by Hoechst 33258 staining based fluorescence assay
    Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 48 hrs by Hoechst 33258 staining based fluorescence assay
    		[PMID: 38718553]
    A549 IC50
    1.97 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    A549 IC50
    3.82 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    A549 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) A549 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) A549 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    A549 IC50
    10 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
    		[PMID: 37676247]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Growth inhibition of human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Growth inhibition of human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		10.1039/C5MD00314H
    A549 IC50
    10.12 3
    Compound: 2
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    A549 IC50
    10.12 3
    Compound: Etoposideg
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    A549 IC50
    32.05 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    A549 IC50
    32.61 3
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    A549 IC50
    10.44 3
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    A549 IC50
    10.71 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    A549 IC50
    38.5 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    A549 IC50
    100 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    A549 GI50
    4.46 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    A549 IC50
    11 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 21397370]
    A549 IC50
    4.7 3
    Compound: Etoposide
    Anticancer activity against human A549 cells by MTT assay
    Anticancer activity against human A549 cells by MTT assay
    		10.1039/C4MD00279B
    A549 IC50
    11.92 3
    Compound: 2
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    A549 IC50
    4.8 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    		[PMID: 34786945]
    A549 IC50
    13.71 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    A549 IC50
    4.9 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 3 days by MTT assay
    Antiproliferative activity against human A549 cells incubated for 3 days by MTT assay
    		[PMID: 32992133]
    A549 IC50
    13.78 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    A549 IC50
    5.62 3
    Compound: 2
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    A549 IC50
    14.3 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    A549 IC50
    5.62 3
    Compound: 2
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    		[PMID: 17988764]
    A549 IC50
    14.3 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    A549 IC50
    5.87 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    A549 IC50
    14.7 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    A549 IC50
    5.9 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    A549 IC50
    14.8 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    A549 IC50
    50 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    A549 IC50
    14.9 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    A549 IC50
    6 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    A549 IC50
    15.1 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human A549 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    A549 IC50
    6.21 3
    Compound: 2
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    A549 IC50
    6.74 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    A549 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    16 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
    Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
    		[PMID: 20413315]
    A549 IC50
    67.25 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    A549 IC50
    16.6 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    A549 IC50
    68 3
    Compound: Eto
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    A549 IC50
    167.97 3
    Compound: VP-16
    Cytotoxicity against human A549 cells
    Cytotoxicity against human A549 cells
    		[PMID: 24775914]
    A549 IC50
    8.01 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 36 hrs by MTT assay
    Cytotoxicity against human A549 cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    A549 IC50
    170 1
    Compound: 1a
    In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line
    In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line
    		[PMID: 14980682]
    A549 IC50
    8.37 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 18844422]
    A549 IC50
    18.2 3
    Compound: Etop
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 26216018]
    A549 IC50
    8.9 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    A549 IC50
    19.83 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    A549 IC50
    8.91 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    A549 IC50
    9.1 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    A549 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    Growth inhibition of human A549 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    A549 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    A549 IC50
    9.3 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    A549 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human lung adenocarcinoma cell line A549 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human lung adenocarcinoma cell line A549 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 2 days by MTT assay
    Cytotoxicity against human A549 cells after 2 days by MTT assay
    		[PMID: 22325897]
    A549 IC50
    2.17 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 19782567]
    A549 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 19036584]
    A549 IC50
    2.27 3
    Compound: V
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    A549 IC50
    9.98 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction of cell growth by SRB method
    Cytotoxicity against human A549 cells assessed as reduction of cell growth by SRB method
    		[PMID: 18782668]
    A549 IC50
    2.27 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 38107170]
    A549 IC50
    9469.5 1
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    A549 IC50
    2.34 3
    Compound: 2, Etop
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    ACHN IC50
    2.04 3
    Compound: 2
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    A549 IC50
    2.4 3
    Compound: Etoposide
    Antiproliferation activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    ACHN IC50
    2.15 3
    Compound: VP-16
    Antiproliferative activity against human ACHN cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human ACHN cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    A549 IC50
    2.45 3
    Compound: 2
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    ACHN IC50
    2.15 3
    Compound: VP-16
    Antiproliferative activity against human ACHN cells after 96 hrs by MTT assay
    Antiproliferative activity against human ACHN cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    ACHN IC50
    7.61 3
    Compound: 2, Etop
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    A549 IC50
    2.46 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    A549 IC50
    2.56 1
    Compound: 1, VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 21145139]
    ACHN IC50
    7.61 3
    Compound: 2a, VP-16
    Cytotoxicity against human ACHN cells after 72 hrs by MTT assay
    Cytotoxicity against human ACHN cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    A549 IC50
    2.58 3
    Compound: 2
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Anticancer activity against human AGS cells after 3 days by MTT assay
    Anticancer activity against human AGS cells after 3 days by MTT assay
    		[PMID: 21621882]
    A549 IC50
    2.58 3
    Compound: 3
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    		[PMID: 19419803]
    A549 IC50
    2.58 3
    Compound: 3
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    		[PMID: 19013074]
    A549 IC50
    2.675 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    A549 IC50
    2.8 3
    Compound: 2a, VP-16
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    A549 IC50
    2.87 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by Alamar Blue assay
    Cytotoxicity against human A549 cells after 48 hrs by Alamar Blue assay
    		[PMID: 25466187]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    A549 IC50
    20.9 3
    Compound: etoposide
    Cytotoxicity against human A549 cell line by MTT assay
    Cytotoxicity against human A549 cell line by MTT assay
    		[PMID: 17243725]
    AGS IC50
    0.36 3
    Compound: etoposide
    Antitumor against human AGS cells after 72 hrs by MTT assay
    Antitumor against human AGS cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    A549 IC50
    21.4 3
    Compound: etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    Astrocyte IC50
    > 10 3
    Compound: Etoposide
    Cytotoxicity against normal human astrocytes assessed as cell viability incubated for 72 hrs by WST-1 method
    Cytotoxicity against normal human astrocytes assessed as cell viability incubated for 72 hrs by WST-1 method
    		[PMID: 26355532]
    A549 IC50
    22.5 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    Astrocyte EC50
    0.433 3
    Compound: 2
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    		[PMID: 17417631]
    A549 IC50
    23.8 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    B16 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human B16 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human B16 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    B16 IC50
    0.13 3
    Compound: Etoposide
    Cytotoxicity activity against mouse B16 cells after 48 hrs by NRU assay
    Cytotoxicity activity against mouse B16 cells after 48 hrs by NRU assay
    		[PMID: 20570625]
    A549 IC50
    23.94 3
    Compound: VP16; 2
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    A549 IC50
    24.31 3
    Compound: vp16
    Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    B16 IC50
    0.28 3
    Compound: etoposide
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    		[PMID: 19919064]
    A549 IC50
    24.9 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 22244588]
    B16 IC50
    0.32 3
    Compound: ETP
    Cytotoxic activity against solid tumor, B16 (murine melanoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, B16 (murine melanoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    A549 IC50
    24.9 3
    Compound: 5, VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 22041063]
    B16 IC50
    1.39 3
    Compound: 2a, VP-16
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    A549 IC50
    241.9 3
    Compound: Etoposide
    Antiproliferative against human A549 cells after 48 hrs by MTT assay
    Antiproliferative against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    B16 IC50
    1.85 3
    Compound: 2
    Cytotoxicity against human B16 cells after 48 hrs by MTT assay
    Cytotoxicity against human B16 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    A549 IC50
    25.6 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    B16 IC50
    9 3
    Compound: Etoposide
    Cytotoxicity activity against mouse B16 cells after 24 hrs by NRU assay
    Cytotoxicity activity against mouse B16 cells after 24 hrs by NRU assay
    		[PMID: 20570625]
    A549 IC50
    29.7 3
    Compound: VP16
    Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    B16-F10 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human B16-F10 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human B16-F10 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    A549 IC50
    3.01 3
    Compound: Etoposide
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    Anticancer activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    B16-F10 IC50
    18.69 3
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    A549 IC50
    3.08 3
    Compound: Etoposide
    Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    B16-F10 IC50
    18.71 3
    Compound: Etoposide
    Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
    Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    A549 IC50
    3.08 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    B16-F10 IC50
    3.8 6
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    A549 IC50
    3.08 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    		[PMID: 38784476]
    B16-F10 IC50
    4.12 6
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    A549 IC50
    3.2 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    Bel-7402 IC50
    1.03 3
    Compound: etoposide
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    		[PMID: 19685913]
    A549 IC50
    3.2 3
    Compound: 2, VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    Bel-7402 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human Bel7402 cells after 5 days by MTT assay
    Cytotoxicity against human Bel7402 cells after 5 days by MTT assay
    		[PMID: 8778240]
    BEL-7404 tumor cell line IC50
    7.76 3
    Compound: Etoposide
    Antiproliferative activity against human Bel-7404 tumor cell line assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human Bel-7404 tumor cell line assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    A549 IC50
    3.25 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    A549 IC50
    3.82 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    BGC-823 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human BGC-823 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human BGC-823 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    BGC-823 IC50
    2.88 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human BGC-823 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human BGC-823 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) A549 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) A549 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    BGC-823 IC50
    30.74 3
    Compound: VP-16
    Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
    Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    A549 IC50
    3.9 3
    Compound: Etoposide
    Growth inhibition of human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Growth inhibition of human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		10.1039/C5MD00314H
    BT-474 IC50
    6.6 3
    Compound: Etoposide
    Antiproliferative activity against human BT474 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human BT474 cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    A549 IC50
    32.05 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    BT-549 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    A549 IC50
    32.61 3
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    BT-549 IC50
    1.24 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    A549 IC50
    38.5 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    BT-549 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human BT549 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    BV-173 IC50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human BV173 cells after 72 hrs by MTT assay
    Cytotoxicity against human BV173 cells after 72 hrs by MTT assay
    		[PMID: 17459529]
    A549 IC50
    4.7 3
    Compound: Etoposide
    Anticancer activity against human A549 cells by MTT assay
    Anticancer activity against human A549 cells by MTT assay
    		10.1039/C4MD00279B
    A549 IC50
    4.8 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    		[PMID: 34786945]
    C6 IC50
    < 1.85 3
    Compound: vp16
    Antiproliferative activity against human C6 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human C6 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    A549 IC50
    4.9 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human A549 cells incubated for 3 days by MTT assay
    Antiproliferative activity against human A549 cells incubated for 3 days by MTT assay
    		[PMID: 32992133]
    C6 IC50
    4.32 3
    Compound: Etoposide
    Cytotoxicity against rat C6 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against rat C6 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33243532]
    A549 IC50
    5.62 3
    Compound: 2
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    Cytotoxicity against human A549 cells by sulforhodamine B assay
    		[PMID: 17988764]
    C6 EC50
    6.8 x 10-4 41
    Compound: etoposide
    Inhibition of tubulin polymerization in rat C6 cells after 4 hrs
    Inhibition of tubulin polymerization in rat C6 cells after 4 hrs
    		[PMID: 8988604]
    A549 IC50
    5.62 3
    Compound: 2
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    Caco-2 IC50
    18.6 3
    Compound: Etoposide
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    Caco-2 IC50
    9.4 6
    Compound: Etoposide
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    A549 IC50
    5.87 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    A549 IC50
    5.9 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    CAKI-1 ED50
    > 100 3
    Compound: 1
    Dose required for reduction in human renal CAKI-1 cancer cells after 3 days incubation
    Dose required for reduction in human renal CAKI-1 cancer cells after 3 days incubation
    		[PMID: 15456257]
    A549 IC50
    50 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    CAKI-1 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human CAKI-1 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human CAKI-1 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    A549 IC50
    6 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    Calu-1 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    A549 IC50
    6.21 3
    Compound: 2
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human gastric cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human gastric cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    A549 IC50
    6.74 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human lung cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human lung cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    A549 IC50
    664 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against A549 cell line
    In vivo antiproliferative activity against A549 cell line
    		[PMID: 15084135]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human colon cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human colon cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    A549 IC50
    67.25 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    CAPAN-1 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    A549 IC50
    68 3
    Compound: Eto
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    CCD-18Co IC50
    18.42 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-18Co cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human CCD-18Co cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    A549 IC50
    8.01 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 36 hrs by MTT assay
    Cytotoxicity against human A549 cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    CCD-18Co IC50
    20.3 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-18Co cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human CCD-18Co cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    CCD-18Co IC50
    43.6 6
    Compound: Etoposide
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    A549 IC50
    8.37 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 18844422]
    A549 IC50
    8.91 3
    Compound: VP-16
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    CCD-18Co IC50
    44.4 3
    Compound: Etoposide
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    A549 IC50
    8.9 6
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    CCD-841CoN IC50
    7.6 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-841CoN cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human CCD-841CoN cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    A549 IC50
    9.1 3
    Compound: 2; VP-16
    Cytotoxicity against human A549 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    CCD-841CoN IC50
    8.71 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-841CoN cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human CCD-841CoN cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    A549 IC50
    9.3 3
    Compound: etoposide
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    CCRF-CEM CC50
    0.09 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 19036584]
    CCRF-CEM IC50
    0.12 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 48 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 19782567]
    CCRF-CEM IC50
    0.24 3
    Compound: etoposide
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    A549 IC50
    9.51 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells after 2 days by MTT assay
    Cytotoxicity against human A549 cells after 2 days by MTT assay
    		[PMID: 22325897]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    A549 IC50
    9.9 3
    Compound: VP-16
    Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
    		[PMID: 38107170]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    A549 IC50
    9.98 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction of cell growth by SRB method
    Cytotoxicity against human A549 cells assessed as reduction of cell growth by SRB method
    		[PMID: 18782668]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human CCRF-CEM cells by MTT assay
    Cytotoxicity against human CCRF-CEM cells by MTT assay
    		[PMID: 30543429]
    A549 IC50
    9469.5 1
    Compound: VP-16
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    CCRF-CEM IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    A549 IC50
    > 10 3
    Compound: 3; Etop
    Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    CCRF-CEM IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    A549 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by MTT assay
    Antiproliferative activity against human A549 cells by MTT assay
    		[PMID: 29072457]
    CCRF-CEM GI50
    1.26 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    A549 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    		[PMID: 30543429]
    CCRF-CEM GI50
    1.6 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 72 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    A549 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human A549 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    CCRF-CEM GI50
    1.6 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    A549 IC50
    > 30 3
    Compound: ETP
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    CCRF-CEM IC50
    1146 14
    Compound: Etoposide
    Cytotoxicity was assessed using human leukemic cell line CCRF-CEM
    Cytotoxicity was assessed using human leukemic cell line CCRF-CEM
    		[PMID: 11170627]
    A549 IC50
    > 50 3
    Compound: Etoposide
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 31404864]
    CCRF-CEM GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    A549 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human A549 cells after 48 hrs by SRB assay
    Anticancer activity against human A549 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    CCRF-SB IC50
    0.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-SB cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human CCRF-SB cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    A549 IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human A549 cells by SRB assay
    Antiproliferative activity against human A549 cells by SRB assay
    		[PMID: 31546197]
    CCRF-SB CC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    CCRF-SB IC50
    0.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    CHO IC50
    0.35 3
    Compound: ETP
    Cytotoxic activity against solid tumor, CHO (Chinese hamster ovaric carcinoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, CHO (Chinese hamster ovaric carcinoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    COLO 205 GI50
    0.13 3
    Compound: 2, Eto
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    COLO 205 GI50
    0.13 3
    Compound: 2, Eto
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    COLO 205 GI50
    0.13 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    COLO 205 GI50
    0.13 3
    Compound: 2, VP-16
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    ACHN ED50
    13 6
    Compound: VP-16
    Inhibition of growth of renal cancer ACHN cell line
    Inhibition of growth of renal cancer ACHN cell line
    		[PMID: 8389875]
    COLO 205 GI50
    0.13 3
    Compound: 2
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    COLO 205 IC50
    0.43 3
    Compound: Etoposide
    Antiproliferative activity against human COLO205 cells after 48 hrs by MTT assay
    Antiproliferative activity against human COLO205 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    ACHN IC50
    2.04 3
    Compound: 2
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    ACHN IC50
    2.15 3
    Compound: VP-16
    Antiproliferative activity against human ACHN cells after 96 hrs by MTT assay
    Antiproliferative activity against human ACHN cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    COLO 205 IC50
    0.47 3
    Compound: Etoposide
    Anticancer activity against human COLO205 cells by MTT assay
    Anticancer activity against human COLO205 cells by MTT assay
    		10.1039/C4MD00279B
    ACHN IC50
    2.15 3
    Compound: VP-16
    Antiproliferative activity against human ACHN cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human ACHN cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    COLO 205 IC50
    1.07 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    ACHN IC50
    7.61 3
    Compound: 2, Etop
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    Anticancer activity against human ACHN cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    COLO 205 IC50
    12.3 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    ACHN IC50
    7.61 3
    Compound: 2a, VP-16
    Cytotoxicity against human ACHN cells after 72 hrs by MTT assay
    Cytotoxicity against human ACHN cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    COLO 205 IC50
    14.23 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human COLO205 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    COLO 205 IC50
    5.12 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    		[PMID: 19013074]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    COLO 205 IC50
    5.3 3
    Compound: Etoposide
    Cytotoxicity against human colon cancer line COLO205 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human colon cancer line COLO205 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    Cytotoxicity against human AGS cells after 3 days by MTT assay
    		[PMID: 19419803]
    COLO 205 IC50
    7.24 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    CWR22R IC50
    0.364 3
    Compound: 2
    Antiproliferative activity against human 22Rv1 cells after 96 hrs by propidium iodide-based monolayer assay
    Antiproliferative activity against human 22Rv1 cells after 96 hrs by propidium iodide-based monolayer assay
    		[PMID: 26854430]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Anticancer activity against human AGS cells after 3 days by MTT assay
    Anticancer activity against human AGS cells after 3 days by MTT assay
    		[PMID: 21621882]
    DLD-1 IC50
    0.57 3
    Compound: Etoposide
    Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    		[PMID: 34786945]
    AGS IC50
    0.36 3
    Compound: Etoposide
    Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    DLD-1 IC50
    10 3
    Compound: etoposide
    Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
    Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
    		[PMID: 20413315]
    AGS IC50
    0.36 3
    Compound: etoposide
    Antitumor against human AGS cells after 72 hrs by MTT assay
    Antitumor against human AGS cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    DLD-1 IC50
    2 3
    Compound: Etoposide
    Cytotoxicity against human DLD1 cells assessed as growth inhibition after 48 hrs by resazurin assay
    Cytotoxicity against human DLD1 cells assessed as growth inhibition after 48 hrs by resazurin assay
    		[PMID: 26592897]
    Astrocyte EC50
    0.433 3
    Compound: 2
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    		[PMID: 17417631]
    DLD-1 IC50
    20 3
    Compound: Etoposide
    Growth inhibition of human DLD1 cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    Growth inhibition of human DLD1 cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    		[PMID: 24527835]
    Astrocyte IC50
    > 10 3
    Compound: Etoposide
    Cytotoxicity against normal human astrocytes assessed as cell viability incubated for 72 hrs by WST-1 method
    Cytotoxicity against normal human astrocytes assessed as cell viability incubated for 72 hrs by WST-1 method
    		[PMID: 26355532]
    DLD-1 IC50
    27 3
    Compound: Etoposide
    Cytotoxicity against human DLD1 cells after 48 hrs
    Cytotoxicity against human DLD1 cells after 48 hrs
    		[PMID: 19115839]
    DLD-1 IC50
    3.3 3
    Compound: etoposide
    Cytotoxicity against human DLD1 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    Cytotoxicity against human DLD1 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    		[PMID: 26225905]
    B16 IC50
    0.13 3
    Compound: Etoposide
    Cytotoxicity activity against mouse B16 cells after 48 hrs by NRU assay
    Cytotoxicity activity against mouse B16 cells after 48 hrs by NRU assay
    		[PMID: 20570625]
    DLD-1 IC50
    8.11 3
    Compound: ETP
    Antiproliferative activity against human DLD1 cells after 48 hrs by SRB assay
    Antiproliferative activity against human DLD1 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    B16 IC50
    0.28 3
    Compound: etoposide
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    		[PMID: 19919064]
    DMS-53 IC50
    1.5 3
    Compound: etoposide
    Antiproliferative activity at human DMS53 cells after 72 hrs by MTT assay
    Antiproliferative activity at human DMS53 cells after 72 hrs by MTT assay
    		[PMID: 22861499]
    DU-145 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 30543429]
    B16 IC50
    0.32 3
    Compound: ETP
    Cytotoxic activity against solid tumor, B16 (murine melanoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, B16 (murine melanoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    B16 IC50
    1.39 3
    Compound: 2a, VP-16
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    DU-145 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells after 48 hrs by SRB assay
    Anticancer activity against human DU145 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    B16 IC50
    1.85 3
    Compound: 2
    Cytotoxicity against human B16 cells after 48 hrs by MTT assay
    Cytotoxicity against human B16 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    DU-145 IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells by SRB assay
    Antiproliferative activity against human DU145 cells by SRB assay
    		[PMID: 31546197]
    B16 IC50
    9 3
    Compound: Etoposide
    Cytotoxicity activity against mouse B16 cells after 24 hrs by NRU assay
    Cytotoxicity activity against mouse B16 cells after 24 hrs by NRU assay
    		[PMID: 20570625]
    DU-145 IC50
    0.001 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    DU-145 IC50
    0.02 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    B16 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human B16 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human B16 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    DU-145 IC50
    0.4 3
    Compound: VP-16
    Antiproliferative activity against human DU145 cells assessed as cell viability incubated for 72 hrs by MTT assay
    Antiproliferative activity against human DU145 cells assessed as cell viability incubated for 72 hrs by MTT assay
    		[PMID: 25799376]
    DU-145 CC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 96 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human DU145 cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    B16-F10 IC50
    18.69 3
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferation activity against human DU145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human DU145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 21601964]
    B16-F10 IC50
    18.71 3
    Compound: Etoposide
    Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
    Antiproliferative activity against mouse B16F10 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    B16-F10 IC50
    3.8 6
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human DU145 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    B16-F10 IC50
    4.12 6
    Compound: Etoposide
    Cytotoxicity against mouse B16F10 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against mouse B16F10 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    DU-145 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    B16-F10 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human B16-F10 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human B16-F10 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    DU-145 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells by MTT assay
    Antiproliferative activity against human DU145 cells by MTT assay
    		[PMID: 32196342]
    BEAS-2B IC50
    21 3
    Compound: VP-16
    Antiproliferative activity against human BEAS-2B cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human BEAS-2B cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    DU-145 IC50
    1.15 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human DU145 cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    BEAS-2B IC50
    > 10 3
    Compound: 3; Etop
    Antiproliferative activity against human BEAS-2B cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human BEAS-2B cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    DU-145 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human DU145 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    BGC-823 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human BGC-823 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human BGC-823 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    DU-145 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by ELISA reader assay
    Cytotoxicity against human DU145 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    BGC-823 IC50
    2.88 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human BGC-823 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human BGC-823 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    DU-145 IC50
    1.42 3
    Compound: ETO
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    BGC-823 IC50
    25.72 3
    Compound: VP-16
    Cytotoxicity against human BGC823 cells
    Cytotoxicity against human BGC823 cells
    		[PMID: 24775914]
    DU-145 IC50
    1.44 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 21115246]
    BGC-823 IC50
    30.74 3
    Compound: VP-16
    Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
    Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    DU-145 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 ATCC HTB 81 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 ATCC HTB 81 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    BT-474 IC50
    6.6 3
    Compound: Etoposide
    Antiproliferative activity against human BT474 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human BT474 cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    DU-145 IC50
    1.63 3
    Compound: etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    DU-145 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    BT-549 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    DU-145 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    BT-549 IC50
    1.24 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    BT-549 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human BT549 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human BT549 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    DU-145 IC50
    1.97 3
    Compound: V
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    DU-145 IC50
    1.98 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    BV-173 IC50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human BV173 cells after 72 hrs by MTT assay
    Cytotoxicity against human BV173 cells after 72 hrs by MTT assay
    		[PMID: 17459529]
    Bel-7402 IC50
    0.08 3
    Compound: etoposide
    Cytotoxicity against human Bel7402 cells
    Cytotoxicity against human Bel7402 cells
    		[PMID: 23092389]
    DU-145 IC50
    10.64 3
    Compound: ETP
    Antiproliferative activity against human DU145 cells after 48 hrs by SRB assay
    Antiproliferative activity against human DU145 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    Bel-7402 IC50
    1.03 3
    Compound: etoposide
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    		[PMID: 19685913]
    DU-145 GI50
    13 3
    Compound: ETP
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    		[PMID: 35580424]
    DU-145 IC50
    13.1 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    Bel-7402 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human Bel7402 cells after 5 days by MTT assay
    Cytotoxicity against human Bel7402 cells after 5 days by MTT assay
    		[PMID: 8778240]
    C-33-A IC50
    0.084 6
    Compound: Etoposide
    Cytotoxic activity against human C-33A cervix tumor cell line
    Cytotoxic activity against human C-33A cervix tumor cell line
    		[PMID: 15149673]
    DU-145 IC50
    13.8 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by MTT assay
    Cytotoxicity against human DU145 cells after 4 days by MTT assay
    		[PMID: 20619511]
    C6 EC50
    6.8 x 10-4 41
    Compound: etoposide
    Inhibition of tubulin polymerization in rat C6 cells after 4 hrs
    Inhibition of tubulin polymerization in rat C6 cells after 4 hrs
    		[PMID: 8988604]
    DU-145 IC50
    13.85 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 24904965]
    C6 IC50
    4.32 3
    Compound: Etoposide
    Cytotoxicity against rat C6 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against rat C6 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33243532]
    DU-145 IC50
    16.43 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    C6 IC50
    < 1.85 3
    Compound: vp16
    Antiproliferative activity against human C6 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human C6 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    DU-145 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    DU-145 IC50
    2.03 3
    Compound: 2
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    CAKI-1 ED50
    2.2 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human renal cancer(CAKI-1) cell line
    The compound was tested for tumor cell growth inhibitory activity against human renal cancer(CAKI-1) cell line
    		[PMID: 10395485]
    DU-145 IC50
    2.03 3
    Compound: 3
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    CAKI-1 ED50
    > 100 3
    Compound: 1
    Dose required for reduction in human renal CAKI-1 cancer cells after 3 days incubation
    Dose required for reduction in human renal CAKI-1 cancer cells after 3 days incubation
    		[PMID: 15456257]
    DU-145 IC50
    2.03 3
    Compound: 3
    Cytotoxicity against human DU145 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human DU145 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    CAKI-1 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human CAKI-1 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human CAKI-1 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    DU-145 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by CCK8 assay
    Cytotoxicity against human DU145 cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    CAPAN-1 IC50
    0.15 3
    Compound: Etoposide
    Cytostatic activity against human Capan1 cells
    Cytostatic activity against human Capan1 cells
    		[PMID: 30738653]
    DU-145 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells measured on day 4 by CCK8 assay
    Cytotoxicity against human DU145 cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    CAPAN-1 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    DU-145 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human DU-145 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human DU-145 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    CCD-18Co IC50
    18.42 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-18Co cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human CCD-18Co cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    DU-145 IC50
    2.13 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    CCD-18Co IC50
    20.3 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-18Co cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human CCD-18Co cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    DU-145 IC50
    2.19 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human DU145 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    CCD-18Co IC50
    43.6 6
    Compound: Etoposide
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    DU-145 IC50
    2.19 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 21419530]
    CCD-18Co IC50
    44.4 3
    Compound: Etoposide
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    Cytotoxicity against human CCD-18Co cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    DU-145 IC50
    2.35 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    CCD-841CoN IC50
    7.6 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-841CoN cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human CCD-841CoN cells assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    DU-145 IC50
    2.4 3
    Compound: etoposide
    Cytotoxicity against human DU145 cells by SRB microtiter plate assay
    Cytotoxicity against human DU145 cells by SRB microtiter plate assay
    		[PMID: 17585747]
    CCD-841CoN IC50
    8.71 3
    Compound: Etoposide
    Antiproliferative activity against human CCD-841CoN cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human CCD-841CoN cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    DU-145 IC50
    2.47 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    CCRF-CEM CC50
    0.09 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    DU-145 IC50
    2.94 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 22318164]
    DU-145 IC50
    21.07 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 3 days
    Cytotoxicity against human DU145 cells after 3 days
    		[PMID: 19954977]
    CCRF-CEM GI50
    1.26 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    CCRF-CEM GI50
    1.6 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    DU-145 IC50
    3 3
    Compound: VP16
    Cytotoxicity against human DU145 cells after 96 hrs
    Cytotoxicity against human DU145 cells after 96 hrs
    		[PMID: 22276775]
    CCRF-CEM GI50
    1.6 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 72 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    DU-145 IC50
    3.1 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    CCRF-CEM GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    DU-145 IC50
    3.17 3
    Compound: 2
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    CCRF-CEM IC50
    0.002 3
    Compound: VP-16
    Tested for the inhibitory activity against CCRF CEM T- cell leukemia cells
    Tested for the inhibitory activity against CCRF CEM T- cell leukemia cells
    		[PMID: 7932571]
    DU-145 IC50
    3.7 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    CCRF-CEM IC50
    0.12 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-CEM cells after 48 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    DU-145 IC50
    3.85 3
    Compound: 2
    Cytotoxicity against human DU145 cells by sulforhodamine B assay
    Cytotoxicity against human DU145 cells by sulforhodamine B assay
    		[PMID: 17988764]
    CCRF-CEM IC50
    0.24 3
    Compound: etoposide
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    DU-145 IC50
    4.13 3
    Compound: Etopo
    Antiproliferative activity against human DU-145 cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human DU-145 cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    DU-145 IC50
    5.16 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 19836231]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    DU-145 IC50
    5.21 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    CCRF-CEM IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human CCRF-CEM cells by MTT assay
    Cytotoxicity against human CCRF-CEM cells by MTT assay
    		[PMID: 30543429]
    DU-145 IC50
    6.17 6
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    CCRF-CEM IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-CEM cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    DU-145 IC50
    64.26 3
    Compound: Etoposideg
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    CCRF-CEM IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human CCRF-CEM cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    DU-145 IC50
    64.26 3
    Compound: 2
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    CCRF-CEM IC50
    1146 14
    Compound: Etoposide
    Cytotoxicity was assessed using human leukemic cell line CCRF-CEM
    Cytotoxicity was assessed using human leukemic cell line CCRF-CEM
    		[PMID: 11170627]
    DU-145 IC50
    9.29 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    DU-145 IC50
    9.8 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34479036]
    DU-145 IC50
    9.8 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    DU-145 IC50
    9.8 3
    Compound: VP-16
    Cytotoxicity against human DU145 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human DU145 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    EBC-1 IC50
    15.7 3
    Compound: Etoposide
    Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    EL4 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    EL4 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    CCRF-SB CC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    F460pv8/eto IC50
    0.74 3
    Compound: Etoposide
    Inhibitory activity against F460pv8/eto cell line using MTT assay
    Inhibitory activity against F460pv8/eto cell line using MTT assay
    		[PMID: 10780913]
    CCRF-SB IC50
    0.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    Antiproliferative activity against human CCRF-SB cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    FaDu IC50
    16.01 3
    Compound: ETP
    Antiproliferative activity against human FADU cells after 48 hrs by SRB assay
    Antiproliferative activity against human FADU cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    CCRF-SB IC50
    0.1 3
    Compound: VP-16
    Antiproliferative activity against human CCRF-SB cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human CCRF-SB cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    FHC IC50
    49.31 6
    Compound: Etoposide
    Cytotoxicity against human FHC cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human FHC cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    G-361 IC50
    2.3 3
    Compound: VP-16
    Antiproliferative activity against human G-361 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human G-361 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    G-361 IC50
    3.8 3
    Compound: Etoposide
    Antiproliferation activity against human G361 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human G361 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    CHO IC50
    0.35 3
    Compound: ETP
    Cytotoxic activity against solid tumor, CHO (Chinese hamster ovaric carcinoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, CHO (Chinese hamster ovaric carcinoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    GLC4 cell line IC50
    0.82 3
    Compound: Etoposide
    Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on continuous incubation
    Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on continuous incubation
    		[PMID: 7783142]
    GLC4 cell line IC50
    4 3
    Compound: Etoposide
    Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on 2 hr incubation
    Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on 2 hr incubation
    		[PMID: 7783142]
    H69AR IC50
    30 6
    Compound: Etoposide
    Cytotoxicity against human H69AR cells after 3 days by MTT assay
    Cytotoxicity against human H69AR cells after 3 days by MTT assay
    		[PMID: 21216051]
    COLO ED50
    59 6
    Compound: VP-16
    Inhibition of growth of colon carcinoma COLO 2-1 cell line
    Inhibition of growth of colon carcinoma COLO 2-1 cell line
    		[PMID: 8389875]
    H69AR IC50
    45.9 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H69AR cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human NCI-H69AR cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33276991]
    HaCaT IC50
    0.55 3
    Compound: etoposide
    Cytotoxicity against human HaCaT cells after 72 hrs by MTT assay
    Cytotoxicity against human HaCaT cells after 72 hrs by MTT assay
    		[PMID: 19919064]
    HaCaT IC50
    6 3
    Compound: 1
    Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    HBL-100 GI50
    1.4 3
    Compound: Etoposide
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    HBL-100 GI50
    1.4 3
    Compound: VP-16
    Cytotoxicity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    HBL-100 GI50
    1.4 3
    Compound: Etoposide
    Growth inhibition of human HBL100 cells after 48 hrs by SRB assay
    Growth inhibition of human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    HBL-100 GI50
    1.9 3
    Compound: VP-16
    Antiproliferative activity against human HBL100 cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    HBL-100 GI50
    2.3 3
    Compound: VP-16
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    HBL-100 GI50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    HCC70 IC50
    > 50 3
    Compound: Etoposide
    Antiproliferative activity against human HCC70 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human HCC70 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    HCC70 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HCC70 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human HCC70 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    HCCLM9 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HCCLM9 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HCCLM9 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HCT-116 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    HCT-116 IC50
    > 10 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    HCT-116 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human HCT116 cells by MTT assay
    Cytotoxicity against human HCT116 cells by MTT assay
    		[PMID: 30543429]
    HCT-116 IC50
    > 20 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 24 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 24 hrs by SRB assay
    		[PMID: 26595875]
    HCT-116 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human HCT116 cells after 48 hrs by SRB assay
    Anticancer activity against human HCT116 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HCT-116 IC50
    0.25 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    COLO 205 GI50
    0.13 3
    Compound: 2
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    HCT-116 IC50
    0.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    COLO 205 GI50
    0.13 3
    Compound: 2, Eto
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    HCT-116 IC50
    0.34 6
    Compound: 1
    Compound was tested for its in vitro cytotoxicity in HCT116 cell line after 72 hours
    Compound was tested for its in vitro cytotoxicity in HCT116 cell line after 72 hours
    		10.1016/S0960-894X(00)80646-0
    COLO 205 GI50
    0.13 3
    Compound: 2, Eto
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    HCT-116 IC50
    0.37 3
    Compound: VP-16
    Antiproliferative activity against doxorubicin sensitive human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against doxorubicin sensitive human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    COLO 205 GI50
    0.13 3
    Compound: 2, VP-16
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    HCT-116 IC50
    0.38 3
    Compound: VP-16
    Cytotoxicity against human HCT-116 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human HCT-116 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    COLO 205 GI50
    0.13 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    HCT-116 IC50
    0.41 3
    Compound: EP
    Growth inhibition human HCT116 cells after 72 hrs by MTS assay
    Growth inhibition human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 30633861]
    COLO 205 GI50
    18.1 3
    Compound: Etoposide
    In vitro cytotoxicity against human colon cancer COLO 205 cell line
    In vitro cytotoxicity against human colon cancer COLO 205 cell line
    		[PMID: 9871772]
    HCT-116 IC50
    0.49 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition by MTS assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition by MTS assay
    		[PMID: 28055208]
    COLO 205 IC50
    0.43 3
    Compound: Etoposide
    Antiproliferative activity against human COLO205 cells after 48 hrs by MTT assay
    Antiproliferative activity against human COLO205 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    HCT-116 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    COLO 205 IC50
    0.47 3
    Compound: Etoposide
    Anticancer activity against human COLO205 cells by MTT assay
    Anticancer activity against human COLO205 cells by MTT assay
    		10.1039/C4MD00279B
    HCT-116 IC50
    0.52 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    COLO 205 IC50
    1.07 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    HCT-116 IC50
    0.66 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    COLO 205 IC50
    12.3 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    HCT-116 IC50
    0.68 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    COLO 205 IC50
    14.23 3
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human COLO205 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    HCT-116 IC50
    0.87 3
    Compound: VP-16
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24095018]
    COLO 205 IC50
    5.12 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    HCT-116 IC50
    0.91 3
    Compound: VP-16
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    COLO 205 IC50
    5.3 3
    Compound: Etoposide
    Cytotoxicity against human colon cancer line COLO205 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human colon cancer line COLO205 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    HCT-116 IC50
    1 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTS assay
    		[PMID: 24328269]
    COLO 205 IC50
    7.24 6
    Compound: Etoposide
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    HCT-116 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity in human HCT116 cells by SRB assay
    Cytotoxicity in human HCT116 cells by SRB assay
    		[PMID: 26812172]
    COLO 320DM ED50
    14 6
    Compound: VP-16
    Inhibition of growth of colon carcinoma COLO 320DM
    Inhibition of growth of colon carcinoma COLO 320DM
    		[PMID: 8389875]
    HCT-116 IC50
    1.06 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    CT26 IC50
    0.2 3
    Compound: etoposide
    Antiproliferative activity against mouse CT26 cell line
    Antiproliferative activity against mouse CT26 cell line
    		[PMID: 16686539]
    HCT-116 IC50
    1.06 3
    Compound: Etoposide
    Growth inhibition of human HCT116 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human HCT116 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    CWR22R IC50
    0.364 3
    Compound: 2
    Antiproliferative activity against human 22Rv1 cells after 96 hrs by propidium iodide-based monolayer assay
    Antiproliferative activity against human 22Rv1 cells after 96 hrs by propidium iodide-based monolayer assay
    		[PMID: 26854430]
    HCT-116 IC50
    1.1 3
    Compound: Eto
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    CWR22R IC50
    2.3 3
    Compound: Etoposide
    Cytotoxicity against human 22Rv1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human 22Rv1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 38237151]
    HCT-116 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against p53-expressing human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against p53-expressing human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    HCT-116 IC50
    1.2 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    HCT-116 IC50
    1.22 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    Caco-2 IC50
    18.6 3
    Compound: Etoposide
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    HCT-116 IC50
    1.25 3
    Compound: Etoposide
    Cytotoxicity in human HCT-116 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human HCT-116 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    Caco-2 IC50
    9.4 6
    Compound: Etoposide
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    HCT-116 IC50
    1.36 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    HCT-116 IC50
    1.4 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    HCT-116 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HCT-116 IC50
    1.7 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    HCT-116 IC50
    1.7 3
    Compound: VP16
    Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    HCT-116 IC50
    1.7 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells after 3 days by XTT assay
    Antiproliferative activity against human HCT116 cells after 3 days by XTT assay
    		[PMID: 19691293]
    HCT-116 IC50
    1.7 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells by XTT assay
    Cytotoxicity against human HCT116 cells by XTT assay
    		[PMID: 17368022]
    HCT-116 IC50
    1.78 6
    Compound: 1
    Compound was tested for its in vitro cytotoxicity in HCT-VP35 cell line after 72 hours
    Compound was tested for its in vitro cytotoxicity in HCT-VP35 cell line after 72 hours
    		10.1016/S0960-894X(00)80646-0
    HCT-116 IC50
    1.87 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells by SRB assay
    Cytotoxicity against human HCT116 cells by SRB assay
    		[PMID: 17194596]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    Calu-1 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human Calu-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    HCT-116 IC50
    11.9 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 4 days by MTT assay
    Cytotoxicity against human HCT116 cells after 4 days by MTT assay
    		[PMID: 20619511]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human colon cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human colon cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    HCT-116 IC50
    1200 6
    Compound: etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS reduction assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS reduction assay
    		[PMID: 16441091]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human gastric cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human gastric cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    HCT-116 IC50
    13.5 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) HCT116 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) HCT116 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    HCT-116 IC50
    13.5 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    Cancer cell lines GI50
    1.3 3
    Compound: Etoposide
    Growth inhibition of human lung cancer cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human lung cancer cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20884089]
    DAN-G IC50
    0.38 3
    Compound: Etoposide
    Growth inhibition against human DAN-G cell lines
    Growth inhibition against human DAN-G cell lines
    		[PMID: 15189040]
    HCT-116 IC50
    14.39 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 4 days
    Cytotoxicity against human HCT116 cells after 4 days
    		[PMID: 19800803]
    DLD-1 IC50
    0.57 3
    Compound: Etoposide
    Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst staining based assay
    		[PMID: 34786945]
    HCT-116 IC50
    15.6 3
    Compound: Vp-16
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    DLD-1 IC50
    10 3
    Compound: etoposide
    Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
    Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
    		[PMID: 20413315]
    HCT-116 IC50
    17.92 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 3 days
    Cytotoxicity against human HCT116 cells after 3 days
    		[PMID: 19954977]
    DLD-1 IC50
    2 3
    Compound: Etoposide
    Cytotoxicity against human DLD1 cells assessed as growth inhibition after 48 hrs by resazurin assay
    Cytotoxicity against human DLD1 cells assessed as growth inhibition after 48 hrs by resazurin assay
    		[PMID: 26592897]
    HCT-116 IC50
    2.13 3
    Compound: Vp-16
    Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    DLD-1 IC50
    20 3
    Compound: Etoposide
    Growth inhibition of human DLD1 cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    Growth inhibition of human DLD1 cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    		[PMID: 24527835]
    HCT-116 IC50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 26595875]
    DLD-1 IC50
    27 3
    Compound: Etoposide
    Cytotoxicity against human DLD1 cells after 48 hrs
    Cytotoxicity against human DLD1 cells after 48 hrs
    		[PMID: 19115839]
    HCT-116 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    HCT-116 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against resistant human HCT116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against resistant human HCT116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    DLD-1 IC50
    3.3 3
    Compound: etoposide
    Cytotoxicity against human DLD1 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    Cytotoxicity against human DLD1 cells assessed as inhibition of cell growth incubated for 48 hrs by Hoechst assay
    		[PMID: 26225905]
    DLD-1 IC50
    5.1 3
    Compound: Etoposide
    Cytotoxicity against human DLD-1 cells assessed as inhibition of cell growth measured after 48 hrs by Hoechst 33258 staining based fluorescence assay
    Cytotoxicity against human DLD-1 cells assessed as inhibition of cell growth measured after 48 hrs by Hoechst 33258 staining based fluorescence assay
    		[PMID: 38718553]
    HCT-116 IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    DLD-1 IC50
    8.11 3
    Compound: ETP
    Antiproliferative activity against human DLD1 cells after 48 hrs by SRB assay
    Antiproliferative activity against human DLD1 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    HCT-116 IC50
    25.5 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    DMS-53 IC50
    1.5 3
    Compound: etoposide
    Antiproliferative activity at human DMS53 cells after 72 hrs by MTT assay
    Antiproliferative activity at human DMS53 cells after 72 hrs by MTT assay
    		[PMID: 22861499]
    HCT-116 IC50
    26.1 3
    Compound: VP16
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    HCT-116 IC50
    26.14 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as cell viability incubated for 24 hrs by MTT assay
    Cytotoxicity against human HCT-116 cells assessed as cell viability incubated for 24 hrs by MTT assay
    		[PMID: 35567964]
    HCT-116 IC50
    3 3
    Compound: ET
    Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HCT-116 IC50
    3.1 3
    Compound: Etoposide
    Antiproliferative activity against p53-null human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against p53-null human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    HCT-116 IC50
    3.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    HCT-116 IC50
    3.52 3
    Compound: VP-16
    Antiproliferative activity against doxorubicin resistant human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against doxorubicin resistant human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HCT-116 IC50
    4.9 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HCT116 cells incubated for 3 days by MTT assay
    Antiproliferative activity against human HCT116 cells incubated for 3 days by MTT assay
    		[PMID: 32992133]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    HCT-116 GI50
    5 3
    Compound: Etoposide
    Growth inhibition of human HCT116 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human HCT116 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    DU-145 CC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 96 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    DU-145 GI50
    13 3
    Compound: ETP
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition for 72 hrs by MTT assay
    		[PMID: 35580424]
    HCT-116 IC50
    6.03 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    DU-145 GI50
    2 3
    Compound: 2
    In vitro cytotoxic activity against prostate (DU-145) cancer cell line.
    In vitro cytotoxic activity against prostate (DU-145) cancer cell line.
    		[PMID: 10465531]
    HCT-116 IC50
    71.3 3
    Compound: vp16
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    DU-145 IC50
    0.001 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    HCT-116 IC50
    9.5 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 2 days
    Cytotoxicity against human HCT116 cells after 2 days
    		[PMID: 21419530]
    DU-145 IC50
    0.02 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    HCT-116 IC50
    9.9 6
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    DU-145 IC50
    0.4 3
    Compound: VP-16
    Antiproliferative activity against human DU145 cells assessed as cell viability incubated for 72 hrs by MTT assay
    Antiproliferative activity against human DU145 cells assessed as cell viability incubated for 72 hrs by MTT assay
    		[PMID: 25799376]
    HCT-15 IC50
    > 10 3
    Compound: etoposide
    Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    HCT-15 IC50
    0.28 3
    Compound: ETO
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human DU145 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 21601964]
    HCT-15 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    HCT-15 IC50
    0.46 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 72 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human DU145 cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    HCT-15 IC50
    0.9 3
    Compound: Etoposide
    Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    DU-145 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferation activity against human DU145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human DU145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    HCT-15 IC50
    1.06 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human HCT15 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    HCT-15 IC50
    1.09 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 4 days by ELISA reader assay
    Cytotoxicity against human HCT15 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    DU-145 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    DU-145 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells by MTT assay
    Antiproliferative activity against human DU145 cells by MTT assay
    		[PMID: 32196342]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    DU-145 IC50
    1.15 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human DU145 cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    DU-145 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human DU145 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human HCT15 cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 21601964]
    DU-145 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by ELISA reader assay
    Cytotoxicity against human DU145 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    DU-145 IC50
    1.3 3
    Compound: VP-16
    Antiproliferative activity against human DU145 prostate cell line
    Antiproliferative activity against human DU145 prostate cell line
    		[PMID: 10498216]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HCT15 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    DU-145 IC50
    1.42 3
    Compound: ETO
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    HCT-15 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human HCT15 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    DU-145 IC50
    1.44 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 21115246]
    HCT-15 GI50
    1.25 3
    Compound: etoposide
    Antiproliferative activity against human HCT15 cells by SRB assay
    Antiproliferative activity against human HCT15 cells by SRB assay
    		[PMID: 19394218]
    DU-145 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human DU145 ATCC HTB 81 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 ATCC HTB 81 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    HCT-15 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    HCT-15 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    DU-145 IC50
    1.63 3
    Compound: etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    DU-145 IC50
    1.65 3
    Compound: 3; Etop
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    HCT-15 IC50
    1.33 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    DU-145 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    HCT-15 IC50
    1.33 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 22318164]
    DU-145 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human DU-145 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    HCT-15 IC50
    1.45 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human colon tumor cell line HCT-15 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human colon tumor cell line HCT-15 after 72 hr of incubation was determined
    		[PMID: 15482917]
    DU-145 IC50
    1.97 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    		[PMID: 38784476]
    HCT-15 IC50
    1.48 3
    Compound: 2
    Cytotoxicity against human HCT-15 cells by sulforhodamine B assay
    Cytotoxicity against human HCT-15 cells by sulforhodamine B assay
    		[PMID: 17988764]
    DU-145 IC50
    1.97 3
    Compound: V
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    HCT-15 IC50
    1.6 3
    Compound: etoposide
    Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    DU-145 IC50
    1.98 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    HCT-15 IC50
    1.8 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-15 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-15 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    DU-145 IC50
    10.64 3
    Compound: ETP
    Antiproliferative activity against human DU145 cells after 48 hrs by SRB assay
    Antiproliferative activity against human DU145 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    HCT-15 GI50
    10.02 3
    Compound: etoposide
    Antiproliferative activity against multidrug resistant human HCT15/CLO2 cells by SRB assay
    Antiproliferative activity against multidrug resistant human HCT15/CLO2 cells by SRB assay
    		[PMID: 19394218]
    DU-145 IC50
    13.1 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    HCT-15 IC50
    12.23 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    DU-145 IC50
    13.8 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 4 days by MTT assay
    Cytotoxicity against human DU145 cells after 4 days by MTT assay
    		[PMID: 20619511]
    HCT-15 IC50
    18.87 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by CCK8 assay
    Cytotoxicity against human HCT15 cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    DU-145 IC50
    13.85 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 24904965]
    HCT-15 IC50
    18.87 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells measured on day 4 by CCK8 assay
    Cytotoxicity against human HCT15 cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    DU-145 IC50
    16.43 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    HCT-15 IC50
    19.7 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 24 hrs by WST-1 assay
    Antiproliferative activity against human HCT15 cells after 24 hrs by WST-1 assay
    		[PMID: 28181805]
    DU-145 IC50
    2.03 3
    Compound: 2
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    HCT-15 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells by MTT assay
    Cytotoxicity against human HCT15 cells by MTT assay
    		[PMID: 21115246]
    DU-145 IC50
    2.03 3
    Compound: 3
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    Cytotoxicity against human DU145 cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    HCT-15 ED50
    2.2 6
    Compound: etoposide
    Cytotoxicity against human HCT15 cells by SRB method
    Cytotoxicity against human HCT15 cells by SRB method
    		[PMID: 16252909]
    DU-145 IC50
    2.03 3
    Compound: 3
    Cytotoxicity against human DU145 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human DU145 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    HCT-15 IC50
    2.38 3
    Compound: Etopo
    Antiproliferative activity against human HCT-15 cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human HCT-15 cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    DU-145 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    HCT-15 IC50
    2.43 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB method
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    DU-145 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells measured on day 4 by CCK8 assay
    Cytotoxicity against human DU145 cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    HCT-15 IC50
    2.45 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    DU-145 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by CCK8 assay
    Cytotoxicity against human DU145 cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    HCT-15 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    DU-145 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human DU-145 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human DU-145 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    HCT-15 IC50
    2.8 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 3 days by SRB assay
    Cytotoxicity against human HCT15 cells after 3 days by SRB assay
    		[PMID: 18321715]
    DU-145 IC50
    2.13 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    HCT-15 IC50
    2.82 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 3 days by CCK8 assay
    Cytotoxicity against human HCT15 cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    DU-145 IC50
    2.19 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 21419530]
    HCT-15 IC50
    2.94 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    DU-145 IC50
    2.19 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human DU145 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    HCT-15 IC50
    2.94 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    DU-145 IC50
    2.35 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
    Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    HCT-15 IC50
    2.95 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    HCT-15 IC50
    4.6 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    DU-145 IC50
    2.4 3
    Compound: etoposide
    Cytotoxicity against human DU145 cells by SRB microtiter plate assay
    Cytotoxicity against human DU145 cells by SRB microtiter plate assay
    		[PMID: 17585747]
    DU-145 IC50
    2.45 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells in presence of 10% fetal bovine serum
    Cytotoxicity against human DU145 cells in presence of 10% fetal bovine serum
    		[PMID: 20188578]
    HCT-15 IC50
    5.12 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    DU-145 IC50
    2.47 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    HCT-15 IC50
    5.4 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    DU-145 IC50
    2.94 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days
    Cytotoxicity against human DU145 cells after 2 days
    		[PMID: 22318164]
    HCT-15 IC50
    5.54 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells measured after 2 days by MTT assay
    Cytotoxicity against human HCT15 cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    DU-145 IC50
    21.07 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 3 days
    Cytotoxicity against human DU145 cells after 3 days
    		[PMID: 19954977]
    HCT-15 IC50
    6.9 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    DU-145 IC50
    2373.3 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against DU-145 cell line
    In vivo antiproliferative activity against DU-145 cell line
    		[PMID: 15084135]
    HCT-15 IC50
    7.15 3
    Compound: 2
    Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    DU-145 IC50
    29.79 3
    Compound: etoposide
    Cytotoxicity against human DU145 cells
    Cytotoxicity against human DU145 cells
    		[PMID: 18178085]
    HCT-15 IC50
    7.74 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 4 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    HCT-15 IC50
    9.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    DU-145 IC50
    3 3
    Compound: VP16
    Cytotoxicity against human DU145 cells after 96 hrs
    Cytotoxicity against human DU145 cells after 96 hrs
    		[PMID: 22276775]
    DU-145 IC50
    3.02 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    		[PMID: 36493620]
    HCT-15 IC50
    9.45 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 24904965]
    DU-145 IC50
    3.1 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    HCT-8 IC50
    10 3
    Compound: VP16
    Cytotoxicity against human HCT8 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    DU-145 IC50
    3.17 3
    Compound: 2
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    Anticancer activity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    HCT-8 IC50
    10.89 3
    Compound: VP16; 2
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    DU-145 IC50
    3.7 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    HCT-8 IC50
    26.3 3
    Compound: 2; VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    HCT-8 IC50
    6.4 3
    Compound: etoposide
    Cytotoxicity against human HCT8 cells after 5 days by MTT assay
    Cytotoxicity against human HCT8 cells after 5 days by MTT assay
    		[PMID: 8778240]
    DU-145 IC50
    3.85 3
    Compound: 2
    Cytotoxicity against human DU145 cells by sulforhodamine B assay
    Cytotoxicity against human DU145 cells by sulforhodamine B assay
    		[PMID: 17988764]
    DU-145 IC50
    4.13 3
    Compound: Etopo
    Antiproliferative activity against human DU-145 cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human DU-145 cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    HCT-8 IC50
    6.54 3
    Compound: VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    DU-145 IC50
    5.16 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 19836231]
    HCT-8 ED50
    62.9 3
    Compound: 1
    Dose required for reduction in human ileocecal HCT-8 cancer cells after 3 day incubation
    Dose required for reduction in human ileocecal HCT-8 cancer cells after 3 day incubation
    		[PMID: 15456257]
    DU-145 IC50
    5.21 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    HCT-8 IC50
    7.06 3
    Compound: 2, VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    HCT-8 IC50
    7.06 3
    Compound: 2, VP-16
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    DU-145 IC50
    6.17 6
    Compound: Etoposide
    Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    DU-145 IC50
    64.26 3
    Compound: 2
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    HEF IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against HEF after 72 hrs by MTT assay
    Cytotoxicity against HEF after 72 hrs by MTT assay
    		[PMID: 30447888]
    DU-145 IC50
    64.26 3
    Compound: Etoposideg
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    HEK293 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as decrease in cell growth after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    DU-145 IC50
    7.47 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation
    Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation
    		[PMID: 35123005]
    HEK293 IC50
    0.41 3
    Compound: ETO
    Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
    Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    DU-145 IC50
    9.29 3
    Compound: Etoposide
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    Cytotoxicity against human DU145 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    HEK293 IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 27533261]
    DU-145 IC50
    9.8 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    HEK293 IC50
    0.69 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 48 hrs by MTT assay
    Cytotoxicity against HEK293 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    DU-145 IC50
    9.8 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells
    Antiproliferative activity against human DU-145 cells
    		[PMID: 32688198]
    HEK293 IC50
    0.72 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 2 days by CCK-8 assay
    Cytotoxicity against HEK293 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    DU-145 IC50
    9.8 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34479036]
    HEK293 IC50
    1.04 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 4 days by CCK-8 assay
    Cytotoxicity against HEK293 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    DU-145 IC50
    9.8 3
    Compound: VP-16
    Cytotoxicity against human DU145 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human DU145 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    HEK293 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human HEK293 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human HEK293 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    DU-145 IC50
    9.87 3
    Compound: Etoposide
    Antiproliferative activity against human DU-145 cells incubated for 72 hrs by microplate reader analysis
    Antiproliferative activity against human DU-145 cells incubated for 72 hrs by microplate reader analysis
    		[PMID: 37418826]
    HEK293 IC50
    1.74 3
    Compound: Etoposide
    Antiproliferative activity against HEK293 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against HEK293 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    DU-145 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human DU145 cells by MTT assay
    Cytotoxicity against human DU145 cells by MTT assay
    		[PMID: 30543429]
    HEK293 IC50
    7.51 3
    Compound: ETP
    Antiproliferative activity against HEK293 cells after 48 hrs by SRB assay
    Antiproliferative activity against HEK293 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    DU-145 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human DU145 cells after 48 hrs by SRB assay
    Anticancer activity against human DU145 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HEK293 IC50
    702.8 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HEK293 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) HEK293 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    DU-145 IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human DU145 cells by SRB assay
    Antiproliferative activity against human DU145 cells by SRB assay
    		[PMID: 31546197]
    HEK-293T IC50
    1.39 3
    Compound: VP-16
    Cytotoxicity against human HEK293T cells measured after 72 hrs by MTT assay
    Cytotoxicity against human HEK293T cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HEK-293T IC50
    11.47 3
    Compound: Etoposide
    Cytotoxicity against HEK293T cells after 36 hrs by MTT assay
    Cytotoxicity against HEK293T cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    HEK-293T IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    EBC-1 IC50
    15.7 3
    Compound: Etoposide
    Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human EBC-1 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    HEK-293T IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against HEK293T cells assessed as cells growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against HEK293T cells assessed as cells growth inhibition after 48 hrs by MTT assay
    		[PMID: 27994737]
    HEK-293T IC50
    28 3
    Compound: Etoposide
    Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    HEL IC50
    0.92 3
    Compound: ETP
    Growth inhibition of HEL cells after 72 hrs by MTT assay
    Growth inhibition of HEL cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    EL4 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    EL4 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against mouse EL4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    HeLa IC50
    > 50 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by SRB assay
    		[PMID: 31404864]
    F460pv8/eto IC50
    0.74 3
    Compound: Etoposide
    Inhibitory activity against F460pv8/eto cell line using MTT assay
    Inhibitory activity against F460pv8/eto cell line using MTT assay
    		[PMID: 10780913]
    HeLa IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human HeLa cells after 48 hrs by SRB assay
    Anticancer activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    FHC IC50
    49.31 6
    Compound: Etoposide
    Cytotoxicity against human FHC cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human FHC cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    HeLa IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells by SRB assay
    Antiproliferative activity against human HeLa cells by SRB assay
    		[PMID: 31546197]
    FaDu IC50
    16.01 3
    Compound: ETP
    Antiproliferative activity against human FADU cells after 48 hrs by SRB assay
    Antiproliferative activity against human FADU cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    HeLa IC50
    0.18 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days by CCK8 assay
    Cytotoxicity against human HeLa cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    HeLa IC50
    0.18 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    G-361 IC50
    0.28 6
    Compound: Etoposide
    Cytotoxic activity of compound against G-361 melanoma human tumor cell line
    Cytotoxic activity of compound against G-361 melanoma human tumor cell line
    		[PMID: 12459024]
    HeLa IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HeLa cells by MTT assay
    Antiproliferative activity against human HeLa cells by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    0.38 6
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days by MTT assay
    Cytotoxicity against human HeLa cells after 3 days by MTT assay
    		[PMID: 21216051]
    G-361 IC50
    2.3 3
    Compound: VP-16
    Antiproliferative activity against human G-361 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human G-361 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    G-361 IC50
    3.8 3
    Compound: Etoposide
    Antiproliferation activity against human G361 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human G361 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    HeLa IC50
    0.47 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    G-402 ED50
    4.8 6
    Compound: VP-16
    Inhibition of growth of renal cancer G-402 cell line
    Inhibition of growth of renal cancer G-402 cell line
    		[PMID: 8389875]
    HeLa IC50
    0.54 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    HeLa GI50
    0.62 3
    Compound: 2
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    HeLa GI50
    0.64 3
    Compound: 2
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 24953821]
    GLIOMA#108 IC50
    76 3
    Compound: Etoposide
    Inhibitory activity against GLIOMA#108 cell line
    Inhibitory activity against GLIOMA#108 cell line
    		[PMID: 9554873]
    GLIOMA#112 IC50
    62 3
    Compound: Etoposide
    Inhibitory activity against GLIOMA#112 cell line
    Inhibitory activity against GLIOMA#112 cell line
    		[PMID: 9554873]
    HeLa EC50
    0.81 3
    Compound: VP-16
    Tested for inhibitory activity against Topoisomerase II isolated from HeLa cells by using SDS-K+ precipitation method
    Tested for inhibitory activity against Topoisomerase II isolated from HeLa cells by using SDS-K+ precipitation method
    		10.1016/S0960-894X(00)80048-7
    HeLa EC50
    0.81 3
    Compound: VP-16
    Compound was tested for topoisomerase II inhibition in purified HeLa cells by SDS/K+ precipitation method
    Compound was tested for topoisomerase II inhibition in purified HeLa cells by SDS/K+ precipitation method
    		10.1016/0960-894X(95)00044-T
    HeLa EC50
    0.81 3
    Compound: VP-16
    Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II.
    Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II.
    		10.1016/0960-894X(95)00043-S
    HeLa EC50
    0.81 3
    Compound: 6 (VP-16)
    Tested for inhibition of topoisomerase II isolated from HeLa cells by DNA-cleavage assay
    Tested for inhibition of topoisomerase II isolated from HeLa cells by DNA-cleavage assay
    		[PMID: 8410993]
    HeLa IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    H69AR IC50
    30 6
    Compound: Etoposide
    Cytotoxicity against human H69AR cells after 3 days by MTT assay
    Cytotoxicity against human H69AR cells after 3 days by MTT assay
    		[PMID: 21216051]
    HeLa IC50
    1.2 3
    Compound: Etoposide
    Antiproliferation activity against human Hela cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human Hela cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    H69AR IC50
    45.9 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H69AR cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human NCI-H69AR cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33276991]
    HeLa IC50
    1.2 3
    Compound: VP16
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    HBL-100 GI50
    1.4 3
    Compound: Etoposide
    Growth inhibition of human HBL100 cells after 48 hrs by SRB assay
    Growth inhibition of human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    HeLa IC50
    1.26 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days by CCK-8 assay
    Cytotoxicity against human HeLa cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    HBL-100 GI50
    1.4 3
    Compound: Etoposide
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    HeLa IC50
    1.29 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 4 days by ELISA reader assay
    Cytotoxicity against human HeLa cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    HBL-100 GI50
    1.4 3
    Compound: Etoposide
    Antiproliferative activity against human HBL-100 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human HBL-100 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    		[PMID: 37531922]
    HeLa IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 21601964]
    HBL-100 GI50
    1.4 3
    Compound: VP-16
    Cytotoxicity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    HeLa IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HeLa cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HBL-100 GI50
    1.9 3
    Compound: VP-16
    Antiproliferative activity against human HBL100 cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    HeLa IC50
    1.41 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human HeLa cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    HBL-100 GI50
    2.3 3
    Compound: Etoposide
    Growth inhibition of human HBL100 cells
    Growth inhibition of human HBL100 cells
    		[PMID: 21986585]
    HeLa IC50
    1.52 3
    Compound: 2a, VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    HBL-100 GI50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    HeLa IC50
    1.58 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    HBL-100 GI50
    2.3 3
    Compound: VP-16
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    HeLa IC50
    1.605 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    HCC 2998 GI50
    3.46 3
    Compound: Etoposide
    In vitro cytotoxicity against human colon cancer HCC 2998 cell line
    In vitro cytotoxicity against human colon cancer HCC 2998 cell line
    		[PMID: 9871772]
    HeLa IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    1.93 3
    Compound: V
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    HCC70 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HCC70 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human HCC70 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    HCC70 IC50
    > 50 3
    Compound: Etoposide
    Antiproliferative activity against human HCC70 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human HCC70 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    HeLa IC50
    10.03 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    HeLa IC50
    10.03 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    HCCLM9 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HCCLM9 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HCCLM9 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HCT cell line IC50
    5.2 6
    Compound: 1
    Compound was evaluated for in vitro cytotoxicity against HCT/VP35 cells
    Compound was evaluated for in vitro cytotoxicity against HCT/VP35 cells
    		10.1016/S0960-894X(00)80029-3
    HeLa IC50
    10.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    HeLa IC50
    11.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    HeLa IC50
    12.12 3
    Compound: VP16; 2
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    HeLa IC50
    12.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    HeLa IC50
    13.5 3
    Compound: VP16
    Cytotoxicity against human HeLa cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    HCT-116 GI50
    5 3
    Compound: Etoposide
    Growth inhibition of human HCT116 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human HCT116 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    HeLa IC50
    15 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    HCT-116 GI50
    6.16 3
    Compound: Etoposide
    In vitro cytotoxicity against human colon cancer HCT 116 cell line
    In vitro cytotoxicity against human colon cancer HCT 116 cell line
    		[PMID: 9871772]
    HeLa IC50
    15.93 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    HeLa IC50
    16 3
    Compound: Etoposide
    Growth inhibition of human HeLa cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    Growth inhibition of human HeLa cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    		[PMID: 24527835]
    HCT-116 IC50
    0.25 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    HeLa IC50
    17.68 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    HCT-116 IC50
    0.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    HeLa IC50
    18.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 4 days by MTT assay
    Cytotoxicity against human HeLa cells after 4 days by MTT assay
    		[PMID: 20619511]
    HCT-116 IC50
    0.34 6
    Compound: 1
    Compound was tested for its in vitro cytotoxicity in HCT116 cell line after 72 hours
    Compound was tested for its in vitro cytotoxicity in HCT116 cell line after 72 hours
    		10.1016/S0960-894X(00)80646-0
    HeLa GI50
    2 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    HCT-116 IC50
    0.35 6
    Compound: 1
    Tested for in vitro cytotoxicity against HCT116 cells
    Tested for in vitro cytotoxicity against HCT116 cells
    		10.1016/S0960-894X(00)80029-3
    HeLa IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    HCT-116 IC50
    0.37 3
    Compound: VP-16
    Antiproliferative activity against doxorubicin sensitive human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against doxorubicin sensitive human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HeLa IC50
    2.15 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 19836231]
    HCT-116 IC50
    0.38 3
    Compound: VP-16
    Cytotoxicity against human HCT-116 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human HCT-116 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HeLa IC50
    2.24 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    HeLa IC50
    2.35 6
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    HCT-116 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    HCT-116 IC50
    0.41 3
    Compound: EP
    Growth inhibition human HCT116 cells after 72 hrs by MTS assay
    Growth inhibition human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 30633861]
    HeLa IC50
    2.36 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 21419530]
    HCT-116 IC50
    0.49 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition by MTS assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition by MTS assay
    		[PMID: 28055208]
    HeLa IC50
    2.4 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    HCT-116 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    HeLa IC50
    2.4 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells by MTT assay
    Antiproliferative activity against human HeLa cells by MTT assay
    		[PMID: 32196342]
    HCT-116 IC50
    0.52 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    HeLa IC50
    2.66 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    HCT-116 IC50
    0.66 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    HeLa IC50
    2.7 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 33831559]
    HCT-116 IC50
    0.68 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    HeLa IC50
    2.71 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    HCT-116 IC50
    0.87 3
    Compound: VP-16
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24095018]
    HeLa IC50
    2.75 3
    Compound: 2
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    HCT-116 IC50
    0.91 3
    Compound: VP-16
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    HeLa IC50
    2.76 3
    Compound: 5, VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 22041063]
    HCT-116 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity in human HCT116 cells by SRB assay
    Cytotoxicity in human HCT116 cells by SRB assay
    		[PMID: 26812172]
    HeLa IC50
    2.9 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 18258438]
    HeLa IC50
    2.9 3
    Compound: etoposide
    Growth inhibition of human HeLa cells by MTT assay
    Growth inhibition of human HeLa cells by MTT assay
    		[PMID: 17482821]
    HCT-116 IC50
    1 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTS assay
    		[PMID: 24328269]
    HCT-116 IC50
    1.06 3
    Compound: Etoposide
    Growth inhibition of human HCT116 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human HCT116 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    HeLa IC50
    2.91 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    HCT-116 IC50
    1.06 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    HeLa IC50
    2.91 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    HCT-116 IC50
    1.1 3
    Compound: Eto
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    HeLa IC50
    2.97 3
    Compound: Vp-16
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    HeLa IC50
    21.4 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    HCT-116 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against p53-expressing human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against p53-expressing human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    HCT-116 IC50
    1.2 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    HeLa IC50
    22.35 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    HeLa IC50
    225.5 3
    Compound: VP16
    Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    HCT-116 IC50
    1.22 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    HCT-116 IC50
    1.25 3
    Compound: Etoposide
    Cytotoxicity in human HCT-116 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human HCT-116 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    HeLa IC50
    23.33 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 24 hrs by MTT assay
    		[PMID: 21983445]
    HCT-116 IC50
    1.36 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    HeLa IC50
    24.9 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    HCT-116 IC50
    1.4 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    HeLa IC50
    28.61 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    HCT-116 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HeLa IC50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human HeLa cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    HCT-116 IC50
    1.7 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    HeLa IC50
    3 3
    Compound: Eto
    Antitumor activity against human HeLa cells after 72 hrs by MTT assay
    Antitumor activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    HCT-116 IC50
    1.7 3
    Compound: VP16
    Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    HeLa IC50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 96 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    HCT-116 IC50
    1.7 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells by XTT assay
    Cytotoxicity against human HCT116 cells by XTT assay
    		[PMID: 17368022]
    HeLa GI50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    HCT-116 IC50
    1.7 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells after 3 days by XTT assay
    Antiproliferative activity against human HCT116 cells after 3 days by XTT assay
    		[PMID: 19691293]
    HeLa GI50
    3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    HCT-116 IC50
    1.78 6
    Compound: 1
    Compound was tested for its in vitro cytotoxicity in HCT-VP35 cell line after 72 hours
    Compound was tested for its in vitro cytotoxicity in HCT-VP35 cell line after 72 hours
    		10.1016/S0960-894X(00)80646-0
    HeLa IC50
    3.2 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    HCT-116 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 38237151]
    HeLa IC50
    3.2 3
    Compound: VP16
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    HeLa IC50
    3.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 22318164]
    HCT-116 IC50
    1.87 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells by SRB assay
    Cytotoxicity against human HCT116 cells by SRB assay
    		[PMID: 17194596]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    HeLa IC50
    3.23 3
    Compound: Etoposide
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Antiproliferative activity against human HCT116 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human HCT116 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    HeLa GI50
    3.3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    HCT-116 IC50
    1.9 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    HeLa GI50
    3.3 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    HCT-116 IC50
    11.9 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 4 days by MTT assay
    Cytotoxicity against human HCT116 cells after 4 days by MTT assay
    		[PMID: 20619511]
    HeLa GI50
    3.3 3
    Compound: Etoposide
    Growth inhibition of human HeLa cells after 48 hrs by SRB assay
    Growth inhibition of human HeLa cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    HeLa IC50
    3.4 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    HCT-116 IC50
    1200 6
    Compound: etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS reduction assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS reduction assay
    		[PMID: 16441091]
    HCT-116 IC50
    13.5 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) HCT116 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) HCT116 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    HeLa GI50
    3.56 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    HCT-116 IC50
    13.5 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    HeLa IC50
    3.6 3
    Compound: etoposide
    Antiproliferative effect against human HeLa cells after 69 hrs by MTT assay
    Antiproliferative effect against human HeLa cells after 69 hrs by MTT assay
    		[PMID: 16499324]
    HCT-116 IC50
    14.39 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 4 days
    Cytotoxicity against human HCT116 cells after 4 days
    		[PMID: 19800803]
    HeLa IC50
    3.9 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    HCT-116 IC50
    15.11 3
    Compound: etoposide
    Cytotoxicity against human HCT116 cells
    Cytotoxicity against human HCT116 cells
    		[PMID: 18178085]
    HeLa IC50
    3.9 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    HCT-116 IC50
    15.6 3
    Compound: Vp-16
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    HeLa IC50
    32.05 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    HeLa IC50
    32.45 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HCT-116 IC50
    17.92 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 3 days
    Cytotoxicity against human HCT116 cells after 3 days
    		[PMID: 19954977]
    HeLa IC50
    4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 21570846]
    HCT-116 IC50
    2 3
    Compound: 3; Etop
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    HeLa IC50
    4.12 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    HCT-116 IC50
    2.13 3
    Compound: Vp-16
    Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    HCT-116 IC50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 26595875]
    HeLa IC50
    4.13 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human HeLa cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    HCT-116 IC50
    2.4 3
    Compound: VP-16
    Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    HeLa IC50
    4.36 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    HeLa IC50
    4.39 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 36 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    HCT-116 IC50
    2.5 3
    Compound: etoposide
    Tested for the cytotoxicity to inhibit replication assay against the human colon tumor cell line HCT116
    Tested for the cytotoxicity to inhibit replication assay against the human colon tumor cell line HCT116
    		[PMID: 7525959]
    HCT-116 IC50
    2.5 3
    Compound: etopside
    Cytotoxicity against HCT116 cells.
    Cytotoxicity against HCT116 cells.
    		[PMID: 7473578]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    HCT-116 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    HCT-116 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against resistant human HCT116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against resistant human HCT116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    HCT-116 IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    HeLa IC50
    4.73 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    HCT-116 IC50
    23 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as inhibition of cell growth
    Cytotoxicity against human HCT-116 cells assessed as inhibition of cell growth
    		[PMID: 36690039]
    HeLa GI50
    40 3
    Compound: Etoposide
    Growth inhibitory concentration of compound was determined against HeLa cells by alamar blue assay
    Growth inhibitory concentration of compound was determined against HeLa cells by alamar blue assay
    		[PMID: 15026047]
    HCT-116 IC50
    25.5 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 21724394]
    HeLa IC50
    40.4 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
    Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
    		[PMID: 22244588]
    HCT-116 IC50
    26.1 3
    Compound: VP16
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    HeLa IC50
    41.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    HCT-116 IC50
    26.14 3
    Compound: Etoposide
    Cytotoxicity against human HCT-116 cells assessed as cell viability incubated for 24 hrs by MTT assay
    Cytotoxicity against human HCT-116 cells assessed as cell viability incubated for 24 hrs by MTT assay
    		[PMID: 35567964]
    HeLa IC50
    5.35 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    HeLa IC50
    5.7 1
    Compound: VP-16
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 24422592]
    HCT-116 IC50
    3 3
    Compound: ET
    Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HCT-116 IC50
    3.1 3
    Compound: Etoposide
    Antiproliferative activity against p53-null human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against p53-null human HCT116 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26595875]
    HeLa IC50
    50.6 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    HCT-116 IC50
    3.3 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    HeLa IC50
    59.38 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    HeLa IC50
    6.27 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 2 days by MTT assay
    Cytotoxicity against human HeLa cells after 2 days by MTT assay
    		[PMID: 21821321]
    HCT-116 IC50
    3.52 3
    Compound: VP-16
    Antiproliferative activity against doxorubicin resistant human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against doxorubicin resistant human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HCT-116 IC50
    4.9 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HCT116 cells incubated for 3 days by MTT assay
    Antiproliferative activity against human HCT116 cells incubated for 3 days by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    6.27 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    HeLa IC50
    63.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    HeLa IC50
    7.21 3
    Compound: Etoposide
    Cytotoxic activity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxic activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    HCT-116 IC50
    5 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    HeLa IC50
    7.32 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by CCK8 assay
    Cytotoxicity against human HeLa cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    HCT-116 IC50
    6.03 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    HeLa IC50
    7.32 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells measured on day 4 by CCK8 assay
    Cytotoxicity against human HeLa cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    HCT-116 IC50
    71.3 3
    Compound: vp16
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HeLa IC50
    7.43 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    HCT-116 IC50
    9.5 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 2 days
    Cytotoxicity against human HCT116 cells after 2 days
    		[PMID: 21419530]
    HeLa IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells measured after 2 days by MTT assay
    Cytotoxicity against human HeLa cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    HeLa IC50
    7.89 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    HCT-116 IC50
    9.9 6
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
    		[PMID: 22032697]
    HCT-116 IC50
    > 10 3
    Compound: Etoposide
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    HeLa ED50
    7.9 6
    Compound: 4
    Cytotoxicity against human HeLa cells after 4 days by trypan blue assay
    Cytotoxicity against human HeLa cells after 4 days by trypan blue assay
    		[PMID: 1602298]
    HCT-116 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    HeLa GI50
    8 3
    Compound: 2
    Growth inhibition of HeLa cells after 48 hrs by MTT assay
    Growth inhibition of HeLa cells after 48 hrs by MTT assay
    		[PMID: 17894480]
    HCT-116 IC50
    > 10 3
    Compound: VP-16
    Cytotoxicity against human HCT116 cells by MTT assay
    Cytotoxicity against human HCT116 cells by MTT assay
    		[PMID: 30543429]
    HeLa IC50
    8 3
    Compound: ET
    Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HCT-116 IC50
    > 20 3
    Compound: Etoposide
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 24 hrs by SRB assay
    Antiproliferative activity against human HCT116 cells assessed as cell viability after 24 hrs by SRB assay
    		[PMID: 26595875]
    HeLa IC50
    8.09 3
    Compound: Etopo
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    HeLa IC50
    8.12 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HeLa cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    HCT-116 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human HCT116 cells after 48 hrs by SRB assay
    Anticancer activity against human HCT116 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HeLa IC50
    8.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    HeLa IC50
    8.3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by Ez-cytoX based microplate reader method
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by Ez-cytoX based microplate reader method
    		[PMID: 34597897]
    HeLa IC50
    8.32 3
    Compound: Etoposide
    Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    HeLa IC50
    8.43 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days
    Cytotoxicity against human HeLa cells after 3 days
    		[PMID: 19954977]
    HeLa IC50
    8.93 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 20356735]
    HeLa IC50
    9.1 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    HeLa IC50
    9.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    HeLa IC50
    9.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    HeLa IC50
    96.26 3
    Compound: Etoposideg
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    HeLa IC50
    96.26 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    HeLa S3 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human HeLaS3 cells by MTT assay
    Antiproliferative activity against human HeLaS3 cells by MTT assay
    		[PMID: 29072457]
    HeLa S3 IC50
    43.1 3
    Compound: Etoposide
    Antiproliferative activity against human HeLaS3 cells after 24 hrs by WST-1 assay
    Antiproliferative activity against human HeLaS3 cells after 24 hrs by WST-1 assay
    		[PMID: 28181805]
    HCT-15 ED50
    2.2 6
    Compound: etoposide
    Cytotoxicity against human HCT15 cells by SRB method
    Cytotoxicity against human HCT15 cells by SRB method
    		[PMID: 16252909]
    Hep 3B2 IC50
    6.7 3
    Compound: Etoposide
    Cytotoxicity against human Hep3B cells after 72 hrs by MTT assay
    Cytotoxicity against human Hep3B cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    HCT-15 GI50
    1.25 3
    Compound: etoposide
    Antiproliferative activity against human HCT15 cells by SRB assay
    Antiproliferative activity against human HCT15 cells by SRB assay
    		[PMID: 19394218]
    HEp-2 IC50
    0.9 3
    Compound: Etoposide
    Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    HCT-15 GI50
    10.02 3
    Compound: etoposide
    Antiproliferative activity against multidrug resistant human HCT15/CLO2 cells by SRB assay
    Antiproliferative activity against multidrug resistant human HCT15/CLO2 cells by SRB assay
    		[PMID: 19394218]
    HEp-2 IC50
    2.15 3
    Compound: 2
    Cytotoxicity against human Hep2 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human Hep2 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    HCT-15 IC50
    0.28 3
    Compound: ETO
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    HEp-2 IC50
    2.15 3
    Compound: 2
    Cytotoxicity against human HEP2 cells by sulforhodamine B assay
    Cytotoxicity against human HEP2 cells by sulforhodamine B assay
    		[PMID: 17988764]
    HCT-15 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    HepG2 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    HCT-15 IC50
    0.46 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 72 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    HepG2 IC50
    > 50000 1
    Compound: VP-16
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    HCT-15 IC50
    0.9 3
    Compound: Etoposide
    Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    HepG2 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human HepG2 cells after 48 hrs by SRB assay
    Anticancer activity against human HepG2 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HCT-15 IC50
    1.06 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human HCT15 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    HepG2 IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells by SRB assay
    Antiproliferative activity against human HepG2 cells by SRB assay
    		[PMID: 31546197]
    HCT-15 IC50
    1.09 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 4 days by ELISA reader assay
    Cytotoxicity against human HCT15 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    HepG2 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HCT15 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HepG2 CC50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 21601964]
    HepG2 IC50
    0.83 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    HepG2 IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human HCT15 cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    HepG2 IC50
    1.748 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    HCT-15 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    HepG2 IC50
    10.5 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    HCT-15 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human HCT15 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    HepG2 IC50
    103.81 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    HCT-15 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    HepG2 IC50
    11.52 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    HCT-15 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human HCT15 cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    HepG2 IC50
    11.8 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    		[PMID: 31546197]
    HCT-15 IC50
    1.29 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells in presence of 10% fetal bovine serum
    Cytotoxicity against human HCT15 cells in presence of 10% fetal bovine serum
    		[PMID: 20188578]
    HepG2 IC50
    12 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    		10.1007/s00044-011-9903-y
    HCT-15 IC50
    1.33 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 22318164]
    HepG2 IC50
    13.4 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    HCT-15 IC50
    1.33 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    HepG2 IC50
    13.65 3
    Compound: Etoposide
    Antiproliferative against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    HCT-15 IC50
    1.45 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human colon tumor cell line HCT-15 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human colon tumor cell line HCT-15 after 72 hr of incubation was determined
    		[PMID: 15482917]
    HepG2 IC50
    15.32 3
    Compound: VP16
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33191085]
    HCT-15 IC50
    1.48 3
    Compound: 2
    Cytotoxicity against human HCT-15 cells by sulforhodamine B assay
    Cytotoxicity against human HCT-15 cells by sulforhodamine B assay
    		[PMID: 17988764]
    HepG2 IC50
    15.32 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    HCT-15 IC50
    1.6 3
    Compound: etoposide
    Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    HepG2 IC50
    15.8 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 27759375]
    HCT-15 IC50
    1.8 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-15 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human HCT-15 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    HepG2 IC50
    15.8 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 21174408]
    HCT-15 IC50
    1.97 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-15 cells incubated for 72 hrs by microplate reader analysis
    Antiproliferative activity against human HCT-15 cells incubated for 72 hrs by microplate reader analysis
    		[PMID: 37418826]
    HepG2 EC50
    15.9 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by Cell Titer-Glo assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by Cell Titer-Glo assay
    		[PMID: 28080063]
    HepG2 IC50
    16 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as survival after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as survival after 3 days by crystal violet staining
    		10.1007/s00044-012-0025-y
    HCT-15 IC50
    12.23 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    HCT-15 IC50
    18.87 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells measured on day 4 by CCK8 assay
    Cytotoxicity against human HCT15 cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    HepG2 IC50
    16.1 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    HCT-15 IC50
    18.87 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by CCK8 assay
    Cytotoxicity against human HCT15 cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    HepG2 IC50
    2.02 3
    Compound: Ref 34, Cpd 2
    Antitumor activity against human HepG2 cells xenografted in BALB/c nude mouse assessed as tumor weight suppression at 1 mg/kg, ip administered every 6 days for 20 days and measured every 2 days by digital caliper method relative to control
    Antitumor activity against human HepG2 cells xenografted in BALB/c nude mouse assessed as tumor weight suppression at 1 mg/kg, ip administered every 6 days for 20 days and measured every 2 days by digital caliper method relative to control
    		[PMID: 32992133]
    HCT-15 IC50
    19.7 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 24 hrs by WST-1 assay
    Antiproliferative activity against human HCT15 cells after 24 hrs by WST-1 assay
    		[PMID: 28181805]
    HepG2 IC50
    2.45 3
    Compound: Etoposide
    Anticancer activity against human HepG2 cells after 48 hrs by MTT assay
    Anticancer activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    HCT-15 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells by MTT assay
    Cytotoxicity against human HCT15 cells by MTT assay
    		[PMID: 21115246]
    HepG2 IC50
    2.66 3
    Compound: vp16
    Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HCT-15 IC50
    2.38 3
    Compound: Etopo
    Antiproliferative activity against human HCT-15 cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human HCT-15 cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    HepG2 IC50
    2.84 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    HCT-15 IC50
    2.43 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB method
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    HepG2 IC50
    20 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 30776691]
    HepG2 IC50
    20 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    HCT-15 IC50
    2.45 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    HCT-15 IC50
    2.58 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    		[PMID: 36493620]
    HepG2 IC50
    20.1 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 29778894]
    HCT-15 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    HepG2 IC50
    20.389 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25019480]
    HCT-15 IC50
    2.8 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 3 days by SRB assay
    Cytotoxicity against human HCT15 cells after 3 days by SRB assay
    		[PMID: 18321715]
    HepG2 IC50
    20.9 3
    Compound: Etop
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    		[PMID: 26216018]
    HCT-15 IC50
    2.82 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 3 days by CCK8 assay
    Cytotoxicity against human HCT15 cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    HepG2 IC50
    20.9 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    HCT-15 IC50
    2.94 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    HepG2 IC50
    21 6
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 3 days by MTT assay
    Cytotoxicity against human HepG2 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HepG2 IC50
    22.11 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		10.1039/C3MD00166K
    HCT-15 IC50
    2.94 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    HCT-15 IC50
    2.95 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    HepG2 IC50
    24.32 6
    Compound: Etoposide
    Cytotoxic activity against human HepG2 cells by MTT assay
    Cytotoxic activity against human HepG2 cells by MTT assay
    		[PMID: 28366267]
    HCT-15 IC50
    4.5 3
    Compound: etoposide
    Antiproliferative activity against human HCT15 cell line
    Antiproliferative activity against human HCT15 cell line
    		[PMID: 16686539]
    HepG2 IC50
    27.07 3
    Compound: VP16; 2
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    HCT-15 IC50
    4.6 3
    Compound: etoposide
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    HepG2 IC50
    27.18 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell growth after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0402-6
    HCT-15 IC50
    5.09 3
    Compound: Etoposide
    Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation
    Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation
    		[PMID: 35123005]
    HepG2 IC50
    3.6 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    HCT-15 IC50
    5.12 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    HepG2 IC50
    30 3
    Compound: VP16
    Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    HCT-15 IC50
    5.4 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    HepG2 IC50
    30.16 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		10.1007/s00044-013-0777-z
    HCT-15 IC50
    5.54 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells measured after 2 days by MTT assay
    Cytotoxicity against human HCT15 cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    HepG2 IC50
    30.16 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 25078311]
    HCT-15 IC50
    6.9 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    HepG2 IC50
    30.16 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24836071]
    HCT-15 IC50
    7.15 3
    Compound: 2
    Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    HepG2 IC50
    33.98 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 26397393]
    HCT-15 IC50
    7.74 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 4 days by CCK-8 assay
    Cytotoxicity against human HCT15 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    HepG2 IC50
    4 3
    Compound: VP16
    Cytotoxicity against human HepG2 cells after 96 hrs
    Cytotoxicity against human HepG2 cells after 96 hrs
    		[PMID: 22276775]
    HCT-15 IC50
    9.27 3
    Compound: Etoposide
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    HepG2 IC50
    4.1 3
    Compound: VP-16
    Growth inhibition of human HepG2 cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human HepG2 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20346660]
    HCT-15 IC50
    9.45 3
    Compound: Etoposide
    Cytotoxicity against human HCT15 cells after 2 days
    Cytotoxicity against human HCT15 cells after 2 days
    		[PMID: 24904965]
    HepG2 IC50
    4.76 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    HCT-15 IC50
    > 10 3
    Compound: etoposide
    Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    HepG2 IC50
    4.9 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    HepG2 IC50
    40.47 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 25747499]
    HepG2 IC50
    427 3
    Compound: VP16
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    		10.1007/s00044-009-9172-1
    HCT-8 ED50
    62.9 3
    Compound: 1
    Dose required for reduction in human ileocecal HCT-8 cancer cells after 3 day incubation
    Dose required for reduction in human ileocecal HCT-8 cancer cells after 3 day incubation
    		[PMID: 15456257]
    HepG2 IC50
    5.21 3
    Compound: VP16
    Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    HCT-8 ED50
    > 5 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human ileocecal carcinoma (HCT-8) cell line
    The compound was tested for tumor cell growth inhibitory activity against human ileocecal carcinoma (HCT-8) cell line
    		[PMID: 10395485]
    HepG2 IC50
    5.48 3
    Compound: Etoposideg
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    HCT-8 IC50
    10 3
    Compound: VP16
    Cytotoxicity against human HCT8 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    HepG2 IC50
    5.48 3
    Compound: 2
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    HCT-8 IC50
    10.89 3
    Compound: VP16; 2
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    HepG2 IC50
    5.52 3
    Compound: 2
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    HepG2 IC50
    5.62 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    HCT-8 IC50
    26.3 3
    Compound: 2; VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    HCT-8 IC50
    6.4 3
    Compound: etoposide
    Cytotoxicity against human HCT8 cells after 5 days by MTT assay
    Cytotoxicity against human HCT8 cells after 5 days by MTT assay
    		[PMID: 8778240]
    HepG2 IC50
    6.2 6
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    HCT-8 IC50
    6.54 3
    Compound: VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    HepG2 IC50
    6.2 6
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    HepG2 IC50
    6.41 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 23668986]
    HCT-8 IC50
    7.06 3
    Compound: 2, VP-16
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    HCT-8 IC50
    7.06 3
    Compound: 2, VP-16
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    HepG2 EC50
    60.5 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 31096154]
    HEF IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against HEF after 72 hrs by MTT assay
    Cytotoxicity against HEF after 72 hrs by MTT assay
    		[PMID: 30447888]
    HepG2 IC50
    9.14 3
    Compound: Etoposide
    Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    HEK-293T IC50
    1.39 3
    Compound: VP-16
    Cytotoxicity against human HEK293T cells measured after 72 hrs by MTT assay
    Cytotoxicity against human HEK293T cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HepG2 IC50
    9.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    HepG2 EC50
    9.8 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by CellTiter Glo assay
    Cytotoxicity against human HepG2 cells after 48 hrs by CellTiter Glo assay
    		10.1039/C4MD00409D
    HEK-293T IC50
    11.47 3
    Compound: Etoposide
    Cytotoxicity against HEK293T cells after 36 hrs by MTT assay
    Cytotoxicity against HEK293T cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    HEK-293T IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against HEK293T cells assessed as cells growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against HEK293T cells assessed as cells growth inhibition after 48 hrs by MTT assay
    		[PMID: 27994737]
    HFL1 IC50
    87.63 3
    Compound: Etoposide
    Antiproliferative activity against HFL1 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against HFL1 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    HEK-293T IC50
    22 3
    Compound: Etoposide
    Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    HGC-27 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HGC-27 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HGC-27 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HEK-293T IC50
    28 3
    Compound: Etoposide
    Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    HL-60 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human HL60 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human HL60 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    HL-60 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human HL60 cells after 48 hrs by SRB assay
    Anticancer activity against human HL60 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HL-60 IC50
    0.025 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11170674]
    HEK293 IC50
    0.41 3
    Compound: ETO
    Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
    Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    HL-60 IC50
    0.042 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 20415462]
    HEK293 IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 27533261]
    HL-60 IC50
    0.042 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 19769341]
    HEK293 IC50
    0.69 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 48 hrs by MTT assay
    Cytotoxicity against HEK293 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HL-60 IC50
    0.042 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by SRB assay
    Cytotoxicity against human HL60 cells after 24 hrs by SRB assay
    		[PMID: 19685913]
    HEK293 IC50
    0.72 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 2 days by CCK-8 assay
    Cytotoxicity against HEK293 cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    HL-60 IC50
    0.06 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    HEK293 IC50
    1.04 3
    Compound: Etoposide
    Cytotoxicity against HEK293 cells after 4 days by CCK-8 assay
    Cytotoxicity against HEK293 cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    HL-60 IC50
    0.11 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    HEK293 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human HEK293 cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human HEK293 cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    HL-60 IC50
    0.16 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HEK293 IC50
    1.74 3
    Compound: Etoposide
    Antiproliferative activity against HEK293 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against HEK293 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    HL-60 IC50
    0.16 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 5 days by MTT assay
    Cytotoxicity against human HL60 cells after 5 days by MTT assay
    		[PMID: 8778240]
    HEK293 IC50
    7.51 3
    Compound: ETP
    Antiproliferative activity against HEK293 cells after 48 hrs by SRB assay
    Antiproliferative activity against HEK293 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    HL-60 IC50
    0.18 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by CCK8 method
    Cytotoxicity against human HL60 cells after 72 hrs by CCK8 method
    		[PMID: 20071056]
    HEK293 IC50
    702.8 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HEK293 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) HEK293 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    HL-60 IC50
    0.19 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    HL-60 IC50
    0.2 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11908966]
    HEK293 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as decrease in cell growth after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 18507472]
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 14738377]
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by SRB assay
    Cytotoxicity against human HL60 cells by SRB assay
    		[PMID: 18651771]
    HL-60 IC50
    0.21 3
    Compound: etoposide
    Antiproliferative effect against human HL60 cells after 69 hrs
    Antiproliferative effect against human HL60 cells after 69 hrs
    		[PMID: 16499324]
    HL-60 IC50
    0.23 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 15497941]
    HL-60 IC50
    0.25 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11520229]
    HL-60 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    HL-60 IC50
    0.26 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 19449879]
    HL-60 IC50
    0.3 6
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 9917320]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 12398537]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 12398536]
    HEL ED50
    8.64 3
    Compound: 2 (Etoposide)
    Inhibitory activity against human cytomegalovirus (HCMV) in HEL cells
    Inhibitory activity against human cytomegalovirus (HCMV) in HEL cells
    		[PMID: 11311065]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 10514313]
    HEL IC50
    0.92 3
    Compound: ETP
    Growth inhibition of HEL cells after 72 hrs by MTT assay
    Growth inhibition of HEL cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    HL-60 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27598828]
    HL-60 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human HL60 cell line by MTT assay
    Cytotoxicity against human HL60 cell line by MTT assay
    		[PMID: 17243725]
    HL-60 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HL-60 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HL-60 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    HL-60 IC50
    0.31 3
    Compound: 2
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    HEp-2 IC50
    0.9 3
    Compound: Etoposide
    Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    HL-60 IC50
    0.33 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    HEp-2 IC50
    2.15 3
    Compound: 2
    Cytotoxicity against human HEP2 cells by sulforhodamine B assay
    Cytotoxicity against human HEP2 cells by sulforhodamine B assay
    		[PMID: 17988764]
    HL-60 IC50
    0.33 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    HEp-2 IC50
    2.15 3
    Compound: 2
    Cytotoxicity against human Hep2 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human Hep2 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    HL-60 IC50
    0.37 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 3 days by SRB assay
    Cytotoxicity against human HL60 cells after 3 days by SRB assay
    		[PMID: 18321715]
    HFL1 IC50
    87.63 3
    Compound: Etoposide
    Antiproliferative activity against HFL1 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against HFL1 cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    HL-60 IC50
    0.37 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by SRB assay
    Cytotoxicity against human HL60 cells by SRB assay
    		[PMID: 17194596]
    HGC-27 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HGC-27 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HGC-27 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HL-60 IC50
    0.39 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 20524638]
    HL-60 GI50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis
    		[PMID: 25874335]
    HL-60 IC50
    0.42 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs
    Cytotoxicity against human HL60 cells after 48 hrs
    		[PMID: 20053564]
    HL-60 IC50
    0.42 3
    Compound: Etoposide
    Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HL-60 IC50
    0.47 6
    Compound: Etoposide
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 21816519]
    HL-60 IC50
    0.486 3
    Compound: Etop
    Cytotoxicity against human HL60 cells after 72 hrs
    Cytotoxicity against human HL60 cells after 72 hrs
    		[PMID: 20961767]
    HL-60 IC50
    0.486 3
    Compound: Etop, etoposide
    Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs
    Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs
    		[PMID: 18507368]
    HL-60 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27145162]
    HL-60 IC50
    0.5 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 23865778]
    HL-60 IC50
    0.58 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    HL-60 GI50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis
    		[PMID: 25874335]
    HL-60 IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 25014747]
    HL-60 GI50
    140 1
    Compound: VP-16, etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 17962028]
    HL-60 IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    		[PMID: 19419803]
    HL-60 IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells after 3 days by MTT assay
    Cytotoxicity against human HL-60 cells after 3 days by MTT assay
    		[PMID: 19013074]
    HL-60 IC50
    0.8 3
    Compound: etoposide
    Antitumor against human HL60 cells after 72 hrs by MTT assay
    Antitumor against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    HL-60 IC50
    0.85 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HL-60 IC50
    0.025 3
    Compound: Etoposide
    Tested for the cytostatic activity as inhibitory concentration against leukemia HL-60 cells
    Tested for the cytostatic activity as inhibitory concentration against leukemia HL-60 cells
    		10.1016/S0960-894X(97)00071-1
    HL-60 IC50
    0.025 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as reduction in cell survival
    Cytotoxicity against human HL60 cells assessed as reduction in cell survival
    		[PMID: 27234147]
    HL-60 IC50
    0.86 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    HL-60 IC50
    0.025 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11170674]
    HL-60 IC50
    0.86 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    HL-60 IC50
    0.93 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19836231]
    HL-60 IC50
    0.03 3
    Compound: Etoposide
    Cytostatic activity against human HL60 cells
    Cytostatic activity against human HL60 cells
    		[PMID: 30738653]
    HL-60 IC50
    0.97 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    HL-60 IC50
    0.042 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 19769341]
    HL-60 IC50
    0.042 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 20415462]
    HL-60 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days
    Cytotoxicity against human HL60 cells after 2 days
    		[PMID: 21601964]
    HL-60 IC50
    0.042 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by SRB assay
    Cytotoxicity against human HL60 cells after 24 hrs by SRB assay
    		[PMID: 19685913]
    HL-60 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HL60 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HL-60 IC50
    0.06 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    HL-60 IC50
    1.1 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 22704923]
    HL-60 IC50
    0.11 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    HL-60 IC50
    1.15 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 23711769]
    HL-60 IC50
    0.123 3
    Compound: etoposide
    In vitro inhibitory concentration against proliferation of HL60 cells
    In vitro inhibitory concentration against proliferation of HL60 cells
    		[PMID: 12877593]
    HL-60 IC50
    1.15 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by cell counting kit-8 assay
    Cytotoxicity against human HL60 cells after 48 hrs by cell counting kit-8 assay
    		[PMID: 24140948]
    HL-60 IC50
    0.15 6
    Compound: Etoposide
    Cytotoxic activity against human tumor HL-60 leukemia cells
    Cytotoxic activity against human tumor HL-60 leukemia cells
    		[PMID: 15056007]
    HL-60 IC50
    1.2 3
    Compound: ETP
    Cytotoxic activity against human promyelocytic leukemia HL-60 concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against human promyelocytic leukemia HL-60 concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    HL-60 IC50
    0.16 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HL-60 IC50
    1.28 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days
    Cytotoxicity against human HL60 cells after 2 days
    		[PMID: 21419530]
    HL-60 IC50
    0.16 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 5 days by MTT assay
    Cytotoxicity against human HL60 cells after 5 days by MTT assay
    		[PMID: 8778240]
    HL-60 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human topoisomerase 2-sensitive HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human topoisomerase 2-sensitive HL60 cells after 72 hrs by MTT assay
    		[PMID: 20570510]
    HL-60 IC50
    0.18 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells after 72 hrs by CCK8 method
    Cytotoxicity against human HL60 cells after 72 hrs by CCK8 method
    		[PMID: 20071056]
    HL-60 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    HL-60 IC50
    1.81 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 20356735]
    HL-60 IC50
    0.19 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    HL-60 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days by MTT assay
    Cytotoxicity against human HL60 cells after 2 days by MTT assay
    		[PMID: 22325897]
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 14738377]
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 18507472]
    HL-60 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19036584]
    HL-60 IC50
    1.84 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    HL-60 IC50
    0.2 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by SRB assay
    Cytotoxicity against human HL60 cells by SRB assay
    		[PMID: 18651771]
    HL-60 IC50
    0.21 3
    Compound: etoposide
    Antiproliferative effect against human HL60 cells after 69 hrs
    Antiproliferative effect against human HL60 cells after 69 hrs
    		[PMID: 16499324]
    HL-60 IC50
    10.5 3
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 16933865]
    HL-60 IC50
    0.23 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 15497941]
    HL-60 GI50
    140 1
    Compound: VP-16, etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 17962028]
    HL-60 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    HL-60 IC50
    150 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 15974606]
    HL-60 IC50
    0.25 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11520229]
    HL-60 IC50
    1643 14
    Compound: Etoposide
    Cytotoxicity was assessed using drug-sensitive human leukemic cell line HL60/S
    Cytotoxicity was assessed using drug-sensitive human leukemic cell line HL60/S
    		[PMID: 11170627]
    HL-60 IC50
    0.26 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 19449879]
    HL-60 IC50
    18088 14
    Compound: Etoposide
    Cytotoxicity was assessed using vincristine-resistant human leukemic cell line HL60/Vinc
    Cytotoxicity was assessed using vincristine-resistant human leukemic cell line HL60/Vinc
    		[PMID: 11170627]
    HL-60 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    HL-60 IC50
    0.2 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 11908966]
    HL-60 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27598828]
    HL-60 IC50
    2.12 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    HL-60 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human HL60 cell line by MTT assay
    Cytotoxicity against human HL60 cell line by MTT assay
    		[PMID: 17243725]
    HL-60 IC50
    2.13 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    HL-60 IC50
    0.31 3
    Compound: 2
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    HL-60 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19782567]
    HL-60 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HL-60 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HL-60 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    HL-60 IC50
    2.85 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
    		[PMID: 22244588]
    HL-60 IC50
    0.33 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    HL-60 IC50
    2.85 3
    Compound: 5, VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 22041063]
    HL-60 IC50
    20 3
    Compound: ET
    Cytotoxicity against human HL60 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HL-60 IC50
    0.33 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    HL-60 IC50
    0.367 3
    Compound: ETP
    Relative cytotoxicity against human promyelocytic leukemia(HL-60) cells
    Relative cytotoxicity against human promyelocytic leukemia(HL-60) cells
    		[PMID: 10377219]
    HL-60 IC50
    25 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    		[PMID: 15974617]
    HL-60 IC50
    0.37 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by SRB assay
    Cytotoxicity against human HL60 cells by SRB assay
    		[PMID: 17194596]
    HL-60 IC50
    3.3 3
    Compound: Vp-16
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 19251420]
    HL-60 IC50
    0.37 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 3 days by SRB assay
    Cytotoxicity against human HL60 cells after 3 days by SRB assay
    		[PMID: 18321715]
    HL-60 IC50
    315 1
    Compound: etoposide
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 18513974]
    HL-60 IC50
    0.39 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 20524638]
    HL-60 IC50
    48.5 3
    Compound: Etop
    Cytotoxicity against human HL60/MX2 cells after 72 hrs
    Cytotoxicity against human HL60/MX2 cells after 72 hrs
    		[PMID: 20961767]
    HL-60 IC50
    0.3 6
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 9917320]
    HL-60 IC50
    5.4 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 11473438]
    HL-60 IC50
    5.48 3
    Compound: 2
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 23867385]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 10514313]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 12398536]
    HL-60 IC50
    54940 14
    Compound: Etoposide
    Cytotoxicity was assessed using adriamycin-resistant human leukemic cell line HL60/ADR
    Cytotoxicity was assessed using adriamycin-resistant human leukemic cell line HL60/ADR
    		[PMID: 11170627]
    HL-60 IC50
    0.3 6
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 12398537]
    HL-60 IC50
    8.12 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    HL-60 IC50
    0.42 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs
    Cytotoxicity against human HL60 cells after 48 hrs
    		[PMID: 20053564]
    HL-60(TB) IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL-60(TB) cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60(TB) cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    HL-60 IC50
    0.42 3
    Compound: Etoposide
    Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HL60/MX2 IC50
    11.9 3
    Compound: Etoposide
    Cytotoxicity against human HL60/MX2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60/MX2 cells after 72 hrs by MTT assay
    		[PMID: 20570510]
    HL-60 IC50
    0.47 6
    Compound: Etoposide
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    Anticancer activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 21816519]
    HL60/MX2 IC50
    48.5 3
    Compound: Etop, etoposide
    Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs
    Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs
    		[PMID: 18507368]
    HL-60 IC50
    0.486 3
    Compound: Etop
    Cytotoxicity against human HL60 cells after 72 hrs
    Cytotoxicity against human HL60 cells after 72 hrs
    		[PMID: 20961767]
    HL60/MX2 GI50
    5980 1
    Compound: VP-16, etoposide
    Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay
    Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay
    		[PMID: 17962028]
    HL60/MX2 IC50
    9.02 3
    Compound: Etoposide
    Antiproliferative activity against human HL60/MX2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60/MX2 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HL-60 IC50
    0.486 3
    Compound: Etop, etoposide
    Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs
    Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs
    		[PMID: 18507368]
    HMEC IC50
    21.5 3
    Compound: VP-16
    Cytotoxicity against HMEC after 48 hrs by MTT assay
    Cytotoxicity against HMEC after 48 hrs by MTT assay
    		[PMID: 30265994]
    HL-60 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27145162]
    HMLE IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human shGFP-fused HMLE cells after 72 hrs by MTT assay
    Antiproliferative activity against human shGFP-fused HMLE cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    HL-60 IC50
    0.5 3
    Compound: etoposide
    In vitro inhibitory concentration against proliferation of HL60R cells along with 5 (uM) verapamil
    In vitro inhibitory concentration against proliferation of HL60R cells along with 5 (uM) verapamil
    		[PMID: 12877593]
    HL-60 IC50
    0.5 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 23865778]
    HONE1 cell line IC50
    1.2 3
    Compound: etoposide
    Cytotoxicity against human HONE1 cells after 72 hrs by methylene blue dye assay
    Cytotoxicity against human HONE1 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19785430]
    HL-60 IC50
    0.58 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    HONE1 cell line IC50
    1.2 3
    Compound: Etoposide
    Cytotoxicity against human HONE1 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HONE1 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    HL-60 IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 25014747]
    HOP-62 GI50
    0.8 3
    Compound: 2, Eto
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    HL-60 IC50
    0.61 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells
    Cytotoxicity against human HL60 cells
    		10.1039/C2MD20199B
    HOP-62 GI50
    0.8 3
    Compound: 2, Eto
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    HL-60 IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells after 3 days by MTT assay
    Cytotoxicity against human HL-60 cells after 3 days by MTT assay
    		[PMID: 19013074]
    HOP-62 GI50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HOP62 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    HOP-62 GI50
    0.8 3
    Compound: 2, VP-16
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    HL-60 IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    		[PMID: 19419803]
    HL-60 IC50
    0.8 3
    Compound: etoposide
    Antitumor against human HL60 cells after 72 hrs by MTT assay
    Antitumor against human HL60 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    HOS GI50
    36.56 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human HOS cells by MTT assay
    Cytotoxicity against human HOS cells by MTT assay
    		[PMID: 32992133]
    Hs 683 IC50
    1 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    HL-60 IC50
    0.85 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    Cytotoxicity against human HL60 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HL-60 IC50
    0.86 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 72 hrs by ATPlite assay
    		[PMID: 26793989]
    Hs 683 GI50
    1.5 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    HL-60 IC50
    0.86 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by ATPlite assay
    		[PMID: 27096049]
    Hs 683 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    Hs-578T IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human Hs 578T cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human Hs 578T cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    HL-60 IC50
    0.93 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19836231]
    HL-60 IC50
    0.97 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    HSC-2 IC50
    24 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells by MTT assay
    Cytotoxicity against human HSC2 cells by MTT assay
    		[PMID: 12828488]
    HSC-2 IC50
    24 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells by MTT assay
    Cytotoxicity against human HSC2 cells by MTT assay
    		[PMID: 11908966]
    HL-60 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HL60 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HSC-2 IC50
    24 3
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 17125230]
    HL-60 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days
    Cytotoxicity against human HL60 cells after 2 days
    		[PMID: 21601964]
    HSC-2 IC50
    24.4 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 15497941]
    HL-60 IC50
    1.15 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 23711769]
    HSC-2 IC50
    24.4 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 12398537]
    HL-60 IC50
    1.15 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by cell counting kit-8 assay
    Cytotoxicity against human HL60 cells after 48 hrs by cell counting kit-8 assay
    		[PMID: 24140948]
    HSC-2 IC50
    41 3
    Compound: etoposide
    Cytotoxicity against human HSC2 cells assessed as cell viability after 24 hrs
    Cytotoxicity against human HSC2 cells assessed as cell viability after 24 hrs
    		[PMID: 15620262]
    HL-60 IC50
    1.1 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 22704923]
    HL-60 IC50
    1.2 3
    Compound: ETP
    Cytotoxic activity against human promyelocytic leukemia HL-60 concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against human promyelocytic leukemia HL-60 concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    HT-1080 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HT1080 cells after 3 days by SRB assay
    Cytotoxicity against human HT1080 cells after 3 days by SRB assay
    		[PMID: 18321715]
    HT-1080 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HT1080 cells by SRB assay
    Cytotoxicity against human HT1080 cells by SRB assay
    		[PMID: 17194596]
    HL-60 IC50
    1.28 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days
    Cytotoxicity against human HL60 cells after 2 days
    		[PMID: 21419530]
    HL-60 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human topoisomerase 2-sensitive HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human topoisomerase 2-sensitive HL60 cells after 72 hrs by MTT assay
    		[PMID: 20570510]
    HT-1080 IC50
    2 3
    Compound: 1
    Antiproliferative activity against human HT-1080 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HT-1080 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    HT-1080 IC50
    750 1
    Compound: VP16
    Antiproliferative activity against human HT1080 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HT1080 cells after 96 hrs by MTT assay
    		[PMID: 21296467]
    HL-60 IC50
    1.4 3
    Compound: Eto, VEPESID
    Cytotoxicity against human HL60 cells
    Cytotoxicity against human HL60 cells
    		[PMID: 21439821]
    HL-60 IC50
    1.44 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells
    Cytotoxicity against human HL60 cells
    		[PMID: 18178085]
    HT-29 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HL-60 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    HT-29 GI50
    0.73 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
    Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
    		[PMID: 19572549]
    HT-29 IC50
    1.42 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    HL-60 IC50
    1.81 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 20356735]
    HL-60 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19036584]
    HT-29 IC50
    1.47 3
    Compound: 2
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    HL-60 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 2 days by MTT assay
    Cytotoxicity against human HL60 cells after 2 days by MTT assay
    		[PMID: 22325897]
    HT-29 IC50
    1.64 3
    Compound: V
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    HL-60 IC50
    1.84 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    HT-29 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    HT-29 IC50
    1.81 3
    Compound: 2, Etop
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    HL-60 IC50
    10.5 3
    Compound: etoposide
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay
    		[PMID: 16933865]
    HL-60 IC50
    12 3
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells assessed as inhibition of cell growth
    Cytotoxicity against human HL-60 cells assessed as inhibition of cell growth
    		[PMID: 36690039]
    HT-29 IC50
    1.81 3
    Compound: 2a, VP-16
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    HL-60 IC50
    150 3
    Compound: etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 15974606]
    HT-29 IC50
    1.87 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    HL-60 IC50
    1643 14
    Compound: Etoposide
    Cytotoxicity was assessed using drug-sensitive human leukemic cell line HL60/S
    Cytotoxicity was assessed using drug-sensitive human leukemic cell line HL60/S
    		[PMID: 11170627]
    HT-29 IC50
    1.98 3
    Compound: 2
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    HL-60 IC50
    18088 14
    Compound: Etoposide
    Cytotoxicity was assessed using vincristine-resistant human leukemic cell line HL60/Vinc
    Cytotoxicity was assessed using vincristine-resistant human leukemic cell line HL60/Vinc
    		[PMID: 11170627]
    HT-29 IC50
    15 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells measured after 24 to 72 hrs by SRB assay
    Cytotoxicity against human HT-29 cells measured after 24 to 72 hrs by SRB assay
    		[PMID: 29656990]
    HL-60 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    HT-29 IC50
    18.5 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    HL-60 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human HL-60 cells assessed as cell growth inhibition by MTT assay
    Cytotoxicity against human HL-60 cells assessed as cell growth inhibition by MTT assay
    		[PMID: 37676247]
    HT-29 IC50
    2 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    HL-60 IC50
    2.12 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    HT-29 IC50
    2.2 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    HL-60 IC50
    2.13 6
    Compound: Etoposide
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    HT-29 IC50
    2.3 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue dye assay
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19785430]
    HT-29 IC50
    2.3 3
    Compound: VP-16
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue assay
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue assay
    		[PMID: 14738395]
    HL-60 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 19782567]
    HL-60 IC50
    2.85 3
    Compound: 2, VP-16
    Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
    		[PMID: 22244588]
    HT-29 IC50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 5 days by sulforhodamine B assay
    Antiproliferative activity against human HT-29 cells after 5 days by sulforhodamine B assay
    		[PMID: 24864039]
    HL-60 IC50
    2.85 3
    Compound: 5, VP-16
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 22041063]
    HT-29 IC50
    2.5 3
    Compound: VP-16
    Antiproliferative activity against human HT-29 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human HT-29 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    HL-60 IC50
    20 3
    Compound: ET
    Cytotoxicity against human HL60 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HT-29 IC50
    2.5 3
    Compound: VP-16
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    HL-60 IC50
    25 1
    Compound: ETOPOSIDE
    Compound was tested for its anticancer activity against HL-60 cells.
    Compound was tested for its anticancer activity against HL-60 cells.
    		10.1016/S0960-894X(96)00486-6
    HT-29 IC50
    21.45 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    HL-60 IC50
    25 3
    Compound: Etoposide
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 24 hrs by MTT assay
    		[PMID: 15974617]
    HT-29 IC50
    21.45 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    HL-60 IC50
    3.3 3
    Compound: Vp-16
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 19251420]
    HT-29 IC50
    25.63 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    HL-60 IC50
    315 1
    Compound: etoposide
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 18513974]
    HT-29 IC50
    30.38 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    HL-60 IC50
    48.5 3
    Compound: Etop
    Cytotoxicity against human HL60/MX2 cells after 72 hrs
    Cytotoxicity against human HL60/MX2 cells after 72 hrs
    		[PMID: 20961767]
    HT-29 GI50
    31.6 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    HL-60 IC50
    490 1
    Compound: Etoposide
    Cytotoxicity against human HL60 cells
    Cytotoxicity against human HL60 cells
    		[PMID: 20863598]
    HT-29 GI50
    31.6 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    HL-60 IC50
    5.4 3
    Compound: VP-16
    Cytotoxicity against human HL60 cells by MTT assay
    Cytotoxicity against human HL60 cells by MTT assay
    		[PMID: 11473438]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    HL-60 IC50
    5.48 3
    Compound: 2
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    		[PMID: 23867385]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 23831811]
    HL-60 IC50
    54940 14
    Compound: Etoposide
    Cytotoxicity was assessed using adriamycin-resistant human leukemic cell line HL60/ADR
    Cytotoxicity was assessed using adriamycin-resistant human leukemic cell line HL60/ADR
    		[PMID: 11170627]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    HL-60 IC50
    6.5 3
    Compound: etoposide
    In vitro inhibitory concentration against proliferation of HL60R cells
    In vitro inhibitory concentration against proliferation of HL60R cells
    		[PMID: 12877593]
    HL-60 IC50
    8.12 3
    Compound: Etoposide
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    HL-60 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human HL60 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human HL60 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    HT-29 IC50
    4.21 6
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    HL-60 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human HL60 cells after 48 hrs by SRB assay
    Anticancer activity against human HL60 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HT-29 IC50
    6.32 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells by MTT assay
    Cytotoxicity against human HT-29 cells by MTT assay
    		[PMID: 19836231]
    HL-60(TB) IC50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HL-60(TB) cells after 72 hrs by MTT assay
    Cytotoxicity against human HL-60(TB) cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    HT-29 IC50
    7.6 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells by MTT assay
    Antiproliferative activity against human HT-29 cells by MTT assay
    		[PMID: 29072457]
    HL60/MX2 GI50
    5980 1
    Compound: VP-16, etoposide
    Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay
    Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay
    		[PMID: 17962028]
    HT-29 IC50
    9 3
    Compound: 1
    Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    HL60/MX2 IC50
    11.9 3
    Compound: Etoposide
    Cytotoxicity against human HL60/MX2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60/MX2 cells after 72 hrs by MTT assay
    		[PMID: 20570510]
    HT-29 GI50
    9.4 3
    Compound: Etoposide
    Growth inhibition of human HT-29 cells after 72 hrs by SRB assay
    Growth inhibition of human HT-29 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    HL60/MX2 IC50
    15.75 3
    Compound: Eto, VEPESID
    Cytotoxicity against human HL60/MX2 cells
    Cytotoxicity against human HL60/MX2 cells
    		[PMID: 21439821]
    HuCC-A1 IC50
    4 6
    Compound: Etoposide
    Cytotoxicity against human HuCCa1 cells after 3 days by MTT assay
    Cytotoxicity against human HuCCa1 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HL60/MX2 IC50
    48.5 3
    Compound: Etop, etoposide
    Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs
    Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs
    		[PMID: 18507368]
    Huh-7 IC50
    17.3 3
    Compound: Vp-16
    Antiproliferative activity against human Huh-7 cells after 72 hrs by SRB assay
    Antiproliferative activity against human Huh-7 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    HL60/MX2 IC50
    9.02 3
    Compound: Etoposide
    Antiproliferative activity against human HL60/MX2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HL60/MX2 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    Huh-7 IC50
    7.4 3
    Compound: VP-16
    Cytotoxicity against human HuH7 cells by MTT assay
    Cytotoxicity against human HuH7 cells by MTT assay
    		[PMID: 30543429]
    HLE ED50
    1.5 6
    Compound: VP-16
    Inhibition of growth of hepatoma HLE cell line
    Inhibition of growth of hepatoma HLE cell line
    		[PMID: 8389875]
    Huh-7 IC50
    8.9 3
    Compound: vp16
    Antiproliferative activity against human Huh-7 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human Huh-7 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HMEC IC50
    21.5 3
    Compound: VP-16
    Cytotoxicity against HMEC after 48 hrs by MTT assay
    Cytotoxicity against HMEC after 48 hrs by MTT assay
    		[PMID: 30265994]
    HUVEC IC50
    > 200 3
    Compound: Etop
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    HMLE IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human shGFP-fused HMLE cells after 72 hrs by MTT assay
    Antiproliferative activity against human shGFP-fused HMLE cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    HUVEC IC50
    1.25 3
    Compound: VP-16
    Cytotoxicity against HUVEC assessed as cell viability after 48 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as cell viability after 48 hrs by MTT assay
    		[PMID: 24012378]
    HOP-62 GI50
    0.8 3
    Compound: 2, Eto
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    HUVEC IC50
    1.342 3
    Compound: Etoposide
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    HUVEC IC50
    1.86 3
    Compound: Etoposide
    Cytotoxicity against HUVEC by sulforhodamine B assay
    Cytotoxicity against HUVEC by sulforhodamine B assay
    		[PMID: 21936523]
    HOP-62 GI50
    0.8 3
    Compound: 2, Eto
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    HOP-62 GI50
    0.8 3
    Compound: 2, VP-16
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    HUVEC IC50
    29 3
    Compound: Etop
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    HOP-62 GI50
    0.8 3
    Compound: Etoposide
    Cytotoxicity against human HOP62 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HOP62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    HUVEC IC50
    5.2 3
    Compound: Etoposide
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 30776691]
    HOS GI50
    36.56 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human HOS cells by MTT assay
    Cytotoxicity against human HOS cells by MTT assay
    		[PMID: 32992133]
    HUVEC IC50
    5.21 3
    Compound: Etoposide
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 29778894]
    HSC-2 IC50
    24 3
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 17125230]
    IMR-32 IC50
    6.3 3
    Compound: Etoposide
    Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    HSC-2 IC50
    24.4 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 12398537]
    J82 IC50
    0.8 3
    Compound: Etoposide
    Anticancer activity against human J82 cells after 3 days by MTT assay
    Anticancer activity against human J82 cells after 3 days by MTT assay
    		[PMID: 21621882]
    HSC-2 IC50
    24.4 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HSC2 cells after 24 hrs by MTT assay
    		[PMID: 15497941]
    J82 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    		[PMID: 19419803]
    HSC-2 IC50
    24 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells by MTT assay
    Cytotoxicity against human HSC2 cells by MTT assay
    		[PMID: 11908966]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    		[PMID: 19013074]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    HSC-2 IC50
    24 6
    Compound: etoposide
    Cytotoxicity against human HSC2 cells by MTT assay
    Cytotoxicity against human HSC2 cells by MTT assay
    		[PMID: 12828488]
    HSC-2 IC50
    41 3
    Compound: etoposide
    Cytotoxicity against human HSC2 cells assessed as cell viability after 24 hrs
    Cytotoxicity against human HSC2 cells assessed as cell viability after 24 hrs
    		[PMID: 15620262]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    HT-1080 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HT1080 cells by SRB assay
    Cytotoxicity against human HT1080 cells by SRB assay
    		[PMID: 17194596]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    HT-1080 IC50
    0.25 3
    Compound: etoposide
    Cytotoxicity against human HT1080 cells after 3 days by SRB assay
    Cytotoxicity against human HT1080 cells after 3 days by SRB assay
    		[PMID: 18321715]
    J82 IC50
    2.8 3
    Compound: etoposide
    Antitumor against human J82 cells after 72 hrs by MTT assay
    Antitumor against human J82 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    HT-1080 IC50
    2 3
    Compound: 1
    Antiproliferative activity against human HT-1080 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HT-1080 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    Jurkat IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human Jurkat cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human Jurkat cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    HT-1080 IC50
    750 1
    Compound: VP16
    Antiproliferative activity against human HT1080 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HT1080 cells after 96 hrs by MTT assay
    		[PMID: 21296467]
    Jurkat IC50
    1.2 3
    Compound: VP-16
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    Jurkat IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    Jurkat IC50
    2.8 6
    Compound: Etoposide
    Anticancer activity against human Jurkat cells after 48 hrs by MTT assay
    Anticancer activity against human Jurkat cells after 48 hrs by MTT assay
    		[PMID: 21816519]
    Jurkat IC50
    5.35 3
    Compound: Etoposide
    Cytotoxicity against human Jurkat cells after 2 days by MTT assay
    Cytotoxicity against human Jurkat cells after 2 days by MTT assay
    		[PMID: 22325897]
    K562 IC50
    > 200 3
    Compound: Etop
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    K562 IC50
    0.163 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as cell growth inhibition after 72 hrs by MTS assay
    Cytotoxicity against human K562 cells assessed as cell growth inhibition after 72 hrs by MTS assay
    		[PMID: 25922181]
    K562 IC50
    0.183 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    K562 IC50
    0.32 3
    Compound: etoposide
    Cytotoxicity against human K562 cells after 5 days by XTT assay
    Cytotoxicity against human K562 cells after 5 days by XTT assay
    		[PMID: 18076140]
    K562 IC50
    0.32 3
    Compound: etoposide
    Growth inhibition of K562 cells by XTT assay after 5 days
    Growth inhibition of K562 cells by XTT assay after 5 days
    		[PMID: 17411092]
    K562 IC50
    0.345 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27484511]
    HT-29 GI50
    0.73 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
    Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay
    		[PMID: 19572549]
    K562 IC50
    0.413 3
    Compound: 2
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    		[PMID: 27503681]
    HT-29 GI50
    15.13 3
    Compound: Etoposide
    In vitro cytotoxicity against human colon cancer HT 29 cell line
    In vitro cytotoxicity against human colon cancer HT 29 cell line
    		[PMID: 9871772]
    K562 IC50
    0.413 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    HT-29 GI50
    31.6 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    K562 IC50
    0.42 3
    Compound: 1
    Cytotoxicity against human K562 cells after 72 hrs by MTS assay
    Cytotoxicity against human K562 cells after 72 hrs by MTS assay
    		[PMID: 20006518]
    HT-29 GI50
    31.6 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    K562 IC50
    0.51 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    K562 IC50
    0.76 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    K562 IC50
    0.76 3
    Compound: Etoposide
    Growth inhibition of human K562 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human K562 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 23831811]
    K562 IC50
    0.764 3
    Compound: 2
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    		[PMID: 29678463]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    K562 IC50
    0.98 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    HT-29 GI50
    31.62 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    K562 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method
    		[PMID: 32992133]
    K562 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells by MTT assay
    Cytotoxicity against human K562 cells by MTT assay
    		[PMID: 21115246]
    HT-29 GI50
    9.4 3
    Compound: Etoposide
    Growth inhibition of human HT-29 cells after 72 hrs by SRB assay
    Growth inhibition of human HT-29 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    K562 IC50
    1.22 3
    Compound: Etoposide
    Cytotoxicity against human etoposide-sensitive K562 cells after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay
    Cytotoxicity against human etoposide-sensitive K562 cells after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay
    		[PMID: 29656990]
    HT-29 IC50
    0.2 3
    Compound: VP-16
    Antiproliferative activity against human HT-29 colon cell line
    Antiproliferative activity against human HT-29 colon cell line
    		[PMID: 10498216]
    HT-29 IC50
    1.3 6
    Compound: Etoposide
    Cytotoxic activity of compound against HT-29 colon human tumor cell line
    Cytotoxic activity of compound against HT-29 colon human tumor cell line
    		[PMID: 12459024]
    K562 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    HT-29 IC50
    1.42 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    K562 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    HT-29 IC50
    1.47 3
    Compound: 2
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    K562 IC50
    1.64 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    HT-29 IC50
    1.64 3
    Compound: V
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    K562 IC50
    1.77 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HT-29 IC50
    1.7 6
    Compound: 1
    Growth inhibition of HT-29 (human colon adenocarcinoma) cell line.
    Growth inhibition of HT-29 (human colon adenocarcinoma) cell line.
    		[PMID: 2002477]
    K562 IC50
    1.79 3
    Compound: Etoposide
    Cytotoxicity in human K562 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human K562 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    HT-29 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    K562 IC50
    1.87 3
    Compound: Etoposide
    Cytotoxicity against human K-562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K-562 cells after 72 hrs by MTT assay
    		[PMID: 16872135]
    HT-29 IC50
    1.81 3
    Compound: 2, Etop
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    Anticancer activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    K562 IC50
    1.98 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human K562 cells by SRB assay
    Cytotoxicity against human K562 cells by SRB assay
    		[PMID: 32992133]
    HT-29 IC50
    1.81 3
    Compound: 2a, VP-16
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    K562 IC50
    10.79 3
    Compound: VP16
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33191085]
    HT-29 IC50
    1.87 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    K562 IC50
    11.3 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB assay
    		[PMID: 35182774]
    HT-29 IC50
    1.98 3
    Compound: 2
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    K562 IC50
    12 3
    Compound: ET
    Cytotoxicity against human K562 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    HT-29 IC50
    10 3
    Compound: 1
    Tested for cytotoxicity against Colon carcinoma type HT-29 cell line expressing MDR-1 (-) gene; 35% of cells were affected
    Tested for cytotoxicity against Colon carcinoma type HT-29 cell line expressing MDR-1 (-) gene; 35% of cells were affected
    		[PMID: 11844671]
    K562 GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    HT-29 IC50
    15 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells measured after 24 to 72 hrs by SRB assay
    Cytotoxicity against human HT-29 cells measured after 24 to 72 hrs by SRB assay
    		[PMID: 29656990]
    K562 GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    HT-29 IC50
    1700 1
    Compound: 1a
    In vitro cytotoxicity against the HT-29 (human colon carcinoma) neoplastic cell line
    In vitro cytotoxicity against the HT-29 (human colon carcinoma) neoplastic cell line
    		[PMID: 14980682]
    K562 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 2 days
    Cytotoxicity against human K562 cells after 2 days
    		[PMID: 22318164]
    K562 IC50
    2.11 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 2 days by MTT assay
    Cytotoxicity against human K562 cells after 2 days by MTT assay
    		[PMID: 21821321]
    HT-29 IC50
    18.5 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human HT-29 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    K562 IC50
    2.3 3
    Compound: etoposide
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    HT-29 IC50
    2 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    HT-29 IC50
    2.2 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    K562 IC50
    2.41 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 4 days by ELISA reader assay
    Cytotoxicity against human K562 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    HT-29 IC50
    2.3 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells after 5 days by sulforhodamine B assay
    Antiproliferative activity against human HT-29 cells after 5 days by sulforhodamine B assay
    		[PMID: 24864039]
    K562 IC50
    2.85 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 24 hrs by MTT assay
    Cytotoxicity against human K562 cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    HT-29 IC50
    2.3 3
    Compound: VP-16
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue assay
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue assay
    		[PMID: 14738395]
    K562 IC50
    22.81 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells by MTT assay
    Antiproliferative activity against human K562 cells by MTT assay
    		[PMID: 32992133]
    HT-29 IC50
    2.3 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue dye assay
    Cytotoxicity against human HT-29 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19785430]
    K562 IC50
    242.8 3
    Compound: VP-16
    Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    HT-29 IC50
    2.5 3
    Compound: VP-16
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    K562 IC50
    3.1 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 17459529]
    HT-29 IC50
    2.5 3
    Compound: VP-16
    Antiproliferative activity against human HT-29 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human HT-29 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    K562 IC50
    3.1 3
    Compound: etoposide
    Antiproliferative activity against human K562 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human K562 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    K562 IC50
    3.1 3
    Compound: etoposide
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    HT-29 IC50
    21.45 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    HT-29 IC50
    21.45 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    K562 IC50
    3.39 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 32992133]
    HT-29 IC50
    2366.7 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against HT-29 cell line
    In vivo antiproliferative activity against HT-29 cell line
    		[PMID: 15084135]
    K562 IC50
    3.39 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    HT-29 IC50
    25.63 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    K562 IC50
    4.39 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as reduction in viable cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in viable cells after 48 hrs by MTT assay
    		[PMID: 26916436]
    K562 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against human K562 ATCC CCL 243 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 ATCC CCL 243 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    HT-29 IC50
    30.38 3
    Compound: etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    K562 IC50
    5.16 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    HT-29 IC50
    4.21 6
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    HT-29 IC50
    6.32 3
    Compound: Etoposide
    Cytotoxicity against human HT-29 cells by MTT assay
    Cytotoxicity against human HT-29 cells by MTT assay
    		[PMID: 19836231]
    K562 IC50
    6.7 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human K562 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    HT-29 IC50
    6.6 3
    Compound: etoposide
    Antiproliferative activity against human HT29 cell line
    Antiproliferative activity against human HT29 cell line
    		[PMID: 16686539]
    K562 IC50
    66 3
    Compound: Etop
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    HT-29 IC50
    7.6 3
    Compound: Etoposide
    Antiproliferative activity against human HT-29 cells by MTT assay
    Antiproliferative activity against human HT-29 cells by MTT assay
    		[PMID: 29072457]
    K562 IC50
    8.45 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    HT-29 IC50
    9 3
    Compound: 1
    Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    K562 IC50
    8.45 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    HT-29 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    K562 IC50
    9.23 3
    Compound: ETP
    Growth inhibition of human K562 cells after 72 hrs by MTT assay
    Growth inhibition of human K562 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    K562 IC50
    9.4 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    K562/A02 GI50
    1.08 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human K562/A02 cells by SRB assay
    Cytotoxicity against human K562/A02 cells by SRB assay
    		[PMID: 32992133]
    K562/A02 IC50
    1.98 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562/A02 cells by MTT assay
    Antiproliferative activity against human K562/A02 cells by MTT assay
    		[PMID: 32992133]
    K562/A02 IC50
    10.58 3
    Compound: Etoposide
    Antiproliferative activity against human K562/A02 cells assessed as reduction in cell viability measured after 2 days by MTT assay
    Antiproliferative activity against human K562/A02 cells assessed as reduction in cell viability measured after 2 days by MTT assay
    		[PMID: 32531682]
    K562/A02 IC50
    151.69 3
    Compound: VP-16
    Cytotoxicity against human K562/A02 cells after 2 days by MTT assay
    Cytotoxicity against human K562/A02 cells after 2 days by MTT assay
    		[PMID: 21821321]
    K562/A02 IC50
    234.7 3
    Compound: VP-16
    Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    K562/Adr IC50
    0.413 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562/ADR cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells incubated for 72 hrs by CCK8 assay
    		[PMID: 32992133]
    K562/Adr IC50
    2.025 3
    Compound: 2
    Antiproliferative activity against human K562/ADR cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells after 72 hrs by CCK8 assay
    		[PMID: 27503681]
    K562/Adr IC50
    2.025 3
    Compound: Etoposide
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    K562/Adr IC50
    2.211 3
    Compound: Etoposide
    Antiproliferative activity against human K562/ADR cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells measured after 72 hrs by CCK8 assay
    		[PMID: 27484511]
    K562/VCR IC50
    11.84 3
    Compound: 2
    Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay
    		[PMID: 29678463]
    KB ED50
    > 10 6
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB-7d cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB-7d cancer cells after 3 days incubation
    		[PMID: 15456257]
    HUVEC IC50
    1.25 3
    Compound: VP-16
    Cytotoxicity against HUVEC assessed as cell viability after 48 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as cell viability after 48 hrs by MTT assay
    		[PMID: 24012378]
    KB ED50
    > 100 3
    Compound: 1
    Dose required for reduction in vincristine resistant human nasopharyngeal KB-VIN cancer cells after 3 days incubation
    Dose required for reduction in vincristine resistant human nasopharyngeal KB-VIN cancer cells after 3 days incubation
    		[PMID: 15456257]
    HUVEC IC50
    1.342 3
    Compound: Etoposide
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    KB IC50
    > 20 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    HUVEC IC50
    1.86 3
    Compound: Etoposide
    Cytotoxicity against HUVEC by sulforhodamine B assay
    Cytotoxicity against HUVEC by sulforhodamine B assay
    		[PMID: 21936523]
    KB IC50
    > 20 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    KB CC50
    0.1 3
    Compound: VP-16
    Compound concentration required to reduce the exponential growth of KB cells by 50%
    Compound concentration required to reduce the exponential growth of KB cells by 50%
    		[PMID: 9767632]
    HUVEC IC50
    29 3
    Compound: Etop
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    KB ED50
    0.12 6
    Compound: 1 (Etoposide)
    Compound was tested for in vitro cytotoxicity in KB cells after 3 days of incubation
    Compound was tested for in vitro cytotoxicity in KB cells after 3 days of incubation
    		[PMID: 2537424]
    HUVEC IC50
    5.2 3
    Compound: Etoposide
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 30776691]
    KB ED50
    0.16 6
    Compound: 1
    Cytotoxicity against human KB cells assessed as reduction in cell number after 3 days by crystal violet staining
    Cytotoxicity against human KB cells assessed as reduction in cell number after 3 days by crystal violet staining
    		[PMID: 2550587]
    HUVEC IC50
    5.21 3
    Compound: Etoposide
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against HUVEC assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 29778894]
    HUVEC IC50
    > 200 3
    Compound: Etop
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    KB ED50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    HaCaT IC50
    0.55 3
    Compound: etoposide
    Cytotoxicity against human HaCaT cells after 72 hrs by MTT assay
    Cytotoxicity against human HaCaT cells after 72 hrs by MTT assay
    		[PMID: 19919064]
    KB IC50
    0.25 6
    Compound: Etoposide
    Cytotoxicity against human KB cells after 3 days by MTT assay
    Cytotoxicity against human KB cells after 3 days by MTT assay
    		[PMID: 21216051]
    HaCaT IC50
    6 3
    Compound: 1
    Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    KB GI50
    0.3 3
    Compound: 2, VP-16
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    KB GI50
    0.3 3
    Compound: 2
    Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    KB ED50
    0.3 3
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    KB GI50
    0.31 3
    Compound: 2, Eto
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    KB GI50
    0.31 3
    Compound: 2, Eto
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    HeLa EC50
    0.81 3
    Compound: 6 (VP-16)
    Tested for inhibition of topoisomerase II isolated from HeLa cells by DNA-cleavage assay
    Tested for inhibition of topoisomerase II isolated from HeLa cells by DNA-cleavage assay
    		[PMID: 8410993]
    KB IC50
    0.42 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells after 48 hrs by MTT assay
    Antiproliferative activity against human KB cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    HeLa EC50
    0.81 3
    Compound: VP-16
    Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II.
    Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II.
    		10.1016/0960-894X(95)00043-S
    KB ED50
    0.5 6
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    HeLa EC50
    0.81 3
    Compound: VP-16
    Compound was tested for topoisomerase II inhibition in purified HeLa cells by SDS/K+ precipitation method
    Compound was tested for topoisomerase II inhibition in purified HeLa cells by SDS/K+ precipitation method
    		10.1016/0960-894X(95)00044-T
    KB IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    KB IC50
    0.6 3
    Compound: Etoposide
    Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%
    Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%
    		[PMID: 12431048]
    HeLa EC50
    0.81 3
    Compound: VP-16
    Inhibitory activity against HeLa cell Topoisomerase II
    Inhibitory activity against HeLa cell Topoisomerase II
    		10.1016/0960-894X(95)00160-U
    HeLa EC50
    0.81 3
    Compound: VP-16
    Tested for inhibitory activity against Topoisomerase II isolated from HeLa cells by using SDS-K+ precipitation method
    Tested for inhibitory activity against Topoisomerase II isolated from HeLa cells by using SDS-K+ precipitation method
    		10.1016/S0960-894X(00)80048-7
    KB IC50
    0.8 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    HeLa ED50
    7.9 6
    Compound: 4
    Cytotoxicity against human HeLa cells after 4 days by trypan blue assay
    Cytotoxicity against human HeLa cells after 4 days by trypan blue assay
    		[PMID: 1602298]
    KB IC50
    0.85 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    KB IC50
    1.02 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells assessed as reduction in cell growth incubated for 2 days by MTT assay
    Antiproliferative activity against human KB cells assessed as reduction in cell growth incubated for 2 days by MTT assay
    		[PMID: 32531682]
    KB IC50
    1.1 3
    Compound: VP-16
    Growth inhibition of human KB cells after 72 hrs by methylene blue assay
    Growth inhibition of human KB cells after 72 hrs by methylene blue assay
    		[PMID: 22060033]
    HeLa GI50
    0.62 3
    Compound: 2
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    KB IC50
    1.1 3
    Compound: VP-16
    Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    HeLa GI50
    0.64 3
    Compound: 2
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 24953821]
    KB IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 14738395]
    HeLa GI50
    2 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    KB IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay
    Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay
    		[PMID: 24106982]
    HeLa GI50
    3 3
    Compound: Etoposide
    Growth inhibition of human HeLa cells
    Growth inhibition of human HeLa cells
    		[PMID: 21986585]
    KB IC50
    1.25 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 18844422]
    HeLa GI50
    3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    KB IC50
    1.3 3
    Compound: etoposide
    Cytotoxicity against human KB cells after 72 hrs by methylene blue dye assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue dye assay
    		[PMID: 19785430]
    HeLa GI50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    KB IC50
    1.5 3
    Compound: VP-16
    Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay
    Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 26160020]
    HeLa GI50
    3.3 3
    Compound: Etoposide
    Growth inhibition of human HeLa cells after 48 hrs by SRB assay
    Growth inhibition of human HeLa cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    KB IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human KB cells by MTT assay
    Cytotoxicity against human KB cells by MTT assay
    		[PMID: 32992133]
    HeLa GI50
    3.3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    KB IC50
    1.737 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human KB cells incubated for 72 hrs by SRB method
    Cytotoxicity against human KB cells incubated for 72 hrs by SRB method
    		[PMID: 32992133]
    HeLa GI50
    3.3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    		[PMID: 37531922]
    KB IC50
    10 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 21570846]
    KB ED50
    11 3
    Compound: 1
    Effective dose required for inhibition of KB-7d cell replication after 3 days of continuous treatment
    Effective dose required for inhibition of KB-7d cell replication after 3 days of continuous treatment
    		[PMID: 15125972]
    HeLa GI50
    3.3 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    HeLa GI50
    3.56 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    KB IC50
    11.8 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells by MTT assay
    Antiproliferative activity against human KB cells by MTT assay
    		[PMID: 31546197]
    HeLa GI50
    40 3
    Compound: Etoposide
    Growth inhibitory concentration of compound was determined against HeLa cells by alamar blue assay
    Growth inhibitory concentration of compound was determined against HeLa cells by alamar blue assay
    		[PMID: 15026047]
    KB IC50
    14.2 3
    Compound: Etoposide
    Cytotoxicity against human KB cells assessed as reduction of cell growth by SRB method
    Cytotoxicity against human KB cells assessed as reduction of cell growth by SRB method
    		[PMID: 18782668]
    HeLa GI50
    8 3
    Compound: 2
    Growth inhibition of HeLa cells after 48 hrs by MTT assay
    Growth inhibition of HeLa cells after 48 hrs by MTT assay
    		[PMID: 17894480]
    KB IC50
    1500 1
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 24657567]
    HeLa IC50
    0.08 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells
    Cytotoxicity against human HeLa cells
    		[PMID: 23092389]
    KB IC50
    153.26 3
    Compound: VP-16
    Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    HeLa IC50
    0.18 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days by CCK8 assay
    Cytotoxicity against human HeLa cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    KB ED50
    17.2 3
    Compound: 1
    Dose required for reduction in etoposide resistant human nasopharyngeal KB-7d cancer cells after 3 days incubation
    Dose required for reduction in etoposide resistant human nasopharyngeal KB-7d cancer cells after 3 days incubation
    		[PMID: 15456257]
    HeLa IC50
    0.18 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    KB IC50
    2 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs
    Cytotoxicity against human KB cells after 72 hrs
    		[PMID: 17125231]
    HeLa IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HeLa cells by MTT assay
    Antiproliferative activity against human HeLa cells by MTT assay
    		[PMID: 32992133]
    KB IC50
    2.27 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human Vincristine-resistant KB cells incubated for 72 hrs by SRB method
    Cytotoxicity against human Vincristine-resistant KB cells incubated for 72 hrs by SRB method
    		[PMID: 32992133]
    HeLa IC50
    0.38 6
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days by MTT assay
    Cytotoxicity against human HeLa cells after 3 days by MTT assay
    		[PMID: 21216051]
    KB IC50
    2.4 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    HeLa IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells
    Cytotoxicity against human HeLa cells
    		[PMID: 19788270]
    KB IC50
    23 3
    Compound: VP-16
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    KB IC50
    28.7 3
    Compound: Etoposide
    Cytotoxicity against human vincristine-resistant KB cells after 72 hrs by MTT assay
    Cytotoxicity against human vincristine-resistant KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    HeLa IC50
    0.47 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    HeLa IC50
    0.54 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    KB IC50
    3.5 3
    Compound: VP-16
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    HeLa IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    KB IC50
    3.88 3
    Compound: 2
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    HeLa IC50
    1.2 3
    Compound: Etoposide
    Antiproliferation activity against human Hela cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human Hela cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    KB IC50
    3.88 3
    Compound: 3
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    HeLa IC50
    1.2 3
    Compound: VP16
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    KB IC50
    3.88 3
    Compound: 3
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    KB EC50
    3.9 6
    Compound: etoposide
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    HeLa IC50
    1.26 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days by CCK-8 assay
    Cytotoxicity against human HeLa cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    HeLa IC50
    1.29 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 4 days by ELISA reader assay
    Cytotoxicity against human HeLa cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    KB EC50
    4.5 3
    Compound: etoposide
    Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
    Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
    		[PMID: 21028898]
    KB IC50
    4.61 1
    Compound: 1, VP-16
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 21145139]
    HeLa IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human HeLa cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HeLa IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 21601964]
    KB IC50
    4.8 3
    Compound: etoposide
    Cytotoxicity against human KB cells by SRB microtiter plate assay
    Cytotoxicity against human KB cells by SRB microtiter plate assay
    		[PMID: 17585747]
    HeLa IC50
    1.41 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human HeLa cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    KB IC50
    475 1
    Compound: VP-16
    Antiproliferative activity against human KB cells after 72 hrs by ethylene blue dye assay
    Antiproliferative activity against human KB cells after 72 hrs by ethylene blue dye assay
    		[PMID: 22698783]
    HeLa IC50
    1.5 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    KB IC50
    54 3
    Compound: VP-16
    Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay
    Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    HeLa IC50
    1.52 3
    Compound: 2a, VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 23182091]
    KB ED50
    7 3
    Compound: 1
    Dose required for reduction in camptothecin resistant human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required for reduction in camptothecin resistant human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    HeLa IC50
    1.57 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells in presence of 10% fetal bovine serum
    Cytotoxicity against human HeLa cells in presence of 10% fetal bovine serum
    		[PMID: 20188578]
    KB IC50
    8.3 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) KB cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) KB cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    HeLa IC50
    1.58 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    KB IC50
    8.3 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) KB cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) KB cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    HeLa IC50
    1.605 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    KB GI50
    8.392 3
    Compound: VP-16
    Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay
    Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay
    		[PMID: 32171161]
    HeLa IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 32992133]
    KYSE-70 cell line IC50
    0.94 3
    Compound: Etoposide
    Antiproliferative activity against human KYSE70 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human KYSE70 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    HeLa IC50
    1.93 3
    Compound: V
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    L02 IC50
    1.22 3
    Compound: VP-16
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HeLa IC50
    10.03 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    L02 IC50
    13 3
    Compound: Etoposide
    Antiproliferative activity against human L02 cells after 48 hrs by MTT assay
    Antiproliferative activity against human L02 cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    HeLa IC50
    10.03 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    L02 IC50
    24.6 3
    Compound: VP-16
    Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    HeLa IC50
    10.4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    L02 IC50
    24.61 3
    Compound: VP-16
    Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    HeLa IC50
    11.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    L02 IC50
    3.78 3
    Compound: Etoposide
    Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    HeLa IC50
    12.12 3
    Compound: VP16; 2
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    L02 IC50
    3480.5 1
    Compound: VP-16
    Cytotoxicity against human L02 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    HeLa IC50
    12.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    L02 IC50
    47.74 3
    Compound: vp16
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HeLa IC50
    13.5 3
    Compound: VP16
    Cytotoxicity against human HeLa cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    L02 IC50
    7.75 3
    Compound: 2
    Cytotoxicity against human L02 cells after 24 hrs by MTT assay
    Cytotoxicity against human L02 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    HeLa IC50
    15 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    L1210 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against mouse L1210 ATCC CCL 219 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse L1210 ATCC CCL 219 cells after 48 hrs by MTT assay
    		[PMID: 18558490]
    HeLa IC50
    15.93 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    L132 GI50
    10.38 3
    Compound: Etoposide
    Growth inhibition of human L-132 cells by MTT assay
    Growth inhibition of human L-132 cells by MTT assay
    		[PMID: 27503682]
    HeLa IC50
    16 3
    Compound: Etoposide
    Growth inhibition of human HeLa cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    Growth inhibition of human HeLa cells assessed as inhibition of cell viability after 72 hrs by MTT assay
    		[PMID: 24527835]
    L6 IC50
    18.99 3
    Compound: Etoposide
    Cytotoxicity against rat L6 cells after 71.5 hrs by Presto Blue assay
    Cytotoxicity against rat L6 cells after 71.5 hrs by Presto Blue assay
    		[PMID: 25466187]
    L929 IC50
    1 3
    Compound: 2
    Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    HeLa IC50
    17.68 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    HeLa IC50
    18.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 4 days by MTT assay
    Cytotoxicity against human HeLa cells after 4 days by MTT assay
    		[PMID: 20619511]
    LAMA-84 IC50
    0.79 3
    Compound: Etoposide
    Cytotoxicity against human LAMA-84 cells after 72 hrs by MTT assay
    Cytotoxicity against human LAMA-84 cells after 72 hrs by MTT assay
    		[PMID: 16872135]
    HeLa IC50
    18.24 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells
    Cytotoxicity against human HeLa cells
    		[PMID: 18178085]
    Lewis lung carcinoma cell line IC50
    1.1 3
    Compound: ETP
    Cytotoxic activity against solid tumor LLC(Lewis lung carcinoma), concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor LLC(Lewis lung carcinoma), concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    HeLa IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    HeLa IC50
    2.15 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 19836231]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    HeLa IC50
    2.24 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    HeLa IC50
    2.35 6
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    LN-229 IC50
    0.43 3
    Compound: Etoposide
    Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    HeLa IC50
    2.36 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 21419530]
    LNCaP IC50
    31.21 3
    Compound: Etoposide
    Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    HeLa IC50
    2.4 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    LNCaP IC50
    50.33 3
    Compound: Etoposide
    Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay
    Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    HeLa IC50
    2.4 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells by MTT assay
    Antiproliferative activity against human HeLa cells by MTT assay
    		[PMID: 32196342]
    LoVo IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human LoVo cells by MTT assay
    Cytotoxicity against human LoVo cells by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    2.56 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth
    		[PMID: 38107170]
    LoVo IC50
    14.9 3
    Compound: 2; VP-16
    Cytotoxicity against human LoVo cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human LoVo cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    HeLa IC50
    2.66 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
    		[PMID: 31227365]
    LoVo IC50
    18.7 3
    Compound: 2; VP-16
    Cytotoxicity against human LoVo cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human LoVo cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    HeLa IC50
    2.7 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 33831559]
    LoVo IC50
    2.3 3
    Compound: ETP
    Cytotoxic activity against solid tumor, LoVo, (human colon adenocarcinoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, LoVo, (human colon adenocarcinoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    HeLa IC50
    2.71 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    LS174T IC50
    0.48 3
    Compound: Etoposide
    Antiproliferative activity against human LS174T cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human LS174T cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    HeLa IC50
    2.75 3
    Compound: 2
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24721832]
    LS174T IC50
    0.9 3
    Compound: Etoposide
    Antiproliferative activity against human LS174T cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human LS174T cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    HeLa IC50
    2.76 3
    Compound: 5, VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by CCK-8 assay
    		[PMID: 22041063]
    M059J IC50
    58.9 3
    Compound: VP16
    Cytotoxicity against human M059J cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human M059J cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    HeLa IC50
    2.9 3
    Compound: etoposide
    Growth inhibition of human HeLa cells by MTT assay
    Growth inhibition of human HeLa cells by MTT assay
    		[PMID: 17482821]
    M21 IC50
    0.2 3
    Compound: 1
    Antiproliferative activity against human M21 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human M21 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    MCF-10A GI50
    > 5 3
    Compound: Etoposide
    Growth inhibition of human MCF10A cells after 72 hrs by celltiter-blue viability assay
    Growth inhibition of human MCF10A cells after 72 hrs by celltiter-blue viability assay
    		[PMID: 21348461]
    HeLa IC50
    2.9 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 18258438]
    HeLa IC50
    2.91 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 23711769]
    MCF-10A IC50
    10.14 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells after 2 days by CCK8 assay
    Cytotoxicity against human MCF10A cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    HeLa IC50
    2.91 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24140948]
    MCF-10A IC50
    102 3
    Compound: Etoposide
    Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    HeLa IC50
    2.97 3
    Compound: Vp-16
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    MCF-10A IC50
    12.23 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells after 2 days
    Cytotoxicity against human MCF10A cells after 2 days
    		[PMID: 24904965]
    HeLa IC50
    21.4 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    MCF-10A IC50
    36.26 3
    Compound: Eto
    Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    HeLa IC50
    22.35 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    MCF-10A IC50
    84.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF10A cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 34791873]
    HeLa IC50
    225.5 3
    Compound: VP16
    Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    MCF7 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    HeLa IC50
    23.33 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 24 hrs by MTT assay
    		[PMID: 21983445]
    MCF7 IC50
    > 100 3
    Compound: Etop
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    HeLa IC50
    24.9 3
    Compound: 2; VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    MCF7 IC50
    > 30 3
    Compound: ETP
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    HeLa IC50
    28.61 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    MCF7 GI50
    > 5 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by celltiter-blue viability assay
    Growth inhibition of human MCF7 cells after 72 hrs by celltiter-blue viability assay
    		[PMID: 21348461]
    HeLa IC50
    3 3
    Compound: Eto
    Antitumor activity against human HeLa cells after 72 hrs by MTT assay
    Antitumor activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    MCF7 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 30660827]
    HeLa IC50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells after 96 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    MCF7 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by SRB assay
    Anticancer activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    HeLa IC50
    3 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human HeLa cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    MCF7 IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells by SRB assay
    Antiproliferative activity against human MCF7 cells by SRB assay
    		[PMID: 31546197]
    HeLa IC50
    3.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 2 days
    Cytotoxicity against human HeLa cells after 2 days
    		[PMID: 22318164]
    MCF7 IC50
    0.008 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells by MTT assay
    Anticancer activity against human MCF7 cells by MTT assay
    		10.1039/C4MD00279B
    HeLa IC50
    3.2 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    MCF7 IC50
    0.03 6
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    HeLa IC50
    3.2 3
    Compound: VP16
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    MCF7 IC50
    0.06 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU60019 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    HeLa IC50
    3.23 3
    Compound: Etoposide
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    Anticancer activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    MCF7 IC50
    0.085 3
    Compound: Etoposide
    Inhibitory activity against MCF-7 wt cell line using MTT assay (ER+,pgR+,wildtype p53)
    Inhibitory activity against MCF-7 wt cell line using MTT assay (ER+,pgR+,wildtype p53)
    		[PMID: 10780913]
    HeLa IC50
    3.38 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by microplate reader analysis
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by microplate reader analysis
    		[PMID: 37418826]
    MCF7 IC50
    0.11 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 50 nM AZD0156 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    0.19 3
    Compound: etoposide
    Antiproliferative effect against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative effect against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 16499324]
    HeLa IC50
    3.4 3
    Compound: etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    HeLa IC50
    3.6 3
    Compound: etoposide
    Antiproliferative effect against human HeLa cells after 69 hrs by MTT assay
    Antiproliferative effect against human HeLa cells after 69 hrs by MTT assay
    		[PMID: 16499324]
    MCF7 GI50
    0.25 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    HeLa IC50
    3.9 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    MCF7 GI50
    0.25 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 24953821]
    HeLa IC50
    3.9 3
    Compound: VP-16
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    MCF7 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MCF7 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    32.05 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    MCF7 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    HeLa IC50
    32.45 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    MCF7 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    HeLa IC50
    4 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 21570846]
    MCF7 GI50
    0.56 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    HeLa IC50
    4.12 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    MCF7 GI50
    0.56 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    HeLa IC50
    4.13 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human HeLa cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    MCF7 IC50
    0.56 3
    Compound: Etoposide
    Additive cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    Additive cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    0.59 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU55933 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    HeLa IC50
    4.36 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    MCF7 IC50
    0.65 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    		[PMID: 35231830]
    HeLa IC50
    4.39 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 36 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    MCF7 IC50
    0.66 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    MCF7 IC50
    0.68 3
    Compound: 2, Etop
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    MCF7 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs
    Cytotoxicity against human MCF7 cells after 48 hrs
    		[PMID: 19115839]
    HeLa IC50
    4.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    HeLa IC50
    4.73 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    MCF7 IC50
    0.73 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days by CCK-8 assay
    Cytotoxicity against human MCF7 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    HeLa IC50
    40.4 3
    Compound: 2, VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
    Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
    		[PMID: 22244588]
    MCF7 IC50
    0.79 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HeLa IC50
    41.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 27060757]
    MCF7 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    HeLa IC50
    5.35 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    MCF7 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    		[PMID: 27010926]
    MCF7 GI50
    0.83 3
    Compound: ET
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    HeLa IC50
    5.7 1
    Compound: VP-16
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 24422592]
    HeLa IC50
    50.6 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    MCF7 GI50
    0.87 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 23999041]
    HeLa IC50
    59.38 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    MCF7 IC50
    1 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    HeLa IC50
    6.27 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 2 days by MTT assay
    Cytotoxicity against human HeLa cells after 2 days by MTT assay
    		[PMID: 21821321]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    HeLa IC50
    6.27 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    MCF7 GI50
    1 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    HeLa IC50
    63.71 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    HeLa IC50
    7.01 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as inhibition of cell proliferation
    Antiproliferative activity against human HeLa cells assessed as inhibition of cell proliferation
    		[PMID: 35123005]
    HeLa IC50
    7.21 3
    Compound: Etoposide
    Cytotoxic activity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxic activity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    MCF7 CC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    HeLa IC50
    7.32 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells measured on day 4 by CCK8 assay
    Cytotoxicity against human HeLa cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    MCF7 IC50
    1 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    HeLa IC50
    7.32 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 48 hrs by CCK8 assay
    Cytotoxicity against human HeLa cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    MCF7 IC50
    1.09 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    HeLa IC50
    7.43 3
    Compound: VP-16
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    MCF7 IC50
    1.2 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    HeLa IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells measured after 2 days by MTT assay
    Cytotoxicity against human HeLa cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    MCF7 IC50
    1.264 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells after 96 hrs by propidium iodide-based monolayer assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by propidium iodide-based monolayer assay
    		[PMID: 26854430]
    HeLa IC50
    7.89 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    MCF7 IC50
    1.36 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    HeLa IC50
    8 3
    Compound: ET
    Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    MCF7 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    HeLa IC50
    8.09 3
    Compound: Etopo
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    MCF7 IC50
    1.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    HeLa IC50
    8.12 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HeLa cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HeLa cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    MCF7 IC50
    1.62 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    HeLa IC50
    8.2 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    MCF7 IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 32992133]
    HeLa IC50
    8.3 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by Ez-cytoX based microplate reader method
    Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by Ez-cytoX based microplate reader method
    		[PMID: 34597897]
    MCF7 IC50
    1.74 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    MCF7 IC50
    1.89 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 4 days by ELISA reader assay
    Cytotoxicity against human MCF7 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    HeLa IC50
    8.32 3
    Compound: Etoposide
    Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    HeLa IC50
    8.43 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells after 3 days
    Cytotoxicity against human HeLa cells after 3 days
    		[PMID: 19954977]
    MCF7 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    HeLa IC50
    8.93 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    		[PMID: 20356735]
    MCF7 IC50
    1.98 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 21115246]
    HeLa IC50
    9.1 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    MCF7 IC50
    10.5 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    HeLa IC50
    9.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    MCF7 IC50
    10.9 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    HeLa IC50
    9.21 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human HeLa cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    MCF7 IC50
    10.9 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    HeLa IC50
    96.26 3
    Compound: 2
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    MCF7 IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    MCF7 IC50
    11.95 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    HeLa IC50
    96.26 3
    Compound: Etoposideg
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    HeLa IC50
    > 50 3
    Compound: Etoposide
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability by SRB assay
    		[PMID: 31404864]
    MCF7 IC50
    12.2 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 ATCC HTB 22 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 ATCC HTB 22 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    HeLa IC50
    > 50 3
    Compound: Etoposide
    Anticancer activity against human HeLa cells assessed as inhibition of cell growth
    Anticancer activity against human HeLa cells assessed as inhibition of cell growth
    		[PMID: 32531682]
    MCF7 IC50
    12.3 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 11473438]
    HeLa IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human HeLa cells after 48 hrs by SRB assay
    Anticancer activity against human HeLa cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    MCF7 IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    HeLa IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human HeLa cells by SRB assay
    Antiproliferative activity against human HeLa cells by SRB assay
    		[PMID: 31546197]
    MCF7 IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 28886509]
    MCF7 IC50
    12.6 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 34791873]
    MCF7 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    HeLa S3 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human HeLaS3 cells by MTT assay
    Antiproliferative activity against human HeLaS3 cells by MTT assay
    		[PMID: 29072457]
    MCF7 IC50
    16.3 3
    Compound: Etoposide
    Cytotoxicity against human breast cancer cell line MCF7 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human breast cancer cell line MCF7 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    HeLa S3 IC50
    43.1 3
    Compound: Etoposide
    Antiproliferative activity against human HeLaS3 cells after 24 hrs by WST-1 assay
    Antiproliferative activity against human HeLaS3 cells after 24 hrs by WST-1 assay
    		[PMID: 28181805]
    MCF7 EC50
    16.4 6
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    Hep 3B2 IC50
    6.7 3
    Compound: Etoposide
    Cytotoxicity against human Hep3B cells after 72 hrs by MTT assay
    Cytotoxicity against human Hep3B cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    MCF7 IC50
    17 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    MCF7 IC50
    17.5 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 4 days by MTT assay
    Cytotoxicity against human MCF7 cells after 4 days by MTT assay
    		[PMID: 20619511]
    MCF7 IC50
    17.76 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    MCF7 IC50
    18.01 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 3 days
    Cytotoxicity against human MCF7 cells after 3 days
    		[PMID: 19954977]
    MCF7 IC50
    18.43 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 22341788]
    MCF7 IC50
    18.75 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells by CCK-8 assay
    Antiproliferative activity against human MCF7 cells by CCK-8 assay
    		[PMID: 35598793]
    MCF7 IC50
    18.9 3
    Compound: Vp-16
    Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    MCF7 IC50
    19 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    MCF7 GI50
    19.9 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    MCF7 GI50
    19.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 23831811]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    MCF7 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    MCF7 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    HepG2 CC50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    MCF7 IC50
    2.08 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    MCF7 GI50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    HepG2 EC50
    15.9 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by Cell Titer-Glo assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by Cell Titer-Glo assay
    		[PMID: 28080063]
    MCF7 GI50
    2.1 3
    Compound: 2, VP-16
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    HepG2 EC50
    60.5 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 31096154]
    MCF7 GI50
    2.1 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    MCF7 IC50
    2.11 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    HepG2 EC50
    9.8 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by CellTiter Glo assay
    Cytotoxicity against human HepG2 cells after 48 hrs by CellTiter Glo assay
    		10.1039/C4MD00409D
    MCF7 GI50
    2.11 3
    Compound: 2, Eto
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    HepG2 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    MCF7 GI50
    2.11 3
    Compound: 2, Eto
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    MCF7 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    HepG2 IC50
    0.83 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    HepG2 IC50
    1.15 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells
    Cytotoxicity against human HepG2 cells
    		[PMID: 24775914]
    MCF7 IC50
    2.69 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    HepG2 IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    MCF7 EC50
    2.8 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days
    Cytotoxicity against human MCF7 cells after 2 days
    		[PMID: 17629328]
    HepG2 IC50
    1.748 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    MCF7 IC50
    20.9 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    HepG2 IC50
    10.5 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    MCF7 IC50
    23.62 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 2 days by SRB assay
    Synergistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 2 days by SRB assay
    		[PMID: 35231830]
    HepG2 IC50
    103.81 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    HepG2 IC50
    11.52 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24095019]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    HepG2 IC50
    11.8 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    		[PMID: 31546197]
    HepG2 IC50
    12 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    		10.1007/s00044-011-9903-y
    MCF7 IC50
    24.01 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    HepG2 IC50
    13.4 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    MCF7 IC50
    27.41 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    HepG2 IC50
    13.65 3
    Compound: Etoposide
    Antiproliferative against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    MCF7 IC50
    29.49 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    HepG2 IC50
    15.32 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    MCF7 IC50
    3.1 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    HepG2 IC50
    15.32 3
    Compound: VP16
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33191085]
    MCF7 IC50
    3.1 6
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    HepG2 IC50
    15.8 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 27759375]
    MCF7 IC50
    3.2 3
    Compound: etoposide
    Cytotoxic activity against human MCF7 cells after 48 hrs by MTT reduction assay
    Cytotoxic activity against human MCF7 cells after 48 hrs by MTT reduction assay
    		[PMID: 17316916]
    HepG2 IC50
    15.8 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 21174408]
    MCF7 IC50
    3.25 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days
    Cytotoxicity against human MCF7 cells after 2 days
    		[PMID: 22318164]
    HepG2 IC50
    16.1 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 28571311]
    MCF7 IC50
    32.82 3
    Compound: 2
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    HepG2 IC50
    16 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as survival after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as survival after 3 days by crystal violet staining
    		10.1007/s00044-012-0025-y
    MCF7 IC50
    35.55 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human MCF7 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    HepG2 IC50
    2.02 3
    Compound: Ref 34, Cpd 2
    Antitumor activity against human HepG2 cells xenografted in BALB/c nude mouse assessed as tumor weight suppression at 1 mg/kg, ip administered every 6 days for 20 days and measured every 2 days by digital caliper method relative to control
    Antitumor activity against human HepG2 cells xenografted in BALB/c nude mouse assessed as tumor weight suppression at 1 mg/kg, ip administered every 6 days for 20 days and measured every 2 days by digital caliper method relative to control
    		[PMID: 32992133]
    MCF7 IC50
    35.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells by XTT assay
    Cytotoxicity against human MCF7 cells by XTT assay
    		[PMID: 18093835]
    MCF7 IC50
    35.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells by XTT assay
    Cytotoxicity against human MCF7 cells by XTT assay
    		[PMID: 17368022]
    HepG2 IC50
    2.114 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    		[PMID: 38784476]
    MCF7 GI50
    4 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    HepG2 IC50
    2.45 3
    Compound: Etoposide
    Anticancer activity against human HepG2 cells after 48 hrs by MTT assay
    Anticancer activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    MCF7 IC50
    4 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    HepG2 IC50
    2.66 3
    Compound: vp16
    Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    HepG2 IC50
    2.84 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    MCF7 IC50
    45 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 35617791]
    MCF7 IC50
    45 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    HepG2 IC50
    20 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 30776691]
    MCF7 IC50
    46.2 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    HepG2 IC50
    20 3
    Compound: VP-16
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    HepG2 IC50
    20.1 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation after 72 hrs by MTS assay
    		[PMID: 29778894]
    MCF7 IC50
    4716.5 1
    Compound: VP-16
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    HepG2 IC50
    20.1 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells measured after 72 hrs by MTS assay
    Cytotoxicity against human HepG2 cells measured after 72 hrs by MTS assay
    		[PMID: 37329714]
    MCF7 IC50
    480 1
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 22564383]
    HepG2 IC50
    20.389 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25019480]
    MCF7 IC50
    5.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    HepG2 IC50
    20.9 3
    Compound: Etop
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    		[PMID: 26216018]
    MCF7 IC50
    50 3
    Compound: Etop
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    HepG2 IC50
    20.9 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human HepG2 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    MCF7 IC50
    50 3
    Compound: Eto
    Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
    Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    HepG2 IC50
    21 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
    		[PMID: 37676247]
    MCF7 IC50
    50 3
    Compound: etoposide
    Growth inhibition of human MCF7 cells by MTT assay
    Growth inhibition of human MCF7 cells by MTT assay
    		[PMID: 17482821]
    MCF7 IC50
    53.8 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    HepG2 IC50
    21 6
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 3 days by MTT assay
    Cytotoxicity against human HepG2 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HepG2 IC50
    22.11 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		10.1039/C3MD00166K
    MCF7 GI50
    55.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    Cytotoxicity against human MCF7 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    		[PMID: 18321710]
    HepG2 IC50
    24.32 6
    Compound: Etoposide
    Cytotoxic activity against human HepG2 cells by MTT assay
    Cytotoxic activity against human HepG2 cells by MTT assay
    		[PMID: 28366267]
    MCF7 IC50
    58.8 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU55933 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    59.75 3
    Compound: Etoposide
    Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    HepG2 IC50
    27.07 3
    Compound: VP16; 2
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    MCF7 ED50
    62.2 3
    Compound: 1
    Dose required for reduction in human breast MCF-7 cancer cells after 3 day incubation
    Dose required for reduction in human breast MCF-7 cancer cells after 3 day incubation
    		[PMID: 15456257]
    HepG2 IC50
    27.18 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell growth after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0402-6
    HepG2 IC50
    3.6 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    MCF7 IC50
    62.7 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 50 nM AZD0156 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    HepG2 IC50
    30 3
    Compound: VP16
    Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
    Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    MCF7 GI50
    7.5 6
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 31546197]
    HepG2 IC50
    30.16 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 24836071]
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 25847767]
    HepG2 IC50
    30.16 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 25078311]
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB method
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    HepG2 IC50
    30.16 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		10.1007/s00044-013-0777-z
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human MCF7 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    HepG2 IC50
    30.2 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells
    Cytotoxicity against human HepG2 cells
    		[PMID: 37329714]
    MCF7 IC50
    8.9 3
    Compound: Etoposide
    Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    MCF7 IC50
    81.09 3
    Compound: Etoposide
    Antiproliferative against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    HepG2 IC50
    33.98 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 26397393]
    HepG2 IC50
    4 3
    Compound: VP16
    Cytotoxicity against human HepG2 cells after 96 hrs
    Cytotoxicity against human HepG2 cells after 96 hrs
    		[PMID: 22276775]
    MCF7 IC50
    82.6 3
    Compound: VP16
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    HepG2 IC50
    4.1 3
    Compound: VP-16
    Growth inhibition of human HepG2 cells after 72 hrs by sulforhodamine B assay
    Growth inhibition of human HepG2 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 20346660]
    MCF7 IC50
    87.4 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU60019 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    HepG2 IC50
    4.76 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    MCF7 IC50
    877.5 1
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    MCF7 IC50
    9.4 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    HepG2 IC50
    4.9 3
    Compound: etoposide
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 3 days by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 3 days by MTT assay
    		[PMID: 21277655]
    HepG2 IC50
    40.47 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    		[PMID: 25747499]
    MCF7 IC50
    9.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    HepG2 IC50
    427 3
    Compound: VP16
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
    		10.1007/s00044-009-9172-1
    MCF7-DOX IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay
    Anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    MCF7-DOX IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7/Dox cells by SRB assay
    Antiproliferative activity against human MCF7/Dox cells by SRB assay
    		[PMID: 31546197]
    HepG2 IC50
    5.21 3
    Compound: VP16
    Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    HepG2 IC50
    5.48 3
    Compound: 2
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    MDA-MB-231 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by MTT assay
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    HepG2 IC50
    5.48 3
    Compound: Etoposideg
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 25462233]
    MDA-MB-231 IC50
    > 50 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    MDA-MB-231 IC50
    0.15 3
    Compound: Etoposide
    Inhibitory activity against MDA-231 cell line using MTT assay (ER-,EGFR+,mutant p53)
    Inhibitory activity against MDA-231 cell line using MTT assay (ER-,EGFR+,mutant p53)
    		[PMID: 10780913]
    HepG2 IC50
    5.52 3
    Compound: 2
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    HepG2 IC50
    5.62 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    MDA-MB-231 IC50
    0.24 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay
    		[PMID: 21216051]
    HepG2 IC50
    5.9 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
    Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
    		[PMID: 38408342]
    MDA-MB-231 IC50
    0.51 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    HepG2 IC50
    6.2 6
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    MDA-MB-231 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human MDA-MB-231 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    HepG2 IC50
    6.2 6
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    MDA-MB-231 IC50
    1.23 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 2 days
    Cytotoxicity against human MDA-MB-231 cells after 2 days
    		[PMID: 21419530]
    HepG2 IC50
    6.41 3
    Compound: Etoposide
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    		[PMID: 23668986]
    MDA-MB-231 IC50
    1.5 3
    Compound: Eto
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    HepG2 IC50
    6.94 3
    Compound: Etoposide
    Anticancer activity against human HepG2 cells assessed as inhibition of cell growth
    Anticancer activity against human HepG2 cells assessed as inhibition of cell growth
    		[PMID: 32531682]
    MDA-MB-231 IC50
    1.53 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    MDA-MB-231 IC50
    1.53 3
    Compound: Etoposide
    Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    HepG2 IC50
    8.1 3
    Compound: VP-16
    Antiproliferative activity against human HepG2 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HepG2 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    HepG2 IC50
    9.14 3
    Compound: Etoposide
    Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    MDA-MB-231 GI50
    1.67 3
    Compound: Eto
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay
    		[PMID: 23999041]
    HepG2 IC50
    9.2 3
    Compound: 2; VP-16
    Cytotoxicity against human HepG2 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    MDA-MB-231 IC50
    1.91 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    MDA-MB-231 IC50
    1.91 3
    Compound: V
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    HepG2 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    HepG2 IC50
    > 50000 1
    Compound: VP-16
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    MDA-MB-231 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    HepG2 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human HepG2 cells after 48 hrs by SRB assay
    Anticancer activity against human HepG2 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    MDA-MB-231 IC50
    10.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 25847767]
    HepG2 IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human HepG2 cells by SRB assay
    Antiproliferative activity against human HepG2 cells by SRB assay
    		[PMID: 31546197]
    MDA-MB-231 IC50
    10.6 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    Hs 683 GI50
    1.5 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    MDA-MB-231 IC50
    11 3
    Compound: etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    MDA-MB-231 IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    Hs 683 IC50
    1 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    Hs 683 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    Growth inhibition of human Hs683 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    MDA-MB-231 IC50
    13.35 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    Hs-578T GI50
    8 3
    Compound: Etoposide
    In vitro cytotoxicity against human breast cancer Hs 578.T cell line
    In vitro cytotoxicity against human breast cancer Hs 578.T cell line
    		[PMID: 9871772]
    MDA-MB-231 IC50
    15.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    Hs-578T IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human Hs 578T cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human Hs 578T cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    MDA-MB-231 IC50
    16.27 3
    Compound: Etoposide
    Cytotoxic activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxic activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    Hs746T IC50
    3.29 6
    Compound: Etoposide
    Cytotoxic activity against human tumor Hs 746.T stomach cells
    Cytotoxic activity against human tumor Hs 746.T stomach cells
    		[PMID: 15056007]
    MDA-MB-231 IC50
    16.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 4 days by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 4 days by MTT assay
    		[PMID: 20619511]
    HuCC-A1 IC50
    4 6
    Compound: Etoposide
    Cytotoxicity against human HuCCa1 cells after 3 days by MTT assay
    Cytotoxicity against human HuCCa1 cells after 3 days by MTT assay
    		[PMID: 21216051]
    MDA-MB-231 IC50
    16.85 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 3 days
    Cytotoxicity against human MDA-MB-231 cells after 3 days
    		[PMID: 19954977]
    HuCC-A1 IC50
    5.1 3
    Compound: Etoposide
    Cytotoxicity against human HuCCa1 cells
    Cytotoxicity against human HuCCa1 cells
    		[PMID: 19788270]
    MDA-MB-231 IC50
    2.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    HuCC-A1 IC50
    6.8 3
    Compound: Etoposide
    Antiproliferative activity against human HuCC-A1 cells assessed as reduction in cell proliferation
    Antiproliferative activity against human HuCC-A1 cells assessed as reduction in cell proliferation
    		[PMID: 33276991]
    MDA-MB-231 IC50
    2.8 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    MDA-MB-231 IC50
    2.87 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    Huh-7 IC50
    17.3 3
    Compound: Vp-16
    Antiproliferative activity against human Huh-7 cells after 72 hrs by SRB assay
    Antiproliferative activity against human Huh-7 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    Huh-7 IC50
    3.8 3
    Compound: 3; Etop
    Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    MDA-MB-231 IC50
    20.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    Huh-7 IC50
    7.4 3
    Compound: VP-16
    Cytotoxicity against human HuH7 cells by MTT assay
    Cytotoxicity against human HuH7 cells by MTT assay
    		[PMID: 30543429]
    MDA-MB-231 IC50
    20.52 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 22341788]
    Huh-7 IC50
    8.9 3
    Compound: vp16
    Antiproliferative activity against human Huh-7 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human Huh-7 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    MDA-MB-231 IC50
    21.2 3
    Compound: VP-16
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    IGROV-1 IC50
    984.5 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against IGROV1 cell line
    In vivo antiproliferative activity against IGROV1 cell line
    		[PMID: 15084135]
    MDA-MB-231 IC50
    21.2 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    IMR-32 IC50
    6.3 3
    Compound: Etoposide
    Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    MDA-MB-231 IC50
    23.22 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    Ishikawa GI50
    11 3
    Compound: Etoposide
    Growth inhibition of human Ishikawa cells
    Growth inhibition of human Ishikawa cells
    		[PMID: 21986585]
    MDA-MB-231 IC50
    24.22 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    J774 IC50
    576.7 1
    Compound: VP-16
    Inhibitory concentration required for cytotoxicity in J774.2 murine macrophage-like cells
    Inhibitory concentration required for cytotoxicity in J774.2 murine macrophage-like cells
    		10.1016/0960-894X(95)00300-I
    MDA-MB-231 IC50
    24.22 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    MDA-MB-231 IC50
    29.27 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    J774.2 IC50
    2133.3 1
    Compound: VP-16
    Inhibitory concentration required for cytotoxicity in hydroxyrubicin-resistant (WP159/R) cells
    Inhibitory concentration required for cytotoxicity in hydroxyrubicin-resistant (WP159/R) cells
    		10.1016/0960-894X(95)00300-I
    J774.2 IC50
    3667.2 1
    Compound: VP-16
    Inhibitory concentration required for cytotoxicity in DOX-resistant (DOX/R) cells
    Inhibitory concentration required for cytotoxicity in DOX-resistant (DOX/R) cells
    		10.1016/0960-894X(95)00300-I
    MDA-MB-231 IC50
    3.32 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    MDA-MB-231 IC50
    3.38 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    J82 IC50
    0.8 3
    Compound: Etoposide
    Anticancer activity against human J82 cells after 3 days by MTT assay
    Anticancer activity against human J82 cells after 3 days by MTT assay
    		[PMID: 21621882]
    J82 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    		[PMID: 19419803]
    MDA-MB-231 IC50
    3.5 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 19836231]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    Cytotoxicity against human J82 cells after 3 days by MTT assay
    		[PMID: 19013074]
    MDA-MB-231 IC50
    3.6 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    MDA-MB-231 IC50
    3.67 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    MDA-MB-231 IC50
    3.85 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    J82 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    MDA-MB-231 IC50
    30.28 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    J82 IC50
    2.8 3
    Compound: etoposide
    Antitumor against human J82 cells after 72 hrs by MTT assay
    Antitumor against human J82 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    MDA-MB-231 IC50
    30.63 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    MDA-MB-231 IC50
    4.2 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    MDA-MB-231 IC50
    4.4 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    MDA-MB-231 IC50
    42 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell survival by clonogenic assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell survival by clonogenic assay
    		[PMID: 34303812]
    MDA-MB-231 IC50
    48 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    MDA-MB-231 IC50
    48 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    MDA-MB-231 IC50
    49.35 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    MDA-MB-231 IC50
    7.2 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    MDA-MB-231 GI50
    7.2 3
    Compound: Etoposide
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by SRB assay
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    MDA-MB-231 IC50
    7.35 3
    Compound: Etoposide
    Cytotoxicity in human MDA-MB-231 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human MDA-MB-231 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    MDA-MB-231 IC50
    7.7 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    MDA-MB-231 IC50
    8.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    MDA-MB-231 IC50
    9.13 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    Jurkat IC50
    1.2 3
    Compound: VP-16
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    MDA-MB-231 IC50
    9.7 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    Jurkat IC50
    1.2 3
    Compound: VP-16
    Antiproliferative activity against human Jurkat cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human Jurkat cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    MDA-MB-435 IC50
    1.7 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-435 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-435 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    Jurkat IC50
    1.4 3
    Compound: Etoposide
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    MDA-MB-435 IC50
    2.81 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 25800514]
    MDA-MB-436 IC50
    39.42 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-436 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human MDA-MB-436 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    Jurkat IC50
    160 1
    Compound: Etoposide
    Growth inhibitory activity against human Jurkat leukemia cell line (JLC)
    Growth inhibitory activity against human Jurkat leukemia cell line (JLC)
    		[PMID: 12620081]
    MDA-MB-453 IC50
    12.5 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    Jurkat IC50
    2.8 6
    Compound: Etoposide
    Anticancer activity against human Jurkat cells after 48 hrs by MTT assay
    Anticancer activity against human Jurkat cells after 48 hrs by MTT assay
    		[PMID: 21816519]
    Jurkat IC50
    5.35 3
    Compound: Etoposide
    Cytotoxicity against human Jurkat cells after 2 days by MTT assay
    Cytotoxicity against human Jurkat cells after 2 days by MTT assay
    		[PMID: 22325897]
    MDA-MB-468 IC50
    0.6 3
    Compound: Etoposide
    Inhibitory activity against MDA-468 cell line using MTT assay (ER-, amplified EGFR, mutant p53)
    Inhibitory activity against MDA-468 cell line using MTT assay (ER-, amplified EGFR, mutant p53)
    		[PMID: 10780913]
    MDA-MB-468 IC50
    0.86 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    MDA-MB-468 IC50
    13.6 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB468 cells by XTT assay
    Cytotoxicity against human MDA-MB468 cells by XTT assay
    		[PMID: 17368022]
    MDA-MB-468 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-468 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    MDA-MB-468 IC50
    6.69 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    K562 GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    K562 GI50
    12.59 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
    Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    K562 IC50
    0.163 3
    Compound: 1
    Cytotoxicity against human K562 cells
    Cytotoxicity against human K562 cells
    		[PMID: 29870668]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells after 72 hrs by MTT assay
    Cytotoxicity against human ME180 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    K562 IC50
    0.163 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as cell growth inhibition after 72 hrs by MTS assay
    Cytotoxicity against human K562 cells assessed as cell growth inhibition after 72 hrs by MTS assay
    		[PMID: 25922181]
    Medulloblastoma cell EC50
    0.208 3
    Compound: 2
    Antiproliferative activity against mouse medulloblastoma cells harboring heterozygous ptch1 gene by MTT assay
    Antiproliferative activity against mouse medulloblastoma cells harboring heterozygous ptch1 gene by MTT assay
    		[PMID: 17417631]
    K562 IC50
    0.183 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    MES-SA GI50
    0.21 3
    Compound: etoposide
    Antiproliferative activity against human MESSA cells by SRB assay
    Antiproliferative activity against human MESSA cells by SRB assay
    		[PMID: 19394218]
    K562 IC50
    0.3 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells
    Antiproliferative activity against human K562 cells
    		[PMID: 29871847]
    MES-SA IC50
    0.3 3
    Compound: etoposide
    Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    K562 IC50
    0.32 3
    Compound: etoposide
    Growth inhibition of K562 cells by XTT assay after 5 days
    Growth inhibition of K562 cells by XTT assay after 5 days
    		[PMID: 17411092]
    MES-SA/Dx5 IC50
    > 10 3
    Compound: etoposide
    Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    MES-SA/Dx5 GI50
    9.72 3
    Compound: etoposide
    Antiproliferative activity against multidrug resistant human MES-SA/Dx5 cells by SRB assay
    Antiproliferative activity against multidrug resistant human MES-SA/Dx5 cells by SRB assay
    		[PMID: 19394218]
    K562 IC50
    0.32 3
    Compound: etoposide
    Cytotoxicity against human K562 cells after 5 days by XTT assay
    Cytotoxicity against human K562 cells after 5 days by XTT assay
    		[PMID: 18076140]
    K562 IC50
    0.345 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27484511]
    MGC-803 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    K562 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    MGC-803 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    K562 IC50
    0.413 3
    Compound: 2
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    		[PMID: 27503681]
    MGC-803 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    MGC-803 IC50
    11.18 3
    Compound: Etoposide
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    K562 IC50
    0.413 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    K562 IC50
    0.42 3
    Compound: 1
    Cytotoxicity against human K562 cells after 72 hrs by MTS assay
    Cytotoxicity against human K562 cells after 72 hrs by MTS assay
    		[PMID: 20006518]
    MGC-803 IC50
    20.91 3
    Compound: Etoposide
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    K562 IC50
    0.51 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    MIA PaCa-2 GI50
    1.1 3
    Compound: 2
    Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    K562 IC50
    0.54 3
    Compound: Etoposide
    Cytostatic activity against human K562 cells
    Cytostatic activity against human K562 cells
    		[PMID: 30738653]
    MIA PaCa-2 IC50
    15 3
    Compound: Eto
    Antitumor activity against human MiaPaCa2 cells after 72 hrs by MTT assay
    Antitumor activity against human MiaPaCa2 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    K562 IC50
    0.76 3
    Compound: Etoposide
    Growth inhibition of human K562 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human K562 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    MIA PaCa-2 IC50
    15.4 3
    Compound: etoposide
    Growth inhibition of human MiaPaCa2 cells by MTT assay
    Growth inhibition of human MiaPaCa2 cells by MTT assay
    		[PMID: 17482821]
    K562 IC50
    0.76 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    MKN-45 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MKN-45 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human MKN-45 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    MOLT-3 IC50
    0.019 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells after 3 days by crystal violet staining
    		10.1007/s00044-011-9903-y
    K562 IC50
    0.764 3
    Compound: 2
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay
    		[PMID: 29678463]
    K562 IC50
    0.98 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    MOLT-3 IC50
    0.024 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as survival after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as survival after 3 days by crystal violet staining
    		10.1007/s00044-012-0025-y
    MOLT-3 IC50
    0.03 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		10.1039/C3MD00166K
    K562 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method
    		[PMID: 32992133]
    K562 IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells by MTT assay
    Cytotoxicity against human K562 cells by MTT assay
    		[PMID: 21115246]
    MOLT-3 IC50
    0.03 3
    Compound: etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		[PMID: 21174408]
    K562 IC50
    1.22 3
    Compound: Etoposide
    Cytotoxicity against human etoposide-sensitive K562 cells after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay
    Cytotoxicity against human etoposide-sensitive K562 cells after 72 hrs by CellTiter96 AQueous one solution cell proliferation assay
    		[PMID: 29656990]
    MOLT-3 IC50
    0.04 6
    Compound: Etoposide
    Cytotoxic activity against human MOLT3 cells by XTT assay
    Cytotoxic activity against human MOLT3 cells by XTT assay
    		[PMID: 28366267]
    K562 IC50
    1.27 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    MOLT-3 IC50
    0.041 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as inhibition of cell growth after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as inhibition of cell growth after 3 days by crystal violet staining
    		10.1007/s00044-012-0402-6
    K562 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    MOLT-3 IC50
    0.041 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    		[PMID: 26397393]
    K562 IC50
    1.64 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 25599951]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    		[PMID: 25019480]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    		[PMID: 24836071]
    K562 IC50
    1.72 3
    Compound: VP-16
    Antiproliferative activity against human K562 cells assessed as cell growth inhibition by MTT assay
    Antiproliferative activity against human K562 cells assessed as cell growth inhibition by MTT assay
    		[PMID: 38107170]
    K562 IC50
    1.77 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    MOLT-3 IC50
    0.051 3
    Compound: etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    		10.1007/s00044-013-0777-z
    K562 IC50
    1.79 3
    Compound: Etoposide
    Cytotoxicity in human K562 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human K562 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells assessed as reduction in cell viability after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells assessed as reduction in cell viability after 48 hrs by XTT assay
    		[PMID: 25078311]
    K562 IC50
    1.87 3
    Compound: Etoposide
    Cytotoxicity against human K-562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K-562 cells after 72 hrs by MTT assay
    		[PMID: 16872135]
    MOLT-3 IC50
    0.11 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		[PMID: 25747499]
    K562 IC50
    1.98 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human K562 cells by SRB assay
    Cytotoxicity against human K562 cells by SRB assay
    		[PMID: 32992133]
    MOLT-3 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27145162]
    K562 IC50
    10.79 3
    Compound: VP16
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 33191085]
    MONO-MAC-6 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    K562 IC50
    11.3 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB assay
    		[PMID: 35182774]
    MRC5 IC50
    > 20 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 24 to 72 hrs by SRB assay
    Cytotoxicity against human MRC5 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    K562 IC50
    12 3
    Compound: ET
    Cytotoxicity against human K562 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    MRC5 IC50
    > 20 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human MRC5 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    K562 IC50
    2.09 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 2 days
    Cytotoxicity against human K562 cells after 2 days
    		[PMID: 22318164]
    MRC5 IC50
    11.23 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human MRC5 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    K562 IC50
    2.11 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 2 days by MTT assay
    Cytotoxicity against human K562 cells after 2 days by MTT assay
    		[PMID: 21821321]
    MRC5 IC50
    11.73 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MRC5 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    K562 IC50
    2.3 3
    Compound: etoposide
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay
    		[PMID: 22582991]
    MRC5 IC50
    11.73 3
    Compound: Etoposide
    Growth inhibition of human MRC5 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human MRC5 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    K562 IC50
    2.41 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 4 days by ELISA reader assay
    Cytotoxicity against human K562 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    MRC5 IC50
    12.7 3
    Compound: Etoposide
    Cytotoxicity in human MRC5 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human MRC5 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    K562 IC50
    2.84 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells in presence of 10% fetal bovine serum
    Cytotoxicity against human K562 cells in presence of 10% fetal bovine serum
    		[PMID: 20188578]
    MRC5 IC50
    12.72 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MRC5 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    K562 IC50
    2.85 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 24 hrs by MTT assay
    Cytotoxicity against human K562 cells after 24 hrs by MTT assay
    		[PMID: 23369687]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Anticancer activity against human MRC5 cells after 3 days by MTT assay
    Anticancer activity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 21621882]
    K562 IC50
    22.81 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells by MTT assay
    Antiproliferative activity against human K562 cells by MTT assay
    		[PMID: 32992133]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 19013074]
    K562 IC50
    242.8 3
    Compound: VP-16
    Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    K562 IC50
    3.1 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 17459529]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    K562 IC50
    3.1 3
    Compound: etoposide
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    K562 IC50
    3.1 3
    Compound: etoposide
    Antiproliferative activity against human K562 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human K562 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    MRC5 IC50
    3.9 3
    Compound: etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    K562 IC50
    3.39 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 32992133]
    MRC5 IC50
    3.9 3
    Compound: VP-16
    Antiproliferative activity against human MRC5 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MRC5 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    K562 IC50
    3.39 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    MRC5 IC50
    3.93 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 19419803]
    K562 IC50
    4.39 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells assessed as reduction in viable cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in viable cells after 48 hrs by MTT assay
    		[PMID: 26916436]
    MRC5 IC50
    33.5 3
    Compound: VP-16
    Cytotoxicity against human MRC5 cells after 48 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    MT4 CC50
    0.08 3
    Compound: VP-16
    Compound concentration required to reduce the exponential growth of MT-4 cells by 50%
    Compound concentration required to reduce the exponential growth of MT-4 cells by 50%
    		[PMID: 9767632]
    K562 IC50
    4.9 3
    Compound: Etoposide
    Cytotoxicity against human K562 ATCC CCL 243 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 ATCC CCL 243 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    K562 IC50
    5.16 3
    Compound: VP-16
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    MT4 CC50
    0.09 3
    Compound: Etoposide
    Cytotoxicity against human MT4 cells infected with HTLV-1 after 96 hrs by MTT assay
    Cytotoxicity against human MT4 cells infected with HTLV-1 after 96 hrs by MTT assay
    		[PMID: 21741130]
    K562 IC50
    522.2 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against K-562 cell line
    In vivo antiproliferative activity against K-562 cell line
    		[PMID: 15084135]
    MT4 IC50
    0.09 3
    Compound: VP16
    Cytotoxicity against human MT4 cells after 96 hrs
    Cytotoxicity against human MT4 cells after 96 hrs
    		[PMID: 22276775]
    K562 IC50
    6.7 3
    Compound: Etoposide
    Antiproliferative activity against human K562 cells after 24 to 72 hrs by SRB assay
    Antiproliferative activity against human K562 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    MT4 IC50
    1.25 3
    Compound: VP-16
    Antiproliferative activity against human MT-4 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human MT-4 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    K562 IC50
    66 3
    Compound: Etop
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    MT4 IC50
    1.25 3
    Compound: VP-16
    Antiproliferative activity against human MT4 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MT4 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    K562 IC50
    8.45 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 23968711]
    N9 IC50
    1.95 3
    Compound: Etoposide
    Cytotoxicity against mouse N9 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse N9 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    NALM-6 IC50
    0.134 3
    Compound: VP-16
    Cytotoxicity against wild type human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against wild type human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    K562 IC50
    8.45 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells after 48 hrs by MTT assay
    		[PMID: 29545100]
    NALM-6 IC50
    0.182 3
    Compound: VP-16
    Cytotoxicity against TOP2B double knockout human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against TOP2B double knockout human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    K562 IC50
    9.23 3
    Compound: ETP
    Growth inhibition of human K562 cells after 72 hrs by MTT assay
    Growth inhibition of human K562 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    K562 IC50
    9.4 3
    Compound: Etoposide
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    NALM-6 IC50
    0.234 3
    Compound: VP-16
    Cytotoxicity against human NALM6 cells expressing 50% TOP2A assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against human NALM6 cells expressing 50% TOP2A assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    K562 IC50
    > 200 3
    Compound: Etop
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    NB-4 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human NB4 cells after 48 hrs by SRB method
    Cytotoxicity against human NB4 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    NB-4 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human NB4 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human NB4 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    NCI-H1299 IC50
    0.23 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 6 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.24 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 6 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.46 3
    Compound: Etoposide
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 6 days by SRB assay
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.71 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 6 days by SRB assay
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    11.13 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 2 days by SRB assay
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 2 days by SRB assay
    		[PMID: 35231830]
    K562/A02 GI50
    1.08 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human K562/A02 cells by SRB assay
    Cytotoxicity against human K562/A02 cells by SRB assay
    		[PMID: 32992133]
    NCI-H1299 IC50
    229.7 3
    Compound: Etoposide
    Anticancer activity against human H1299 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
    Anticancer activity against human H1299 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
    		[PMID: 34425478]
    K562/A02 IC50
    1.98 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562/A02 cells by MTT assay
    Antiproliferative activity against human K562/A02 cells by MTT assay
    		[PMID: 32992133]
    NCI-H1299 IC50
    5.75 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 2 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 2 days by SRB assay
    		[PMID: 35231830]
    K562/A02 IC50
    10.58 3
    Compound: Etoposide
    Antiproliferative activity against human K562/A02 cells assessed as reduction in cell viability measured after 2 days by MTT assay
    Antiproliferative activity against human K562/A02 cells assessed as reduction in cell viability measured after 2 days by MTT assay
    		[PMID: 32531682]
    NCI-H1299 IC50
    8.86 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 2 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 2 days by SRB assay
    		[PMID: 35231830]
    K562/A02 IC50
    151.69 3
    Compound: VP-16
    Cytotoxicity against human K562/A02 cells after 2 days by MTT assay
    Cytotoxicity against human K562/A02 cells after 2 days by MTT assay
    		[PMID: 21821321]
    NCI-H1299 IC50
    9.37 3
    Compound: Etoposide
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 2 days by SRB assay
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 2 days by SRB assay
    		[PMID: 35231830]
    K562/A02 IC50
    234.7 3
    Compound: VP-16
    Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay
    Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay
    		[PMID: 25113878]
    NCI-H1975 IC50
    95 3
    Compound: ET
    Cytotoxicity against human NCI-H1975 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human NCI-H1975 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    K562/Adr IC50
    0.413 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human K562/ADR cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells incubated for 72 hrs by CCK8 assay
    		[PMID: 32992133]
    NCI-H1993 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human NCI-H1993 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human NCI-H1993 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    NCI-H226 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human NCI-H226 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human NCI-H226 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    K562/Adr IC50
    2.025 3
    Compound: 2
    Antiproliferative activity against human K562/ADR cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells after 72 hrs by CCK8 assay
    		[PMID: 27503681]
    K562/Adr IC50
    2.025 3
    Compound: Etoposide
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    		[PMID: 26615886]
    NCI-H226 IC50
    0.24 3
    Compound: Etoposide
    Inhibitory activity against NCI-H226 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H226 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    K562/Adr IC50
    2.211 3
    Compound: Etoposide
    Antiproliferative activity against human K562/ADR cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/ADR cells measured after 72 hrs by CCK8 assay
    		[PMID: 27484511]
    NCI-H322M IC50
    1.59 3
    Compound: Etoposide
    Inhibitory activity against NCI-H322 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H322 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    NCI-H358 IC50
    1.5 3
    Compound: Etoposide
    Inhibitory activity against NCI-H358 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H358 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    K562/VCR IC50
    11.84 3
    Compound: 2
    Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay
    		[PMID: 29678463]
    NCI-H446 IC50
    17.59 1
    Compound: Etoposide
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H446 IC50
    192.16 1
    Compound: Etoposide
    Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H446 IC50
    192.16 1
    Compound: Etoposide
    Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H460 IC50
    < 30 3
    Compound: Eto
    Cytotoxicity against human H460 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human H460 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    NCI-H460 IC50
    > 30 3
    Compound: Etop
    Antiproliferative activity against human H460 cells by MTT assay
    Antiproliferative activity against human H460 cells by MTT assay
    		[PMID: 26216018]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    NCI-H460 GI50
    0.1 3
    Compound: Etoposide
    Growth inhibition of human H460 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human H460 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    KB CC50
    0.1 3
    Compound: VP-16
    Compound concentration required to reduce the exponential growth of KB cells by 50%
    Compound concentration required to reduce the exponential growth of KB cells by 50%
    		[PMID: 9767632]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Inhibitory activity against NCI-H460 cell line using MTT assay
    Inhibitory activity against NCI-H460 cell line using MTT assay
    		[PMID: 10780913]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Inhibitory activity against NCI-H460 cell line using MTT assay(Wild type p53)
    Inhibitory activity against NCI-H460 cell line using MTT assay(Wild type p53)
    		[PMID: 10780913]
    NCI-H460 IC50
    0.2 3
    Compound: etoposide
    Growth inhibition of human H460 cells by MTT assay
    Growth inhibition of human H460 cells by MTT assay
    		[PMID: 17482821]
    NCI-H460 IC50
    0.39 3
    Compound: Etoposide
    Inhibitory activity against H460pv8 cell line using MTT assay
    Inhibitory activity against H460pv8 cell line using MTT assay
    		[PMID: 10780913]
    KB EC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 20102168]
    NCI-H460 IC50
    1 3
    Compound: 2
    Cytotoxicity against human H460 cells after 48 hrs by MTT assay
    Cytotoxicity against human H460 cells after 48 hrs by MTT assay
    		[PMID: 23867385]
    NCI-H460 IC50
    3.65 3
    Compound: Etoposide
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    KB EC50
    3.9 6
    Compound: Etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 23043462]
    KB EC50
    3.9 6
    Compound: etoposide
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    NCI-H460 IC50
    90 1
    Compound: Etoposide
    Cytotoxicity against human NCI-H460 cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human NCI-H460 cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    KB EC50
    4.5 3
    Compound: etoposide
    Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
    Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
    		[PMID: 21028898]
    NCI-H647 IC50
    0.08 3
    Compound: Etoposide
    Inhibitory activity against NCI-H647 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H647 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    KB ED50
    0.12 6
    Compound: 1 (Etoposide)
    Compound was tested for in vitro cytotoxicity in KB cells after 3 days of incubation
    Compound was tested for in vitro cytotoxicity in KB cells after 3 days of incubation
    		[PMID: 2537424]
    NCI-H838 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    KB ED50
    0.16 6
    Compound: 1
    Cytotoxicity against human KB cells assessed as reduction in cell number after 3 days by crystal violet staining
    Cytotoxicity against human KB cells assessed as reduction in cell number after 3 days by crystal violet staining
    		[PMID: 2550587]
    NCI-H929 IC50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H929 cells after 72 hrs by MTT assay
    Cytotoxicity against human NCI-H929 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    NCI-N87 IC50
    1.29 3
    Compound: Etoposide
    Cytotoxicity against human NCI-N87 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human NCI-N87 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    KB ED50
    0.1 6
    Compound: etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 2095375]
    KB ED50
    0.1 6
    Compound: etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 2849640]
    NHDF IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human HDF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HDF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    KB ED50
    0.2 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human nasopharynx carcinoma(KB) cell line.
    The compound was tested for tumor cell growth inhibitory activity against human nasopharynx carcinoma(KB) cell line.
    		[PMID: 10395485]
    NIH3T3 IC50
    62.97 3
    Compound: etoposide
    Cytotoxicity against mouse 3T3 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse 3T3 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    KB ED50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    OVCAR-3 IC50
    2.9 3
    Compound: Etoposide
    Cytotoxicity against human OVCAR3 cells measured after 24 to 72 hrs by SRB assay
    Cytotoxicity against human OVCAR3 cells measured after 24 to 72 hrs by SRB assay
    		[PMID: 29656990]
    KB ED50
    0.3 3
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    P388 IC50
    0.05 3
    Compound: etoposide
    Cytotoxicity against mouse P388 cells after 24 hrs by SRB assay
    Cytotoxicity against mouse P388 cells after 24 hrs by SRB assay
    		[PMID: 19685913]
    P388 IC50
    0.1 3
    Compound: VP-16
    Cytotoxicity against mouse P388 cells by MTT assay
    Cytotoxicity against mouse P388 cells by MTT assay
    		[PMID: 11473438]
    KB ED50
    0.5 6
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    P388 IC50
    0.12 6
    Compound: Etoposide
    Cytotoxicity against mouse P388 cells after 3 days by MTT assay
    Cytotoxicity against mouse P388 cells after 3 days by MTT assay
    		[PMID: 21216051]
    KB ED50
    11 3
    Compound: 1
    Effective dose required for inhibition of KB-7d cell replication after 3 days of continuous treatment
    Effective dose required for inhibition of KB-7d cell replication after 3 days of continuous treatment
    		[PMID: 15125972]
    KB ED50
    17.2 3
    Compound: 1
    Dose required for reduction in etoposide resistant human nasopharyngeal KB-7d cancer cells after 3 days incubation
    Dose required for reduction in etoposide resistant human nasopharyngeal KB-7d cancer cells after 3 days incubation
    		[PMID: 15456257]
    P388 IC50
    0.12 3
    Compound: VP-16
    In vitro cytotoxicity was determined by quantitating P388 murine leukemia cells on a Coulter Counter following a 48 hour exposure of cells to the test compound
    In vitro cytotoxicity was determined by quantitating P388 murine leukemia cells on a Coulter Counter following a 48 hour exposure of cells to the test compound
    		10.1016/0960-894X(95)00043-S
    KB ED50
    23.8 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human KB-7d cell line resistant to etoposide
    The compound was tested for tumor cell growth inhibitory activity against human KB-7d cell line resistant to etoposide
    		[PMID: 10395485]
    P388 IC50
    0.24 3
    Compound: ETP
    Cytotoxic activity against murine lymphocytic leukemia P388 concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against murine lymphocytic leukemia P388 concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    KB ED50
    30.6 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human KB-vin20c cell line resistant to vincristine
    The compound was tested for tumor cell growth inhibitory activity against human KB-vin20c cell line resistant to vincristine
    		[PMID: 10395485]
    P388 IC50
    0.3 3
    Compound: 6 (VP-16)
    In vitro cytotoxicity against P388 murine leukemia cells in culture in a clonogenic assay after 1 hour exposure to drug
    In vitro cytotoxicity against P388 murine leukemia cells in culture in a clonogenic assay after 1 hour exposure to drug
    		[PMID: 8410993]
    KB ED50
    7 3
    Compound: 1
    Dose required for reduction in camptothecin resistant human nasopharyngeal KB cancer cells after 3 days incubation
    Dose required for reduction in camptothecin resistant human nasopharyngeal KB cancer cells after 3 days incubation
    		[PMID: 15456257]
    P388 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against mouse P388 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against mouse P388 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    KB ED50
    > 100 3
    Compound: 1
    Dose required for reduction in vincristine resistant human nasopharyngeal KB-VIN cancer cells after 3 days incubation
    Dose required for reduction in vincristine resistant human nasopharyngeal KB-VIN cancer cells after 3 days incubation
    		[PMID: 15456257]
    PANC-1 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
    Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    KB ED50
    > 10 6
    Compound: 1
    Dose required to cause reduction in human nasopharyngeal KB-7d cancer cells after 3 days incubation
    Dose required to cause reduction in human nasopharyngeal KB-7d cancer cells after 3 days incubation
    		[PMID: 15456257]
    PANC-1 IC50
    24.35 3
    Compound: Etoposide
    Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    KB GI50
    0.3 3
    Compound: 2
    Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    Panel NCI-60 cells GI50
    12 3
    Compound: 1
    Antiproliferative activity against human NCI60 cells after 48 hrs by SRB assay
    Antiproliferative activity against human NCI60 cells after 48 hrs by SRB assay
    		[PMID: 29870668]
    PC-12 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human PC12 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human PC12 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    KB GI50
    0.3 3
    Compound: 2, VP-16
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    KB GI50
    0.31 3
    Compound: 2, Eto
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    PC-3 IC50
    > 100 3
    Compound: Etoposide
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    PC-3 ED50
    > 100 3
    Compound: 1
    Dose required for reduction in human prostate PC-3 cancer cells after 3 days incubation
    Dose required for reduction in human prostate PC-3 cancer cells after 3 days incubation
    		[PMID: 15456257]
    KB GI50
    0.31 3
    Compound: 2, Eto
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    KB GI50
    8.392 3
    Compound: VP-16
    Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay
    Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay
    		[PMID: 32171161]
    PC-3 GI50
    0.6 3
    Compound: Etoposide
    Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    KB IC50
    0.12 6
    Compound: Etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 9214732]
    PC-3 GI50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    KB IC50
    0.164 3
    Compound: Etoposide
    Growth inhibitory activity (antiproliferative) against KB cell lines
    Growth inhibitory activity (antiproliferative) against KB cell lines
    		[PMID: 8691469]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    KB IC50
    0.2 3
    Compound: 1
    Concentration required for 50% reduction in KB cell number after 3-day incubation
    Concentration required for 50% reduction in KB cell number after 3-day incubation
    		[PMID: 1312600]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    KB IC50
    0.2 3
    Compound: 1
    Concentration required for 50% reduction in KB cell number after 3-day incubation
    Concentration required for 50% reduction in KB cell number after 3-day incubation
    		[PMID: 1312601]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    KB IC50
    0.201 6
    Compound: Etoposide
    Cytotoxic activity against human KB nasopha tumor cell line
    Cytotoxic activity against human KB nasopha tumor cell line
    		[PMID: 15149673]
    PC-3 IC50
    1 3
    Compound: VP16
    Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
    Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    KB IC50
    0.25 6
    Compound: Etoposide
    Cytotoxicity against human KB cells after 3 days by MTT assay
    Cytotoxicity against human KB cells after 3 days by MTT assay
    		[PMID: 21216051]
    PC-3 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    PC-3 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs
    Cytotoxicity against human PC3 cells after 48 hrs
    		[PMID: 19115839]
    KB IC50
    0.42 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells after 48 hrs by MTT assay
    Antiproliferative activity against human KB cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    KB IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    		[PMID: 19788270]
    PC-3 GI50
    11.1 3
    Compound: etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    Cytotoxicity against human PC3 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    		[PMID: 18321710]
    KB IC50
    0.6 3
    Compound: Etoposide
    Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%
    Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%
    		[PMID: 12431048]
    PC-3 IC50
    13.18 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    KB IC50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    PC-3 IC50
    13.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by SRB method
    Cytotoxicity against human PC3 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    KB IC50
    0.8 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    PC-3 IC50
    13.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human PC3 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    KB IC50
    0.85 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    PC-3 IC50
    13.9 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    KB IC50
    1.02 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells assessed as reduction in cell growth incubated for 2 days by MTT assay
    Antiproliferative activity against human KB cells assessed as reduction in cell growth incubated for 2 days by MTT assay
    		[PMID: 32531682]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    KB IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 14738395]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    KB IC50
    1.1 3
    Compound: VP-16
    Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    KB IC50
    1.1 3
    Compound: VP-16
    Growth inhibition of human KB cells after 72 hrs by methylene blue assay
    Growth inhibition of human KB cells after 72 hrs by methylene blue assay
    		[PMID: 22060033]
    PC-3 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human PC3 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    KB IC50
    1.1 3
    Compound: VP-16
    Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay
    Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay
    		[PMID: 24106982]
    PC-3 IC50
    17.4 3
    Compound: 2
    Cytotoxicity against human PC-3 cells by sulforhodamine B assay
    Cytotoxicity against human PC-3 cells by sulforhodamine B assay
    		[PMID: 17988764]
    KB IC50
    1.1 3
    Compound: VP-16
    Antiproliferative activity against human KB cells
    Antiproliferative activity against human KB cells
    		[PMID: 25059503]
    PC-3 IC50
    17.5 3
    Compound: 2
    Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    KB IC50
    1.25 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 18844422]
    PC-3 IC50
    18.2 3
    Compound: Eto
    Cytotoxicity against human PC3 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    KB IC50
    1.3 3
    Compound: etoposide
    Antiproliferative activity against drug-resistant tumor cell line KBCamp.
    Antiproliferative activity against drug-resistant tumor cell line KBCamp.
    		[PMID: 10411476]
    PC-3 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    KB IC50
    1.3 3
    Compound: etoposide
    Cytotoxicity against human KB cells after 72 hrs by methylene blue dye assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue dye assay
    		[PMID: 19785430]
    PC-3 IC50
    2.6 3
    Compound: Etoposide
    Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    KB IC50
    1.45 3
    Compound: etoposide
    Antiproliferative activity against drug-resistant tumor cell line KBwt.
    Antiproliferative activity against drug-resistant tumor cell line KBwt.
    		[PMID: 10411476]
    PC-3 GI50
    2.6 3
    Compound: 2, VP-16
    Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    PC-3 IC50
    2.7 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    KB IC50
    1.5 3
    Compound: VP-16
    Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay
    Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 26160020]
    KB IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human KB cells by MTT assay
    Cytotoxicity against human KB cells by MTT assay
    		[PMID: 32992133]
    PC-3 IC50
    30 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    KB IC50
    1.737 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human KB cells incubated for 72 hrs by SRB method
    Cytotoxicity against human KB cells incubated for 72 hrs by SRB method
    		[PMID: 32992133]
    PC-3 IC50
    4.33 3
    Compound: VP-16
    Antiproliferative activity against human PC3 cells assessed as cell viability incubated for 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells assessed as cell viability incubated for 72 hrs by MTT assay
    		[PMID: 25799376]
    KB IC50
    10 3
    Compound: Etoposide
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 21570846]
    PC-3 IC50
    5.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    KB IC50
    11.8 3
    Compound: Etoposide
    Antiproliferative activity against human KB cells by MTT assay
    Antiproliferative activity against human KB cells by MTT assay
    		[PMID: 31546197]
    PC-3 IC50
    5.73 3
    Compound: VP-16
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    KB IC50
    14.2 3
    Compound: Etoposide
    Cytotoxicity against human KB cells assessed as reduction of cell growth by SRB method
    Cytotoxicity against human KB cells assessed as reduction of cell growth by SRB method
    		[PMID: 18782668]
    PC-3 IC50
    69.54 3
    Compound: etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    KB IC50
    1500 1
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    Cytotoxicity against human KB cells after 72 hrs by methylene blue assay
    		[PMID: 24657567]
    PC-3 IC50
    7.2 6
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    PC-3 IC50
    8 3
    Compound: Etoposide
    Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    KB IC50
    153.26 3
    Compound: VP-16
    Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    KB IC50
    2 3
    Compound: VP-16
    Cytotoxicity against human KB cells after 72 hrs
    Cytotoxicity against human KB cells after 72 hrs
    		[PMID: 17125231]
    Raji IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human Raji cells after 48 hrs by MTT assay
    Cytotoxicity against human Raji cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    KB IC50
    2.27 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human Vincristine-resistant KB cells incubated for 72 hrs by SRB method
    Cytotoxicity against human Vincristine-resistant KB cells incubated for 72 hrs by SRB method
    		[PMID: 32992133]
    Raji IC50
    1.68 3
    Compound: Etoposide
    Antiproliferative activity against human Raji cells after 48 hrs by MTT assay
    Antiproliferative activity against human Raji cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    KB IC50
    2.4 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    RAW264.7 IC50
    0.82 3
    Compound: Etoposide
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    KB IC50
    23 3
    Compound: VP-16
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    RKO IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human RKO cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human RKO cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    KB IC50
    23.8 3
    Compound: Etoposide
    Growth inhibitory activity (antiproliferative) against KB/7d cell lines
    Growth inhibitory activity (antiproliferative) against KB/7d cell lines
    		[PMID: 8691469]
    RKO IC50
    1.9 3
    Compound: Etoposide
    Antiproliferative activity against human RKO cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human RKO cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    KB IC50
    26.2 3
    Compound: etoposide
    Antiproliferative activity against drug-resistant tumor cell line KBMDR.
    Antiproliferative activity against drug-resistant tumor cell line KBMDR.
    		[PMID: 10411476]
    RKO IC50
    1.96 3
    Compound: Etoposide
    Antiproliferative activity against human RKO cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human RKO cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    KB IC50
    28.7 3
    Compound: Etoposide
    Cytotoxicity against human vincristine-resistant KB cells after 72 hrs by MTT assay
    Cytotoxicity against human vincristine-resistant KB cells after 72 hrs by MTT assay
    		[PMID: 20187635]
    RPMI-8226 IC50
    0.14 3
    Compound: 2, VP-16
    Cytotoxicity against human RPMI8226 cells after 48 hrs
    Cytotoxicity against human RPMI8226 cells after 48 hrs
    		[PMID: 20053564]
    KB IC50
    3.5 3
    Compound: VP-16
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay
    Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    RPMI-8226 IC50
    0.7 3
    Compound: VP-16
    Cytotoxicity against human RPMI8226 cells after 72 hrs by CCK8 method
    Cytotoxicity against human RPMI8226 cells after 72 hrs by CCK8 method
    		[PMID: 20071056]
    RPMI-8226 IC50
    4.8 3
    Compound: Etoposide
    Cytotoxicity against human RPMI8226 cells after 72 hrs by MTT assay
    Cytotoxicity against human RPMI8226 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    KB IC50
    3.88 3
    Compound: 2
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 24553146]
    KB IC50
    3.88 3
    Compound: 3
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    		[PMID: 23490151]
    RWPE-1 GI50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human RWPE1 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human RWPE1 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    KB IC50
    3.88 3
    Compound: 3
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay
    		[PMID: 24332656]
    RWPE-1 IC50
    27.64 3
    Compound: Etoposide
    Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay
    Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    KB IC50
    4.61 1
    Compound: 1, VP-16
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    		[PMID: 21145139]
    SF-268 IC50
    3.25 3
    Compound: VP-16
    Antiproliferative activity against human SF-268 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SF-268 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    KB IC50
    4.8 3
    Compound: etoposide
    Cytotoxicity against human KB cells by SRB microtiter plate assay
    Cytotoxicity against human KB cells by SRB microtiter plate assay
    		[PMID: 17585747]
    SF-268 GI50
    4.21 3
    Compound: ETO
    Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
    Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
    		10.1007/s00044-013-0798-7
    KB IC50
    475 1
    Compound: VP-16
    Antiproliferative activity against human KB cells after 72 hrs by ethylene blue dye assay
    Antiproliferative activity against human KB cells after 72 hrs by ethylene blue dye assay
    		[PMID: 22698783]
    SF-295 IC50
    13.3 3
    Compound: 2
    Cytotoxicity against human SF295 cells by sulforhodamine B assay
    Cytotoxicity against human SF295 cells by sulforhodamine B assay
    		[PMID: 17988764]
    KB IC50
    54 3
    Compound: VP-16
    Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay
    Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay
    		[PMID: 19053773]
    SF-295 IC50
    13.5 3
    Compound: 2
    Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    KB IC50
    8.3 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) KB cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) KB cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    SGC-7901 IC50
    12.09 3
    Compound: 2
    Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
    Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    KB IC50
    8.3 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) KB cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) KB cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    SGC-7901 IC50
    5.26 3
    Compound: vp16
    Antiproliferative activity against human SGC-7901 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human SGC-7901 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    KB IC50
    > 20 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    SGC-7901 IC50
    6.56 3
    Compound: Vp-16
    Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    KB IC50
    > 20 3
    Compound: Etoposide
    Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method
    Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method
    		[PMID: 14761187]
    SH-SY5Y IC50
    0.89 3
    Compound: VP-16
    Cytotoxicity against human SH-SY5Y cells expressing low level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human SH-SY5Y cells expressing low level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    KB IC50
    > 50 3
    Compound: etoposide
    Antiproliferative activity against drug-resistant tumor cell line KB7D.
    Antiproliferative activity against drug-resistant tumor cell line KB7D.
    		[PMID: 10411476]
    SH-SY5Y IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by SRB method
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by SRB method
    		[PMID: 19425589]
    KB IC50
    > 50 3
    Compound: etoposide
    Antiproliferative activity against drug-resistant tumor cell line KBV20C.
    Antiproliferative activity against drug-resistant tumor cell line KBV20C.
    		[PMID: 10411476]
    SH-SY5Y IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by WST-8 assay
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    SH-SY5Y IC50
    5.37 3
    Compound: 2
    Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
    Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    SiHa IC50
    2.76 3
    Compound: 2, VP-16
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    		[PMID: 22244588]
    SiHa GI50
    3.1 3
    Compound: 2, VP-16
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    SiHa GI50
    3.11 3
    Compound: 2, Eto
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    SiHa IC50
    30.7 3
    Compound: VP-16
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    SiHa IC50
    40.4 3
    Compound: 5, VP-16
    Cytotoxicity against human SiHa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 22041063]
    SK-BR-3 IC50
    0.3 3
    Compound: Etoposide
    Inhibitory activity against SKBR-3 cell line using MTT assay (ER-amplified erB2,mutant p53)
    Inhibitory activity against SKBR-3 cell line using MTT assay (ER-amplified erB2,mutant p53)
    		[PMID: 10780913]
    SK-HEP1 IC50
    0.22 3
    Compound: Etoposide
    Antiproliferative activity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    SK-HEP1 IC50
    0.25 3
    Compound: Etoposide
    Cytotoxicity in human SK-HEP1 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human SK-HEP1 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    SK-HEP1 IC50
    0.38 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    SK-HEP1 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    SK-HEP1 IC50
    0.41 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by SRB assay
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    SK-HEP1 IC50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human SKHEP1 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    SK-HEP1 IC50
    0.63 3
    Compound: Etoposide
    Growth inhibition of human SKHEP1 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human SKHEP1 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    KB 3-1 IC50
    566.5 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against KB-3-1 cell line
    In vivo antiproliferative activity against KB-3-1 cell line
    		[PMID: 15084135]
    SK-HEP1 IC50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human SK-HEP1 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human SK-HEP1 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    KM12 GI50
    5.62 3
    Compound: Etoposide
    In vitro cytotoxicity against human colon cancer KM 12 cell line
    In vitro cytotoxicity against human colon cancer KM 12 cell line
    		[PMID: 9871772]
    SK-HEP1 IC50
    0.78 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    SK-HEP1 IC50
    0.93 3
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    SK-HEP1 IC50
    1.1 3
    Compound: etoposide
    Antiproliferative activity against human SKHEP1 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    SK-HEP1 IC50
    1.1 3
    Compound: etoposide
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    SK-HEP1 IC50
    2.8 3
    Compound: etoposide
    Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    SK-HEP1 IC50
    49.6 3
    Compound: etoposide
    Cytotoxicity against human SK-Hep1 cells by MTT assay
    Cytotoxicity against human SK-Hep1 cells by MTT assay
    		[PMID: 18637688]
    SK-HEP1 IC50
    62 1
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human SKHEP1 cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    L02 IC50
    1.22 3
    Compound: VP-16
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    L02 IC50
    13 3
    Compound: Etoposide
    Antiproliferative activity against human L02 cells after 48 hrs by MTT assay
    Antiproliferative activity against human L02 cells after 48 hrs by MTT assay
    		[PMID: 18514972]
    SK-MEL-1 IC50
    > 30 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SK-MEL-1 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    L02 IC50
    24.6 3
    Compound: VP-16
    Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    SK-MEL-1 IC50
    8 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human SK-MEL-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 29032930]
    L02 IC50
    24.61 3
    Compound: VP-16
    Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
    		[PMID: 24775914]
    SK-MEL-2 ED50
    0.08 6
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB method
    Cytotoxicity against human SK-MEL-2 cells by SRB method
    		[PMID: 16252909]
    L02 IC50
    3.78 3
    Compound: Etoposide
    Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    SK-MEL-2 IC50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    SK-MEL-2 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    L02 IC50
    3480.5 1
    Compound: VP-16
    Cytotoxicity against human L02 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    L02 IC50
    39.1 3
    Compound: VP-16
    Antiproliferative activity against human HL7702 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human HL7702 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    SK-MEL-2 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB method
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    L02 IC50
    47.74 3
    Compound: vp16
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    SK-MEL-2 IC50
    0.41 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by sulforhodamine B assay
    Cytotoxicity against human SK-MEL-2 cells by sulforhodamine B assay
    		[PMID: 21936523]
    SK-MEL-2 IC50
    0.79 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    L02 IC50
    49.6 3
    Compound: Etoposide
    Cytotoxicity against human HL7702 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
    Cytotoxicity against human HL7702 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
    		[PMID: 38408342]
    SK-MEL-2 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    L02 IC50
    7.75 3
    Compound: 2
    Cytotoxicity against human L02 cells after 24 hrs by MTT assay
    Cytotoxicity against human L02 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 26988298]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Anticancer activity against human SK-MEL-2 cells by SRB assay
    Anticancer activity against human SK-MEL-2 cells by SRB assay
    		[PMID: 21420296]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 21182258]
    SK-MEL-2 IC50
    1.33 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    L1210 ED50
    1.58 6
    Compound: Etoposide
    Compound was tested for its antitumor activity and the cytotoxicity against L1210 lymphoid leukemia screen
    Compound was tested for its antitumor activity and the cytotoxicity against L1210 lymphoid leukemia screen
    		[PMID: 3820231]
    SK-MEL-2 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity in human SK-MEL-2 cells by SRB assay
    Cytotoxicity in human SK-MEL-2 cells by SRB assay
    		[PMID: 26812172]
    L1210 ED50
    1.6 6
    Compound: etoposide
    Cytotoxicity against mouse L1210 cells
    Cytotoxicity against mouse L1210 cells
    		[PMID: 2095375]
    SK-MEL-2 IC50
    4.13 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human melanoma tumor cell line SK-MEL-2 by 50% after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human melanoma tumor cell line SK-MEL-2 by 50% after 72 hr of incubation was determined
    		[PMID: 15482917]
    SK-MEL-2 IC50
    5.72 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
    		[PMID: 18321715]
    SK-MEL-2 IC50
    5.72 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 17194596]
    L1210 IC50
    0.2 3
    Compound: etoposide
    In vitro cytotoxic activity against murine L1210 leukemia cells.
    In vitro cytotoxic activity against murine L1210 leukemia cells.
    		[PMID: 9804687]
    L1210 IC50
    0.23 3
    Compound: VP 16
    Antiproliferative activity was evaluated against murine L1210 leukemia cell line
    Antiproliferative activity was evaluated against murine L1210 leukemia cell line
    		[PMID: 11128630]
    SK-MEL-28 IC50
    1 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    L1210 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against mouse L1210 ATCC CCL 219 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse L1210 ATCC CCL 219 cells after 48 hrs by MTT assay
    		[PMID: 18558490]
    SK-MEL-28 IC50
    1.1 3
    Compound: VP-16
    Antiproliferative activity against human SKMEL-28 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human SKMEL-28 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    L1210 IC50
    0.83 3
    Compound: 1 (VP16)
    Inhibitory concentration required to reduce 50 percent L1210 cell growth
    Inhibitory concentration required to reduce 50 percent L1210 cell growth
    		[PMID: 15084135]
    SK-MEL-28 CC50
    1.2 3
    Compound: Etoposide
    Antiproliferative activity against human SK-MEL-28 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SK-MEL-28 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    L1210 IC50
    0.83 3
    Compound: VP-16
    Inhibition of L1210 cell proliferation in cytotoxic assay
    Inhibition of L1210 cell proliferation in cytotoxic assay
    		[PMID: 15658872]
    SK-MEL-28 IC50
    3 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    L1210 IC50
    0.834 3
    Compound: 2
    Inhibitory activity against L1210 cell line
    Inhibitory activity against L1210 cell line
    		[PMID: 14592517]
    SK-MEL-28 GI50
    3.2 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    L1210 IC50
    201.4 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against L1210 cell line
    In vivo antiproliferative activity against L1210 cell line
    		[PMID: 15084135]
    SK-MES-1 CC50
    0.3 3
    Compound: Etoposide
    Antiproliferative activity against human SKMES1 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SKMES1 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SK-MES-1 cells after 3 days by MTT assay
    Cytotoxicity against human SK-MES-1 cells after 3 days by MTT assay
    		[PMID: 19013074]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    SK-MES-1 IC50
    2.5 3
    Compound: etoposide
    Antitumor against human SK-MES1 cells after 72 hrs by MTT assay
    Antitumor against human SK-MES1 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    L132 GI50
    10.38 3
    Compound: Etoposide
    Growth inhibition of human L-132 cells by MTT assay
    Growth inhibition of human L-132 cells by MTT assay
    		[PMID: 27503682]
    L6 IC50
    18.99 3
    Compound: Etoposide
    Cytotoxicity against rat L6 cells after 71.5 hrs by Presto Blue assay
    Cytotoxicity against rat L6 cells after 71.5 hrs by Presto Blue assay
    		[PMID: 25466187]
    SK-MES-1 IC50
    2.8 3
    Compound: Etoposide
    Anticancer activity against human SKMES1 cells after 3 days by MTT assay
    Anticancer activity against human SKMES1 cells after 3 days by MTT assay
    		[PMID: 21621882]
    L929 IC50
    1 3
    Compound: 2
    Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    SK-MES-1 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 3 days by MTT assay
    Cytotoxicity against human SKMES1 cells after 3 days by MTT assay
    		[PMID: 19419803]
    LAMA-84 IC50
    0.79 3
    Compound: Etoposide
    Cytotoxicity against human LAMA-84 cells after 72 hrs by MTT assay
    Cytotoxicity against human LAMA-84 cells after 72 hrs by MTT assay
    		[PMID: 16872135]
    SK-N-MC IC50
    14.04 6
    Compound: Etoposide
    Cytotoxicity against human SK-N-MC cells by MTT assay
    Cytotoxicity against human SK-N-MC cells by MTT assay
    		[PMID: 22341788]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    SK-N-SH IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human SK-N-SH cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human SK-N-SH cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    SK-N-SH IC50
    9.03 3
    Compound: Etoposide
    Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    SK-OV-3 IC50
    ≥ 2.91 3
    Compound: Etoposide
    Anticancer activity against human SKOV3 cells after 48 hrs by SRB assay
    Anticancer activity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide
    Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
    		[PMID: 12699389]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide (VP-16)
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing LLC-PK1 cells
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing LLC-PK1 cells
    		[PMID: 12699389]
    SK-OV-3 IC50
    ≥ 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human SKOV3 cells by SRB assay
    Antiproliferative activity against human SKOV3 cells by SRB assay
    		[PMID: 31546197]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide (VP-16)
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1a-expressing LLC-PK1 cells
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1a-expressing LLC-PK1 cells
    		[PMID: 12699389]
    SK-OV-3 IC50
    0.84 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by SRB assay
    Cytotoxicity against human SKOV3 cells by SRB assay
    		[PMID: 26988298]
    LLC-PK1 IC50
    > 50 3
    Compound: Etoposide (VP-16)
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1b-expressing LLC-PK1 cells
    TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1b-expressing LLC-PK1 cells
    		[PMID: 12699389]
    SK-OV-3 IC50
    1.31 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by sulforhodamine B assay
    Cytotoxicity against human SKOV3 cells by sulforhodamine B assay
    		[PMID: 21936523]
    LN-229 IC50
    0.43 3
    Compound: Etoposide
    Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    SK-OV-3 IC50
    1.72 3
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB method
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    LNCaP IC50
    31.21 3
    Compound: Etoposide
    Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human LNCAP cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    SK-OV-3 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    LNCaP IC50
    50.33 3
    Compound: Etoposide
    Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay
    Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    SK-OV-3 IC50
    1.81 3
    Compound: Etoposide
    Anticancer activity against human SKOV3 cells by SRB assay
    Anticancer activity against human SKOV3 cells by SRB assay
    		[PMID: 21420296]
    SK-OV-3 IC50
    1.81 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by SRB assay
    Cytotoxicity against human SKOV3 cells by SRB assay
    		[PMID: 21182258]
    LS174T IC50
    0.48 3
    Compound: Etoposide
    Antiproliferative activity against human LS174T cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human LS174T cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    LS174T IC50
    0.9 3
    Compound: Etoposide
    Antiproliferative activity against human LS174T cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human LS174T cells harboring beta-catenin mutant assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    SK-OV-3 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 72 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    SK-OV-3 IC50
    1.95 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    SK-OV-3 IC50
    1.96 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    SK-OV-3 IC50
    14.8 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SKOV3 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SKOV3 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SK-OV-3 IC50
    2.39 3
    Compound: VP-16
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    SK-OV-3 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity in human SKOV3 cells by SRB assay
    Cytotoxicity in human SKOV3 cells by SRB assay
    		[PMID: 26812172]
    SK-OV-3 ED50
    2.7 6
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells by SRB method
    Cytotoxicity against human SKOV3 cells by SRB method
    		[PMID: 16252909]
    LoVo IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human LoVo cells by MTT assay
    Cytotoxicity against human LoVo cells by MTT assay
    		[PMID: 32992133]
    SK-OV-3 IC50
    2.9 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    LoVo IC50
    14.9 3
    Compound: 2; VP-16
    Cytotoxicity against human LoVo cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human LoVo cells incubated for 48 hrs by MTT assay
    		[PMID: 31278032]
    SK-OV-3 IC50
    3.46 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human ovarian tumor cell line SK-OV-3 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human ovarian tumor cell line SK-OV-3 after 72 hr of incubation was determined
    		[PMID: 15482917]
    LoVo IC50
    18.7 3
    Compound: 2; VP-16
    Cytotoxicity against human LoVo cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human LoVo cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    SK-OV-3 IC50
    3.84 6
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    LoVo IC50
    2.3 3
    Compound: ETP
    Cytotoxic activity against solid tumor, LoVo, (human colon adenocarcinoma) concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against solid tumor, LoVo, (human colon adenocarcinoma) concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    SK-OV-3 IC50
    4.28 3
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells after 3 days by SRB assay
    Cytotoxicity against human SKOV3 cells after 3 days by SRB assay
    		[PMID: 18321715]
    SK-OV-3 IC50
    4.28 3
    Compound: etoposide
    Cytotoxicity against human SK-OV-3 cells by SRB assay
    Cytotoxicity against human SK-OV-3 cells by SRB assay
    		[PMID: 17194596]
    M059J IC50
    58.9 3
    Compound: VP16
    Cytotoxicity against human M059J cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human M059J cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    M14 GI50
    < 0.01 3
    Compound: 2
    In vitro cytotoxic activity against melanoma (M 14) cancer cell line.
    In vitro cytotoxic activity against melanoma (M 14) cancer cell line.
    		[PMID: 10465531]
    SK-OV-3 IC50
    9.2 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    M21 IC50
    0.2 3
    Compound: 1
    Antiproliferative activity against human M21 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    Antiproliferative activity against human M21 cells assessed as inhibition of cell proliferation measured after 48 hrs by SRB assay
    		[PMID: 34837817]
    SMMC-7721 IC50
    0.15 3
    Compound: Etoposide
    Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    SMMC-7721 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SMMC-7721 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SMMC-7721 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SMMC-7721 IC50
    21.03 3
    Compound: Etoposide
    Cytotoxic activity against human SMMC7721 cells after 72 hrs by MTT assay
    Cytotoxic activity against human SMMC7721 cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    MCF-10A GI50
    > 5 3
    Compound: Etoposide
    Growth inhibition of human MCF10A cells after 72 hrs by celltiter-blue viability assay
    Growth inhibition of human MCF10A cells after 72 hrs by celltiter-blue viability assay
    		[PMID: 21348461]
    SMMC-7721 IC50
    40.44 3
    Compound: Etoposide
    Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
    Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    MCF-10A IC50
    10.14 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells after 2 days by CCK8 assay
    Cytotoxicity against human MCF10A cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    SMMC-7721 IC50
    8.12 3
    Compound: 2
    Anticancer activity against human SMMC7721 cells after 48 hrs by MTT assay
    Anticancer activity against human SMMC7721 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    MCF-10A IC50
    102 3
    Compound: Etoposide
    Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    SNU-638 IC50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    MCF-10A IC50
    12.23 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells after 2 days
    Cytotoxicity against human MCF10A cells after 2 days
    		[PMID: 24904965]
    SNU-638 IC50
    0.23 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells after 3 days by SRB assay
    Cytotoxicity against human SNU638 cells after 3 days by SRB assay
    		[PMID: 18321715]
    MCF-10A IC50
    36.26 3
    Compound: Eto
    Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    SNU-638 IC50
    0.23 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells by SRB assay
    Cytotoxicity against human SNU638 cells by SRB assay
    		[PMID: 17194596]
    MCF-10A IC50
    84.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF10A cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF10A cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 34791873]
    SNU-638 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    MCF-10A IC50
    > 120 3
    Compound: Etoposide
    Cytotoxicity against human MCF-10A cells
    Cytotoxicity against human MCF-10A cells
    		[PMID: 34303812]
    SNU-638 IC50
    0.34 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay
    Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    SNU-638 IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human SNU-638 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human SNU-638 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    SNU-638 IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    SNU-638 IC50
    0.43 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    SNU-638 IC50
    0.5 3
    Compound: etoposide
    Antiproliferative activity against human SNU638 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    SNU-638 IC50
    0.5 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    SNU-638 IC50
    0.52 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    SNU-638 IC50
    0.56 3
    Compound: Etoposide
    Cytotoxicity in human SNU-638 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human SNU-638 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    SNU-638 IC50
    0.82 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    SNU-638 IC50
    1.05 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human SNU638 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    SNU-638 IC50
    1.05 3
    Compound: Etoposide
    Growth inhibition of human SNU638 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human SNU638 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    SNU-638 IC50
    2.57 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells by MTT assay
    Cytotoxicity against human SNU638 cells by MTT assay
    		[PMID: 23608763]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    SW1573 GI50
    15 3
    Compound: VP-16
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    SW1573 GI50
    15 3
    Compound: VP-16
    Cytotoxicity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Growth inhibition of human SW1573 cells after 48 hrs by SRB assay
    Growth inhibition of human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    SW1573 GI50
    3 3
    Compound: VP-16
    Antiproliferative activity against human SW1573 cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    SW480 IC50
    < 0.01 3
    Compound: Etoposide
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU60019 by SRB assay
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    < 0.01 3
    Compound: Etoposide
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 50 nM AZD0156 by SRB assay
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    0.07 3
    Compound: Etoposide
    Cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    0.08 3
    Compound: Etoposide
    Additive cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU55933 by SRB assay
    Additive cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    SW480 IC50
    0.6 3
    Compound: VP16
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    SW480 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    SW480 IC50
    1.11 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    SW480 IC50
    17.11 3
    Compound: 2
    Anticancer activity against human SW480 cells after 48 hrs by MTT assay
    Anticancer activity against human SW480 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    SW480 IC50
    3.5 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU55933 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.6 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.6 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 50 nM AZD0156 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.8 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU60019 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    50 3
    Compound: 1
    Tested for cytotoxicity against Colon adenocarcinoma resistant type SW480 cell line expressing MDR-1 (+) gene; ~50% cells affected by drug
    Tested for cytotoxicity against Colon adenocarcinoma resistant type SW480 cell line expressing MDR-1 (+) gene; ~50% cells affected by drug
    		[PMID: 11844671]
    SW480 IC50
    6.4 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) SW480 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) SW480 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    SW480 IC50
    6.4 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) SW480 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) SW480 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    SW480 IC50
    7.7 6
    Compound: Etoposide
    Cytotoxicity against human SW480 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human SW480 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    SW480 IC50
    7.7 6
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    SW480 IC50
    764 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SW480 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SW-620 IC50
    13.24 3
    Compound: Etoposide
    Cytotoxicity against human SW620 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SW620 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    SW-620 IC50
    20 3
    Compound: Eto
    Antitumor activity against human SW620 cells after 72 hrs by MTT assay
    Antitumor activity against human SW620 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    SW-620 IC50
    20 3
    Compound: etoposide
    Growth inhibition of human SW620 cells by MTT assay
    Growth inhibition of human SW620 cells by MTT assay
    		[PMID: 17482821]
    SW948 IC50
    1.3 3
    Compound: etoposide
    Antiproliferative activity against human SW948 cells after 3 days by XTT assay
    Antiproliferative activity against human SW948 cells after 3 days by XTT assay
    		[PMID: 19691293]
    T47D IC50
    0.05 6
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 3 days by MTT assay
    Cytotoxicity against human T47D cells after 3 days by MTT assay
    		[PMID: 21216051]
    T47D IC50
    0.16 3
    Compound: Etoposide
    Inhibitory activity against T47D cell line using MTT assay (ER+,mutant p53)
    Inhibitory activity against T47D cell line using MTT assay (ER+,mutant p53)
    		[PMID: 10780913]
    T47D IC50
    0.32 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    T47D IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    T47D IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    T47D IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human T47D cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    T47D IC50
    0.94 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by CCK8 assay
    Cytotoxicity against human T47D cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    T47D IC50
    1.21 3
    Compound: ETO
    Cytotoxicity against human T47D cells after 72 hrs by MTT assay
    Cytotoxicity against human T47D cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    T47D IC50
    1.64 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human T47D cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    T47D IC50
    1.84 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 3 days by CCK8 assay
    Cytotoxicity against human T47D cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    T47D IC50
    1.84 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    T47D IC50
    1.96 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human T47D cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    T47D IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    T47D IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    T47D IC50
    13.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by CCK8 assay
    Cytotoxicity against human T47D cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    T47D IC50
    13.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells measured on day 4 by CCK8 assay
    Cytotoxicity against human T47D cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    T47D GI50
    15 3
    Compound: VP-16
    Antiproliferative activity against human T47D cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    T47D IC50
    2.39 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human T47D cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    T47D IC50
    2.57 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days
    Cytotoxicity against human T47D cells after 2 days
    		[PMID: 24904965]
    T47D IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human T47D cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    T47D GI50
    22 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    T47D GI50
    22 3
    Compound: VP-16
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    T47D GI50
    22 3
    Compound: Etoposide
    Growth inhibition of human T47D cells after 48 hrs by SRB assay
    Growth inhibition of human T47D cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    T47D GI50
    22 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    T47D IC50
    3.25 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    T47D IC50
    3.42 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by CCK-8 assay
    Cytotoxicity against human T47D cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    T47D IC50
    4.85 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    T47D IC50
    4.98 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells by MTT assay
    Cytotoxicity against human T47D cells by MTT assay
    		[PMID: 23608763]
    T47D IC50
    5.58 3
    Compound: Etopo
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    T47D IC50
    6.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    T47D IC50
    7 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    T47D GI50
    7.9 6
    Compound: Etoposide
    Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 31546197]
    T47D IC50
    8.2 6
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    T47D IC50
    8.74 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 4 days by CCK-8 assay
    Cytotoxicity against human T47D cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    T47D IC50
    8.81 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    T47D IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells by MTT assay
    Cytotoxicity against human T47D cells by MTT assay
    		[PMID: 25847767]
    T47D IC50
    9.28 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells measured after 2 days by MTT assay
    Cytotoxicity against human T47D cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    T47D IC50
    9.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    T84 IC50
    3 3
    Compound: Etoposide
    Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    T98G IC50
    460 1
    Compound: Etoposide
    Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay
    Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay
    		[PMID: 22564383]
    THP-1 IC50
    < 6.25 3
    Compound: Etop
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    THP-1 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    THP-1 IC50
    1.27 6
    Compound: Etoposide
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    THP-1 IC50
    1.82 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    THP-1 IC50
    1.82 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    THP-1 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells by MTT assay
    Cytotoxicity against human THP1 cells by MTT assay
    		[PMID: 19782567]
    THP-1 IC50
    2.16 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    THP-1 IC50
    2.16 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 2 days by MTT assay
    Cytotoxicity against human THP1 cells after 2 days by MTT assay
    		[PMID: 22325897]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells by MTT assay
    Cytotoxicity against human THP1 cells by MTT assay
    		[PMID: 19036584]
    THP-1 IC50
    3.66 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    THP-1 IC50
    4.42 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    THP-1 IC50
    5.02 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    THP-1 IC50
    59 3
    Compound: Etop
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    THP-1 IC50
    6.34 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    TK-10 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human TK-10 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    Antiproliferative activity against human TK-10 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    		[PMID: 27010926]
    TK-10 IC50
    20.4 6
    Compound: Etoposide
    Anticancer activity against human TK10 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human TK10 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    MCF7 CC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    TK-10 GI50
    5.89 3
    Compound: ET
    Cytotoxicity against human TK10 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human TK10 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    MCF7 EC50
    16.4 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells
    Cytotoxicity against human MCF7 cells
    		[PMID: 23043462]
    TK-10 GI50
    7.19 3
    Compound: Etoposide
    Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    MCF7 EC50
    16.4 6
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    		[PMID: 20073490]
    TK-10 GI50
    7.19 3
    Compound: Etoposide
    Antiproliferative activity against human TK10 cells after 48 hrs by SRB assay
    Antiproliferative activity against human TK10 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    MCF7 EC50
    2.8 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days
    Cytotoxicity against human MCF7 cells after 2 days
    		[PMID: 17629328]
    TK-10 IC50
    9952.5 1
    Compound: etoposide
    Cytotoxicity against human TK10 cells after 48 hrs by SRB assay
    Cytotoxicity against human TK10 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    MCF7 EC50
    2.8 6
    Compound: etoposide
    Cytotoxicity against human MCF7 cells
    Cytotoxicity against human MCF7 cells
    		[PMID: 17672504]
    U-251 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human U251 RCB 0641 cells after 72 hrs by MTT assay
    Cytotoxicity against human U251 RCB 0641 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    U-373MG ATCC GI50
    24.9 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    MCF7 ED50
    62.2 3
    Compound: 1
    Dose required for reduction in human breast MCF-7 cancer cells after 3 day incubation
    Dose required for reduction in human breast MCF-7 cancer cells after 3 day incubation
    		[PMID: 15456257]
    MCF7 ED50
    > 5 2
    Compound: VP-16
    The compound was tested for tumor cell growth inhibitory activity against human breast cancer (MCF-7) cell line.
    The compound was tested for tumor cell growth inhibitory activity against human breast cancer (MCF-7) cell line.
    		[PMID: 10395485]
    U-373MG ATCC IC50
    25 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    U-373MG ATCC IC50
    7 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    U-373MG ATCC IC50
    8.5 3
    Compound: etoposide
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    U-87MG ATCC IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human U87 cells after 72 hrs by MTT assay
    Cytotoxicity against human U87 cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    MCF7 GI50
    0.25 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 24953821]
    U-87MG ATCC IC50
    145 1
    Compound: Etoposide
    Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    MCF7 GI50
    0.25 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    U-87MG ATCC IC50
    27 3
    Compound: Etoposide
    Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    MCF7 GI50
    0.56 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    U-87MG ATCC IC50
    5.09 3
    Compound: vp16
    Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    MCF7 GI50
    0.56 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    U-87MG ATCC IC50
    620 1
    Compound: Etoposide
    Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay
    Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay
    		[PMID: 22564383]
    MCF7 GI50
    0.83 3
    Compound: ET
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    U-87MG ATCC ED50
    73.6 3
    Compound: 1
    Dose required for reduction in human glioblastoma U-87-MG cancer cells after 3 days incubation
    Dose required for reduction in human glioblastoma U-87-MG cancer cells after 3 days incubation
    		[PMID: 15456257]
    MCF7 GI50
    0.87 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 23999041]
    U-937 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human U937 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human U937 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    MCF7 GI50
    1 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    U-937 IC50
    0.92 3
    Compound: etoposide
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    MCF7 GI50
    19.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    U-937 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    U-937 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    MCF7 GI50
    19.9 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    U-937 IC50
    1.4 3
    Compound: etoposide
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    		[PMID: 23865778]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 22104973]
    U-937 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		[PMID: 25800433]
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 23831811]
    U-937 IC50
    10.1 3
    Compound: Etoposide
    Anticancer activity against human U937 cells by MTT assay
    Anticancer activity against human U937 cells by MTT assay
    		10.1039/C4MD00279B
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    U-937 IC50
    10.43 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    MCF7 GI50
    19.95 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    U-937 IC50
    10.56 6
    Compound: etoposide
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    		[PMID: 17689837]
    MCF7 GI50
    2.1 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B based ELISA
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B based ELISA
    		[PMID: 21402478]
    U-937 IC50
    10.56 6
    Compound: Etoposide
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    U-937 IC50
    10.6 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 22704923]
    MCF7 GI50
    2.1 3
    Compound: 2, VP-16
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    MCF7 GI50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    U-937 IC50
    17.94 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    MCF7 GI50
    2.11 3
    Compound: 2, Eto
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    U-937 IC50
    17.94 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    		[PMID: 22325897]
    MCF7 GI50
    2.11 3
    Compound: 2, Eto
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    U-937 IC50
    17.94 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 48 hrs by MTT assay
    Cytotoxicity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    MCF7 GI50
    25 3
    Compound: Etoposide
    Compound was evaluated for in vitro cytotoxicity data against human breast cancer MCF-7 ADR cell line
    Compound was evaluated for in vitro cytotoxicity data against human breast cancer MCF-7 ADR cell line
    		[PMID: 9871772]
    U-937 IC50
    17.96 3
    Compound: Etoposide
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    MCF7 GI50
    4 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    U-937 IC50
    2.27 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    MCF7 GI50
    55.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    Cytotoxicity against human MCF7 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    		[PMID: 18321710]
    U-937 IC50
    2.89 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    MCF7 GI50
    7.5 6
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 31546197]
    U-937 IC50
    6.14 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    MCF7 GI50
    > 5 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by celltiter-blue viability assay
    Growth inhibition of human MCF7 cells after 72 hrs by celltiter-blue viability assay
    		[PMID: 21348461]
    U-937 IC50
    6.7 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    MCF7 IC50
    0.008 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells by MTT assay
    Anticancer activity against human MCF7 cells by MTT assay
    		10.1039/C4MD00279B
    UACC-62 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human UACC62 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human UACC62 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    MCF7 IC50
    0.03 6
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    UACC-62 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human UACC-62 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    Antiproliferative activity against human UACC-62 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    		[PMID: 27010926]
    MCF7 IC50
    0.06 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU60019 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    UACC-62 GI50
    0.89 3
    Compound: Etoposide
    Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    MCF7 IC50
    0.085 3
    Compound: Etoposide
    Inhibitory activity against MCF-7 wt cell line using MTT assay (ER+,pgR+,wildtype p53)
    Inhibitory activity against MCF-7 wt cell line using MTT assay (ER+,pgR+,wildtype p53)
    		[PMID: 10780913]
    UACC-62 GI50
    0.89 3
    Compound: Etoposide
    Antiproliferative activity against human UACC62 cells after 48 hrs by SRB assay
    Antiproliferative activity against human UACC62 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    MCF7 IC50
    0.11 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 50 nM AZD0156 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    UACC-62 IC50
    1.4 6
    Compound: Etoposide
    Anticancer activity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    MCF7 IC50
    0.19 3
    Compound: etoposide
    Antiproliferative effect against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative effect against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 16499324]
    UACC-62 IC50
    1130 1
    Compound: etoposide
    Cytotoxicity against human UACC62 cells after 48 hrs by SRB assay
    Cytotoxicity against human UACC62 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    MCF7 IC50
    0.21 3
    Compound: Eto
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 6 days by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 6 days by MTT assay
    		[PMID: 37438997]
    UACC-62 GI50
    3.41 3
    Compound: ET
    Cytotoxicity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    MCF7 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    Vero IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against African green monkey Vero cells by MTT assay
    Antiproliferative activity against African green monkey Vero cells by MTT assay
    		[PMID: 29072457]
    MCF7 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MCF7 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    Vero IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human Vero cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human Vero cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    MCF7 IC50
    0.5 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 96 hrs by crystal violet assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by crystal violet assay
    		[PMID: 18434163]
    Vero IC50
    16 3
    Compound: ET
    Cytotoxicity against African green monkey Vero cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    MCF7 IC50
    0.54 3
    Compound: Etoposide
    Growth inhibition against human MCF-7 cell lines
    Growth inhibition against human MCF-7 cell lines
    		[PMID: 15189040]
    Vero IC50
    31.14 3
    Compound: 2
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    MCF7 IC50
    0.56 3
    Compound: Etoposide
    Additive cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    Additive cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    		[PMID: 35231830]
    Vero IC50
    50 3
    Compound: Etoposide
    Cytotoxicity against African green monkey Vero cells assessed as cells growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as cells growth inhibition after 48 hrs by MTT assay
    		[PMID: 27994737]
    MCF7 IC50
    0.59 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU55933 by SRB assay
    Synergistic cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    WI-38 IC50
    17.6 3
    Compound: VP16
    Cytotoxicity against human WI38 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    MCF7 IC50
    0.65 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 6 days by SRB assay
    		[PMID: 35231830]
    WI-38 IC50
    25.7 3
    Compound: 2; VP-16
    Cytotoxicity against human WI38 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    MCF7 IC50
    0.66 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Cytotoxicity against human MCF7 cells measured after 6 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    WI-38 IC50
    35.8 3
    Compound: VP16; 2
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    MCF7 IC50
    0.68 3
    Compound: 2, Etop
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 22136907]
    WI-38 IC50
    46.9 3
    Compound: 2; VP-16
    Cytotoxicity against human WI38 cells after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    MCF7 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs
    Cytotoxicity against human MCF7 cells after 48 hrs
    		[PMID: 19115839]
    WiDr GI50
    23 3
    Compound: Etoposide
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    MCF7 IC50
    0.73 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days by CCK-8 assay
    Cytotoxicity against human MCF7 cells after 2 days by CCK-8 assay
    		[PMID: 25481396]
    WiDr GI50
    23 3
    Compound: VP-16
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    WiDr GI50
    23 3
    Compound: VP-16
    Cytotoxicity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    MCF7 IC50
    0.79 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    MCF7 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    WiDr GI50
    23 3
    Compound: Etoposide
    Growth inhibition of human WiDr cells after 48 hrs by SRB assay
    Growth inhibition of human WiDr cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    MCF7 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    		[PMID: 27010926]
    WiDr GI50
    23 3
    Compound: Etoposide
    Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    MCF7 IC50
    0.83 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells
    Anticancer activity against human MCF7 cells
    		[PMID: 31945642]
    WiDr GI50
    26 3
    Compound: VP-16
    Antiproliferative activity against human WiDr cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    WIL2-NS CC50
    0.2 3
    Compound: Etoposide
    Antiproliferative activity against human WIL2-NS cells after 96 hrs by MTT assay
    Antiproliferative activity against human WIL2-NS cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 26988298]
    MCF7 IC50
    1 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Anticancer activity against human XF498 cells by SRB assay
    Anticancer activity against human XF498 cells by SRB assay
    		[PMID: 21420296]
    MCF7 IC50
    1 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 21182258]
    MCF7 IC50
    1 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    XF498 ED50
    2.6 6
    Compound: etoposide
    Cytotoxicity against human XF498 cells by SRB method
    Cytotoxicity against human XF498 cells by SRB method
    		[PMID: 16252909]
    XF498 IC50
    3.14 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 by 50% after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 by 50% after 72 hr of incubation was determined
    		[PMID: 15482917]
    MCF7 IC50
    1.09 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
    		[PMID: 22119124]
    XF498 IC50
    3.45 3
    Compound: VP-16
    Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay
    Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    MCF7 IC50
    1.18 3
    Compound: 3; Etop
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    MCF7 IC50
    1.2 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    XF498 IC50
    3.48 3
    Compound: etoposide
    Cytotoxicity against human XF498 cells after 3 days by SRB assay
    Cytotoxicity against human XF498 cells after 3 days by SRB assay
    		[PMID: 18321715]
    XF498 IC50
    3.48 3
    Compound: etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 17194596]
    MCF7 IC50
    1.264 3
    Compound: 2
    Antiproliferative activity against human MCF7 cells after 96 hrs by propidium iodide-based monolayer assay
    Antiproliferative activity against human MCF7 cells after 96 hrs by propidium iodide-based monolayer assay
    		[PMID: 26854430]
    MCF7 IC50
    1.36 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 30108892]
    Z-138 IC50
    0.85 3
    Compound: Etoposide
    Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    MCF7 IC50
    1.45 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, Eto
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    MCF7 IC50
    1.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay
    		[PMID: 33421712]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, Eto
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    MCF7 IC50
    1.62 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29289884]
    ZR-75-1 GI50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, VP-16
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    MCF7 IC50
    1.71 3
    Compound: Ref 34, Cpd 2
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 32992133]
    MCF7 IC50
    1.74 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
    		[PMID: 27262599]
    ZR-75-1 IC50
    0.24 3
    Compound: Etoposide
    Inhibitory activity against ZR-75-1 cell line using MTT assay (ER+,pgr+,mutant p53)
    Inhibitory activity against ZR-75-1 cell line using MTT assay (ER+,pgr+,mutant p53)
    		[PMID: 10780913]
    MCF7 IC50
    1.89 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 4 days by ELISA reader assay
    Cytotoxicity against human MCF7 cells after 4 days by ELISA reader assay
    		[PMID: 19939682]
    ZR-75-1 IC50
    3.1 3
    Compound: etoposide
    Cytotoxicity against human ZR751cells by SRB microtiter plate assay
    Cytotoxicity against human ZR751cells by SRB microtiter plate assay
    		[PMID: 17585747]
    MCF7 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    ZR-75-30 IC50
    1.5 3
    Compound: Eto
    Antiproliferative activity against human ZR-7530 cells after 72 hrs by MTT assay
    Antiproliferative activity against human ZR-7530 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    ZR-75-30 IC50
    2.5 3
    Compound: etoposide
    Cytotoxicity against human ZR-7530 cells after 72 hrs by MTT assay
    Cytotoxicity against human ZR-7530 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    MCF7 IC50
    1.98 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 21115246]
    MCF7 IC50
    10.5 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 29077404]
    MCF7 IC50
    10.9 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    MCF7 IC50
    10.9 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    MCF7 IC50
    100 3
    Compound: VP-16
    Antiproliferative activity against human MCF-7 breast cell line
    Antiproliferative activity against human MCF-7 breast cell line
    		[PMID: 10498216]
    MCF7 IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    MCF7 IC50
    11.95 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    MCF7 IC50
    12.2 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 ATCC HTB 22 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 ATCC HTB 22 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    MCF7 IC50
    12.3 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 11473438]
    MCF7 IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    MCF7 IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 28886509]
    MCF7 IC50
    12.6 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 34791873]
    MCF7 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    MCF7 IC50
    16.3 3
    Compound: Etoposide
    Cytotoxicity against human breast cancer cell line MCF7 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human breast cancer cell line MCF7 assessed as inhibition of cell viability measured after 24 hrs by MTT assay
    		[PMID: 23305918]
    MCF7 IC50
    17 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    MCF7 IC50
    17.5 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 4 days by MTT assay
    Cytotoxicity against human MCF7 cells after 4 days by MTT assay
    		[PMID: 20619511]
    MCF7 IC50
    17.76 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    MCF7 IC50
    18.01 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 3 days
    Cytotoxicity against human MCF7 cells after 3 days
    		[PMID: 19954977]
    MCF7 IC50
    18.43 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 22341788]
    MCF7 IC50
    18.75 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells by CCK-8 assay
    Antiproliferative activity against human MCF7 cells by CCK-8 assay
    		[PMID: 35598793]
    MCF7 IC50
    18.9 3
    Compound: Vp-16
    Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
    		[PMID: 33979690]
    MCF7 IC50
    19 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    MCF7 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29269253]
    MCF7 IC50
    2.03 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    MCF7 IC50
    2.08 3
    Compound: 2
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		[PMID: 28757065]
    MCF7 IC50
    2.11 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    MCF7 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    MCF7 IC50
    2.56 3
    Compound: VP-16
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 120 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 120 hrs by MTT assay
    		[PMID: 38107170]
    MCF7 IC50
    2.69 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 25615796]
    MCF7 IC50
    20.9 3
    Compound: Eto
    Cytotoxicity against human MCF7 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    MCF7 IC50
    23.62 3
    Compound: Etoposide
    Synergistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 2 days by SRB assay
    Synergistic cytotoxicity against human MCF7 cells in presence of 10 uM 3-Chloro-4-methoxy-N-((4-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide measured after 2 days by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    MCF7 IC50
    23.9 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    MCF7 IC50
    24.01 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    MCF7 IC50
    27.41 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    MCF7 IC50
    29.49 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    MCF7 IC50
    29.66 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    		[PMID: 36996717]
    MCF7 IC50
    3.1 6
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    MCF7 IC50
    3.1 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    MCF7 IC50
    3.2 3
    Compound: etoposide
    Cytotoxic activity against human MCF7 cells after 48 hrs by MTT reduction assay
    Cytotoxic activity against human MCF7 cells after 48 hrs by MTT reduction assay
    		[PMID: 17316916]
    MCF7 IC50
    3.25 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 2 days
    Cytotoxicity against human MCF7 cells after 2 days
    		[PMID: 22318164]
    MCF7 IC50
    32.82 3
    Compound: 2
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    MCF7 IC50
    35.55 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human MCF7 cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    MCF7 IC50
    35.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells by XTT assay
    Cytotoxicity against human MCF7 cells by XTT assay
    		[PMID: 17368022]
    MCF7 IC50
    35.6 3
    Compound: etoposide
    Cytotoxicity against human MCF7 cells by XTT assay
    Cytotoxicity against human MCF7 cells by XTT assay
    		[PMID: 18093835]
    MCF7 IC50
    4 3
    Compound: Etoposide
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    MCF7 IC50
    45 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    MCF7 IC50
    45 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 35617791]
    MCF7 IC50
    45 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
    		[PMID: 38516586]
    MCF7 IC50
    46.2 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    4716.5 1
    Compound: VP-16
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29886322]
    MCF7 IC50
    480 1
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 22564383]
    MCF7 IC50
    5.7 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    MCF7 IC50
    50 3
    Compound: Eto
    Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
    Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    MCF7 IC50
    50 3
    Compound: Etop
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    MCF7 IC50
    50 3
    Compound: etoposide
    Growth inhibition of human MCF7 cells by MTT assay
    Growth inhibition of human MCF7 cells by MTT assay
    		[PMID: 17482821]
    MCF7 IC50
    53.8 3
    Compound: VP-16
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    MCF7 IC50
    58.8 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU55933 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    59.75 3
    Compound: Etoposide
    Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
    		[PMID: 23313635]
    MCF7 IC50
    62.7 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 50 nM AZD0156 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    67000 1
    Compound: VP16
    Antiproliferative activity measured against MCF-7-mdr cells.
    Antiproliferative activity measured against MCF-7-mdr cells.
    		[PMID: 9876111]
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human MCF7 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB method
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    MCF7 IC50
    7.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    		[PMID: 25847767]
    MCF7 IC50
    8.9 3
    Compound: Etoposide
    Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    		[PMID: 33079544]
    MCF7 IC50
    81.09 3
    Compound: Etoposide
    Antiproliferative against human MCF7 cells after 48 hrs by MTT assay
    Antiproliferative against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24996136]
    MCF7 IC50
    82.6 3
    Compound: VP16
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 24 hrs by XTT assay
    Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 24 hrs by XTT assay
    		[PMID: 26649907]
    MCF7 IC50
    87.4 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU60019 by SRB assay
    Antagonistic cytotoxicity against human MCF7 cells measured after 2 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    MCF7 IC50
    877.5 1
    Compound: etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    MCF7 IC50
    9.4 6
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    MCF7 IC50
    9.6 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    MCF7 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    MCF7 IC50
    > 100 3
    Compound: Etop
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    MCF7 IC50
    > 30 3
    Compound: ETP
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 28094224]
    MCF7 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human MCF7 cells after 48 hrs by SRB assay
    Anticancer activity against human MCF7 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    MCF7 IC50
    >= 2.91 3
    Compound: Etoposide
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 30660827]
    MCF7 IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7 cells by SRB assay
    Antiproliferative activity against human MCF7 cells by SRB assay
    		[PMID: 31546197]
    MCF7-DOX IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay
    Anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    MCF7-DOX IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human MCF7/Dox cells by SRB assay
    Antiproliferative activity against human MCF7/Dox cells by SRB assay
    		[PMID: 31546197]
    MDA-MB-231 GI50
    1.67 3
    Compound: Eto
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay
    		[PMID: 23999041]
    MDA-MB-231 GI50
    2 3
    Compound: Etoposide
    In vitro cytotoxicity against human breast cancer MDA-MB 231 cell line
    In vitro cytotoxicity against human breast cancer MDA-MB 231 cell line
    		[PMID: 9871772]
    MDA-MB-231 GI50
    7.2 3
    Compound: Etoposide
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by SRB assay
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 23153810]
    MDA-MB-231 IC50
    0.15 3
    Compound: Etoposide
    Inhibitory activity against MDA-231 cell line using MTT assay (ER-,EGFR+,mutant p53)
    Inhibitory activity against MDA-231 cell line using MTT assay (ER-,EGFR+,mutant p53)
    		[PMID: 10780913]
    MDA-MB-231 IC50
    0.24 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay
    		[PMID: 21216051]
    MDA-MB-231 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells
    Cytotoxicity against human MDA-MB-231 cells
    		[PMID: 19788270]
    MDA-MB-231 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    MDA-MB-231 IC50
    0.51 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    MDA-MB-231 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 2 days by automatic ELISA reader system
    Cytotoxicity against human MDA-MB-231 cells after 2 days by automatic ELISA reader system
    		[PMID: 20392646]
    MDA-MB-231 IC50
    1.23 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 2 days
    Cytotoxicity against human MDA-MB-231 cells after 2 days
    		[PMID: 21419530]
    MDA-MB-231 IC50
    1.5 3
    Compound: Eto
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 23999041]
    MDA-MB-231 IC50
    1.53 3
    Compound: Etoposide
    Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    MDA-MB-231 IC50
    1.53 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    MDA-MB-231 IC50
    1.91 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
    		[PMID: 31281022]
    MDA-MB-231 IC50
    1.91 3
    Compound: V
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 29289881]
    MDA-MB-231 IC50
    1.97 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
    		[PMID: 34838335]
    MDA-MB-231 IC50
    10.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 25847767]
    MDA-MB-231 IC50
    10.6 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    MDA-MB-231 IC50
    11 3
    Compound: etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    MDA-MB-231 IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    MDA-MB-231 IC50
    13.35 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    MDA-MB-231 IC50
    15.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    MDA-MB-231 IC50
    16.25 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells
    Cytotoxicity against human MDA-MB-231 cells
    		[PMID: 18178085]
    MDA-MB-231 IC50
    16.27 3
    Compound: Etoposide
    Cytotoxic activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxic activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    MDA-MB-231 IC50
    16.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 4 days by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 4 days by MTT assay
    		[PMID: 20619511]
    MDA-MB-231 IC50
    16.85 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 3 days
    Cytotoxicity against human MDA-MB-231 cells after 3 days
    		[PMID: 19954977]
    MDA-MB-231 IC50
    2.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    MDA-MB-231 IC50
    2.8 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    MDA-MB-231 IC50
    2.87 3
    Compound: 3; Etop
    Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    MDA-MB-231 IC50
    2.87 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 20093033]
    MDA-MB-231 IC50
    20.3 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    MDA-MB-231 IC50
    20.52 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 22341788]
    MDA-MB-231 IC50
    21.2 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 19394829]
    MDA-MB-231 IC50
    21.2 3
    Compound: VP-16
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 24012378]
    MDA-MB-231 IC50
    23.22 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    MDA-MB-231 IC50
    24.22 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    MDA-MB-231 IC50
    24.22 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    MDA-MB-231 IC50
    29.27 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    MDA-MB-231 IC50
    3.32 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    MDA-MB-231 IC50
    3.38 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    MDA-MB-231 IC50
    3.5 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    Cytotoxicity against human MDA-MB-231 cells by MTT assay
    		[PMID: 19836231]
    MDA-MB-231 IC50
    3.6 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    MDA-MB-231 IC50
    3.66 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 36786551]
    MDA-MB-231 IC50
    3.67 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25240702]
    MDA-MB-231 IC50
    3.85 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    MDA-MB-231 IC50
    30.28 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    MDA-MB-231 IC50
    30.63 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    MDA-MB-231 IC50
    4.2 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by SRB assay
    		[PMID: 26618211]
    MDA-MB-231 IC50
    4.4 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    MDA-MB-231 IC50
    42 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell survival by clonogenic assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell survival by clonogenic assay
    		[PMID: 34303812]
    MDA-MB-231 IC50
    48 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 34303812]
    MDA-MB-231 IC50
    48 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability for 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability for 48 hrs by MTT assay
    		[PMID: 35617791]
    MDA-MB-231 IC50
    48 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
    		[PMID: 38516586]
    MDA-MB-231 IC50
    49.35 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    MDA-MB-231 IC50
    5.6 3
    Compound: VP-16
    Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    MDA-MB-231 IC50
    600 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against MDA-MB-231 cell line
    In vivo antiproliferative activity against MDA-MB-231 cell line
    		[PMID: 15084135]
    MDA-MB-231 IC50
    7.2 6
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    MDA-MB-231 IC50
    7.35 3
    Compound: Etoposide
    Cytotoxicity in human MDA-MB-231 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human MDA-MB-231 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    MDA-MB-231 IC50
    7.7 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    MDA-MB-231 IC50
    8.7 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    MDA-MB-231 IC50
    9.13 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    MDA-MB-231 IC50
    9.7 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    MDA-MB-231 IC50
    > 10 3
    Compound: ETP
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by MTT assay
    Growth inhibition of human MDA-MB-231 cells after 72 hrs by MTT assay
    		[PMID: 30471828]
    MDA-MB-231 IC50
    > 50 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    MDA-MB-435 GI50
    0.9 3
    Compound: Etoposide
    In vitro cytotoxicity against human breast cancer MDA-MB 435 cell line
    In vitro cytotoxicity against human breast cancer MDA-MB 435 cell line
    		[PMID: 9871772]
    MDA-MB-435 IC50
    1.7 3
    Compound: VP16
    Antiproliferative activity against human MDA-MB-435 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MDA-MB-435 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    MDA-MB-435 IC50
    2.81 3
    Compound: VP-16
    Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 25800514]
    MDA-MB-436 IC50
    39.42 3
    Compound: Etoposide
    Antiproliferative activity against human MDA-MB-436 cells measured after 72 hrs by Ez-cytox assay
    Antiproliferative activity against human MDA-MB-436 cells measured after 72 hrs by Ez-cytox assay
    		[PMID: 31398033]
    MDA-MB-453 IC50
    12.5 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    MDA-MB-468 IC50
    0.6 3
    Compound: Etoposide
    Inhibitory activity against MDA-468 cell line using MTT assay (ER-, amplified EGFR, mutant p53)
    Inhibitory activity against MDA-468 cell line using MTT assay (ER-, amplified EGFR, mutant p53)
    		[PMID: 10780913]
    MDA-MB-468 IC50
    0.86 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    MDA-MB-468 IC50
    13.6 3
    Compound: etoposide
    Cytotoxicity against human MDA-MB468 cells by XTT assay
    Cytotoxicity against human MDA-MB468 cells by XTT assay
    		[PMID: 17368022]
    MDA-MB-468 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MDA-MB-468 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30457333]
    MDA-MB-468 IC50
    6.69 3
    Compound: Etoposide
    Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    MDA-N GI50
    < 0.01 3
    Compound: Etoposide
    In vitro cytotoxicity against human breast cancer MDA-N cell line
    In vitro cytotoxicity against human breast cancer MDA-N cell line
    		[PMID: 9871772]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
    Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    ME-180 IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human ME180 cells after 72 hrs by MTT assay
    Cytotoxicity against human ME180 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    MES-SA GI50
    0.21 3
    Compound: etoposide
    Antiproliferative activity against human MESSA cells by SRB assay
    Antiproliferative activity against human MESSA cells by SRB assay
    		[PMID: 19394218]
    MES-SA IC50
    0.3 3
    Compound: etoposide
    Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    MES-SA/Dx5 GI50
    9.72 3
    Compound: etoposide
    Antiproliferative activity against multidrug resistant human MES-SA/Dx5 cells by SRB assay
    Antiproliferative activity against multidrug resistant human MES-SA/Dx5 cells by SRB assay
    		[PMID: 19394218]
    MES-SA/Dx5 IC50
    > 10 3
    Compound: etoposide
    Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 20939516]
    MGC-803 IC50
    1.06 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    MGC-803 IC50
    10.76 3
    Compound: Etoposide
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    		[PMID: 36996717]
    MGC-803 IC50
    11.18 3
    Compound: Etoposide
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
    		[PMID: 32502865]
    MGC-803 IC50
    20.91 3
    Compound: Etoposide
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    		[PMID: 28462840]
    MGC-803 IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
    		[PMID: 26804229]
    MGC-803 IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    MIA PaCa-2 GI50
    1.1 3
    Compound: 2
    Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
    Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 25131956]
    MIA PaCa-2 IC50
    15 3
    Compound: Eto
    Antitumor activity against human MiaPaCa2 cells after 72 hrs by MTT assay
    Antitumor activity against human MiaPaCa2 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    MIA PaCa-2 IC50
    15.4 3
    Compound: etoposide
    Growth inhibition of human MiaPaCa2 cells by MTT assay
    Growth inhibition of human MiaPaCa2 cells by MTT assay
    		[PMID: 17482821]
    MKN-45 IC50
    0.49 6
    Compound: Etoposide
    Cytotoxic activity against human MKN45 stomach tumor cell line
    Cytotoxic activity against human MKN45 stomach tumor cell line
    		[PMID: 15149673]
    MKN-45 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human MKN-45 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human MKN-45 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    MOLT-3 IC50
    0.019 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells after 3 days by crystal violet staining
    		10.1007/s00044-011-9903-y
    MOLT-3 IC50
    0.02 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells
    Cytotoxicity against human MOLT3 cells
    		10.1039/C2MD20199B
    MOLT-3 IC50
    0.024 6
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as survival after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as survival after 3 days by crystal violet staining
    		10.1007/s00044-012-0025-y
    MOLT-3 IC50
    0.03 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		10.1039/C3MD00166K
    MOLT-3 IC50
    0.03 3
    Compound: etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		[PMID: 21174408]
    MOLT-3 IC50
    0.041 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as inhibition of cell growth after 3 days by crystal violet staining
    Cytotoxicity against Homo sapiens (human) MOLT3 cells assessed as inhibition of cell growth after 3 days by crystal violet staining
    		10.1007/s00044-012-0402-6
    MOLT-3 IC50
    0.041 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    		[PMID: 26397393]
    MOLT-3 IC50
    0.04 6
    Compound: Etoposide
    Cytotoxic activity against human MOLT3 cells by XTT assay
    Cytotoxic activity against human MOLT3 cells by XTT assay
    		[PMID: 28366267]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    		[PMID: 24836071]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay
    		[PMID: 25019480]
    MOLT-3 IC50
    0.051 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells assessed as reduction in cell viability after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells assessed as reduction in cell viability after 48 hrs by XTT assay
    		[PMID: 25078311]
    MOLT-3 IC50
    0.051 3
    Compound: etoposide
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay
    		10.1007/s00044-013-0777-z
    MOLT-3 IC50
    0.065 3
    Compound: 1
    Tested for cytotoxicity against parental T-cell leukemia type Molt 3 cell line expressing MDR-1 (-) gene
    Tested for cytotoxicity against parental T-cell leukemia type Molt 3 cell line expressing MDR-1 (-) gene
    		[PMID: 11844671]
    MOLT-3 IC50
    0.11 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells by XTT assay
    Cytotoxicity against human MOLT3 cells by XTT assay
    		[PMID: 25747499]
    MOLT-3 IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human MOLT3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human MOLT3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
    		[PMID: 27145162]
    MOLT-4 IC50
    38 1
    Compound: ETOPOSIDE
    Compound was tested for its anticancer activity against human T-lymphocytic leukemia MOLT-4 cells.
    Compound was tested for its anticancer activity against human T-lymphocytic leukemia MOLT-4 cells.
    		10.1016/S0960-894X(96)00486-6
    MONO-MAC-6 IC50
    2.2 3
    Compound: Etoposide
    Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human MONO-MAC-6 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    MOVP-3 IC50
    7.55 3
    Compound: 1
    Tested for cytotoxicity against VP 16 resistant Molt3 type MOVP-3 cell line expressing MDR-1 (++) gene
    Tested for cytotoxicity against VP 16 resistant Molt3 type MOVP-3 cell line expressing MDR-1 (++) gene
    		[PMID: 11844671]
    MRC5 IC50
    11.23 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human MRC5 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    MRC5 IC50
    11.73 3
    Compound: Etoposide
    Growth inhibition of human MRC5 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human MRC5 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    MRC5 IC50
    11.73 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human MRC5 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    MRC5 IC50
    12.7 3
    Compound: Etoposide
    Cytotoxicity in human MRC5 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human MRC5 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    MRC5 IC50
    12.72 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells after 72 hrs by SRB assay
    Antiproliferative activity against human MRC5 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    MRC5 IC50
    13.48 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
    Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 36786551]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 19013074]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Anticancer activity against human MRC5 cells after 3 days by MTT assay
    Anticancer activity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 21621882]
    MRC5 IC50
    3.9 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    MRC5 IC50
    3.9 3
    Compound: VP-16
    Antiproliferative activity against human MRC5 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MRC5 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    MRC5 IC50
    3.9 3
    Compound: etoposide
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    MRC5 IC50
    3.93 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    Cytotoxicity against human MRC5 cells after 3 days by MTT assay
    		[PMID: 19419803]
    MRC5 IC50
    33.5 3
    Compound: VP-16
    Cytotoxicity against human MRC5 cells after 48 hrs by MTT assay
    Cytotoxicity against human MRC5 cells after 48 hrs by MTT assay
    		[PMID: 30265994]
    MRC5 IC50
    > 20 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells after 24 to 72 hrs by SRB assay
    Cytotoxicity against human MRC5 cells after 24 to 72 hrs by SRB assay
    		[PMID: 26595875]
    MRC5 IC50
    > 20 3
    Compound: Etoposide
    Antiproliferative activity against human MRC5 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human MRC5 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    MRC5 IC50
    > 20 3
    Compound: Etoposide
    Cytotoxicity against human MRC5 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Cytotoxicity against human MRC5 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 39151060]
    MT4 CC50
    0.08 3
    Compound: VP-16
    Compound concentration required to reduce the exponential growth of MT-4 cells by 50%
    Compound concentration required to reduce the exponential growth of MT-4 cells by 50%
    		[PMID: 9767632]
    MT4 CC50
    0.09 3
    Compound: Etoposide
    Cytotoxicity against human MT4 cells infected with HTLV-1 after 96 hrs by MTT assay
    Cytotoxicity against human MT4 cells infected with HTLV-1 after 96 hrs by MTT assay
    		[PMID: 21741130]
    MT4 IC50
    0.09 3
    Compound: VP16
    Cytotoxicity against human MT4 cells after 96 hrs
    Cytotoxicity against human MT4 cells after 96 hrs
    		[PMID: 22276775]
    MT4 IC50
    1.25 3
    Compound: VP-16
    Antiproliferative activity against human MT4 cells after 96 hrs by MTT assay
    Antiproliferative activity against human MT4 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    MT4 IC50
    1.25 3
    Compound: VP-16
    Antiproliferative activity against human MT-4 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human MT-4 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    Medulloblastoma cell EC50
    0.208 3
    Compound: 2
    Antiproliferative activity against mouse medulloblastoma cells harboring heterozygous ptch1 gene by MTT assay
    Antiproliferative activity against mouse medulloblastoma cells harboring heterozygous ptch1 gene by MTT assay
    		[PMID: 17417631]
    N592 IC50
    0.5 3
    Compound: VP-16 (Etoposide)
    Cytotoxicity against human small-cell lung cancer (SCLC)
    Cytotoxicity against human small-cell lung cancer (SCLC)
    		[PMID: 8258835]
    N9 IC50
    1.95 3
    Compound: Etoposide
    Cytotoxicity against mouse N9 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse N9 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    NALM-6 IC50
    0.134 3
    Compound: VP-16
    Cytotoxicity against wild type human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against wild type human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    NALM-6 IC50
    0.182 3
    Compound: VP-16
    Cytotoxicity against TOP2B double knockout human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against TOP2B double knockout human NALM6 cells assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    NALM-6 IC50
    0.234 3
    Compound: VP-16
    Cytotoxicity against human NALM6 cells expressing 50% TOP2A assessed as growth inhibition after 5 days by XTT assay
    Cytotoxicity against human NALM6 cells expressing 50% TOP2A assessed as growth inhibition after 5 days by XTT assay
    		[PMID: 25945730]
    NB-4 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human NB4 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human NB4 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    NB-4 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against human NB4 cells after 48 hrs by SRB method
    Cytotoxicity against human NB4 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    NCI-H1299 IC50
    0.23 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 6 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.24 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 6 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.46 3
    Compound: Etoposide
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 6 days by SRB assay
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    0.71 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 6 days by SRB assay
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 6 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    11.13 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 2 days by SRB assay
    Cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM 2(((2-(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol after 2 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    229.7 3
    Compound: Etoposide
    Anticancer activity against human H1299 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
    Anticancer activity against human H1299 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
    		[PMID: 34425478]
    NCI-H1299 IC50
    5.75 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 2 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU60019 after 2 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    8.86 3
    Compound: Etoposide
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 2 days by SRB assay
    Synergistic cytotoxicity against human NCI-H1299 cells measured in presence of 50 nM AZD0156 after 2 days by SRB assay
    		[PMID: 35231830]
    NCI-H1299 IC50
    9.37 3
    Compound: Etoposide
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 2 days by SRB assay
    Additive cytotoxicity against human NCI-H1299 cells measured in presence of 5 uM KU55933 after 2 days by SRB assay
    		[PMID: 35231830]
    NCI-H1650 IC50
    2.65 3
    Compound: 3; Etop
    Antiproliferative activity against human NCI-H1650 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human NCI-H1650 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    NCI-H1975 IC50
    0.34 3
    Compound: 3; Etop
    Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    NCI-H1975 IC50
    95 3
    Compound: ET
    Cytotoxicity against human NCI-H1975 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human NCI-H1975 cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    NCI-H1993 IC50
    > 0.91 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human NCI-H1993 cells incubated for 48 to 72 hrs by MTT assay
    Antiproliferative activity against human NCI-H1993 cells incubated for 48 to 72 hrs by MTT assay
    		[PMID: 32992133]
    NCI-H2228 IC50
    2.51 3
    Compound: 3; Etop
    Antiproliferative activity against human NCI-H2228 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human NCI-H2228 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    NCI-H226 IC50
    0.24 3
    Compound: Etoposide
    Inhibitory activity against NCI-H226 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H226 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    NCI-H226 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human NCI-H226 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human NCI-H226 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    NCI-H322M IC50
    1.59 3
    Compound: Etoposide
    Inhibitory activity against NCI-H322 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H322 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    NCI-H358 IC50
    1.5 3
    Compound: Etoposide
    Inhibitory activity against NCI-H358 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H358 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    NCI-H446 IC50
    0.24 3
    Compound: 3; Etop
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    NCI-H446 IC50
    17.59 1
    Compound: Etoposide
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H446 IC50
    192.16 1
    Compound: Etoposide
    Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H446 IC50
    192.16 1
    Compound: Etoposide
    Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 35932565]
    NCI-H460 GI50
    0.1 3
    Compound: Etoposide
    Growth inhibition of human H460 cells incubated for 72 hrs by MTT assay
    Growth inhibition of human H460 cells incubated for 72 hrs by MTT assay
    		[PMID: 31718941]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Inhibitory activity against NCI-H460 cell line using MTT assay
    Inhibitory activity against NCI-H460 cell line using MTT assay
    		[PMID: 10780913]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Inhibitory activity against NCI-H460 cell line using MTT assay(Wild type p53)
    Inhibitory activity against NCI-H460 cell line using MTT assay(Wild type p53)
    		[PMID: 10780913]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    		[PMID: 24780599]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    Antiproliferative activity against human H460 cells after 72 hrs by MTT assay
    		[PMID: 27448912]
    NCI-H460 IC50
    0.1 3
    Compound: Etoposide
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
    		[PMID: 33751978]
    NCI-H460 IC50
    0.2 3
    Compound: etoposide
    Growth inhibition of human H460 cells by MTT assay
    Growth inhibition of human H460 cells by MTT assay
    		[PMID: 17482821]
    NCI-H460 IC50
    0.39 3
    Compound: Etoposide
    Inhibitory activity against H460pv8 cell line using MTT assay
    Inhibitory activity against H460pv8 cell line using MTT assay
    		[PMID: 10780913]
    NCI-H460 IC50
    1 3
    Compound: 2
    Cytotoxicity against human H460 cells after 48 hrs by MTT assay
    Cytotoxicity against human H460 cells after 48 hrs by MTT assay
    		[PMID: 23867385]
    NCI-H460 IC50
    1.35 3
    Compound: Etoposide
    Cytostatic activity against human NCI-H460 cells
    Cytostatic activity against human NCI-H460 cells
    		[PMID: 30738653]
    NCI-H460 IC50
    3.65 3
    Compound: Etoposide
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    NCI-H460 IC50
    90 1
    Compound: Etoposide
    Cytotoxicity against human NCI-H460 cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human NCI-H460 cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    NCI-H460 IC50
    < 30 3
    Compound: Eto
    Cytotoxicity against human H460 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human H460 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    NCI-H460 IC50
    > 30 3
    Compound: Etop
    Antiproliferative activity against human H460 cells by MTT assay
    Antiproliferative activity against human H460 cells by MTT assay
    		[PMID: 26216018]
    NCI-H520 GI50
    0.9 3
    Compound: 2
    In vitro cytotoxic activity against lung (H 522) cancer cell line.
    In vitro cytotoxic activity against lung (H 522) cancer cell line.
    		[PMID: 10465531]
    NCI-H520 GI50
    13.5 3
    Compound: etoposide
    Growth inhibition of human NCI-H520 cells
    Growth inhibition of human NCI-H520 cells
    		[PMID: 18502124]
    NCI-H647 IC50
    0.08 3
    Compound: Etoposide
    Inhibitory activity against NCI-H647 cell line using MTT assay(mutant p53)
    Inhibitory activity against NCI-H647 cell line using MTT assay(mutant p53)
    		[PMID: 10780913]
    NCI-H69 IC50
    1192.2 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against NCI-H69 cell line
    In vivo antiproliferative activity against NCI-H69 cell line
    		[PMID: 15084135]
    NCI-H69 IC50
    46 3
    Compound: Etoposide
    Cytotoxicity against human adriamycin resistant H69 cells
    Cytotoxicity against human adriamycin resistant H69 cells
    		[PMID: 19788270]
    NCI-H838 IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human NCI-H838 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    NCI-H929 IC50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human NCI-H929 cells after 72 hrs by MTT assay
    Cytotoxicity against human NCI-H929 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    NCI-N87 IC50
    1.29 3
    Compound: Etoposide
    Cytotoxicity against human NCI-N87 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human NCI-N87 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    NCI/ADR-RES GI50
    25 3
    Compound: 2
    In vitro cytotoxic activity against ADR resistant breast cancer (MCF-7-ADR) cell line.
    In vitro cytotoxic activity against ADR resistant breast cancer (MCF-7-ADR) cell line.
    		[PMID: 10465531]
    NHDF IC50
    > 100 3
    Compound: Etoposide
    Cytotoxicity against human HDF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HDF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    NIH3T3 IC50
    62.97 3
    Compound: etoposide
    Cytotoxicity against mouse 3T3 cells after 48 hrs by MTT assay
    Cytotoxicity against mouse 3T3 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    OVCAR-3 IC50
    2.9 3
    Compound: Etoposide
    Cytotoxicity against human OVCAR3 cells measured after 24 to 72 hrs by SRB assay
    Cytotoxicity against human OVCAR3 cells measured after 24 to 72 hrs by SRB assay
    		[PMID: 29656990]
    P388 ED50
    1.71 6
    Compound: Etoposide
    Compound was tested for its antitumor activity and the cytotoxicity against P-388 lymphocytic leukemia screen
    Compound was tested for its antitumor activity and the cytotoxicity against P-388 lymphocytic leukemia screen
    		[PMID: 3820231]
    P388 ED50
    2.6 6
    Compound: etoposide
    Cytotoxicity against mouse P388 cells
    Cytotoxicity against mouse P388 cells
    		[PMID: 2095375]
    P388 ED50
    5 31
    Compound: etoposide
    compound was tested in vivo for inhibition of P388 murine leukemia cells after iv / ip administration.
    compound was tested in vivo for inhibition of P388 murine leukemia cells after iv / ip administration.
    		[PMID: 9804687]
    P388 IC50
    0.0085 6
    Compound: Etoposide
    Cytotoxic activity of compound against Murine P388 Leukemia
    Cytotoxic activity of compound against Murine P388 Leukemia
    		[PMID: 12459024]
    P388 IC50
    0.0085 6
    Compound: Etoposide
    Cytotoxic activity against murine P388 leukemia cells
    Cytotoxic activity against murine P388 leukemia cells
    		[PMID: 15056007]
    P388 IC50
    0.0085 6
    Compound: Etoposide
    In vitro cytotoxicity was measured towards murine lymphocytic leukemia P388 cells
    In vitro cytotoxicity was measured towards murine lymphocytic leukemia P388 cells
    		[PMID: 15149673]
    P388 IC50
    0.05 3
    Compound: etoposide
    Cytotoxicity against mouse P388 cells after 24 hrs by SRB assay
    Cytotoxicity against mouse P388 cells after 24 hrs by SRB assay
    		[PMID: 19685913]
    P388 IC50
    0.063 6
    Compound: 1
    Growth inhibition of P388-D1 (murine leukemia) cell line.
    Growth inhibition of P388-D1 (murine leukemia) cell line.
    		[PMID: 2002477]
    P388 IC50
    0.08 3
    Compound: etoposide
    Cytotoxicity against mouse P388 cells
    Cytotoxicity against mouse P388 cells
    		[PMID: 23092389]
    P388 IC50
    0.1 3
    Compound: VP-16
    Cytotoxicity against mouse P388 cells by MTT assay
    Cytotoxicity against mouse P388 cells by MTT assay
    		[PMID: 11473438]
    P388 IC50
    0.12 3
    Compound: VP-16
    In vitro cytotoxicity was determined by quantitating P388 murine leukemia cells on a Coulter Counter following a 48 hour exposure of cells to the test compound
    In vitro cytotoxicity was determined by quantitating P388 murine leukemia cells on a Coulter Counter following a 48 hour exposure of cells to the test compound
    		10.1016/0960-894X(95)00043-S
    P388 IC50
    0.12 6
    Compound: Etoposide
    Cytotoxicity against mouse P388 cells after 3 days by MTT assay
    Cytotoxicity against mouse P388 cells after 3 days by MTT assay
    		[PMID: 21216051]
    P388 IC50
    0.24 3
    Compound: ETP
    Cytotoxic activity against murine lymphocytic leukemia P388 concentration of agent required to reduce cell viability by 50%
    Cytotoxic activity against murine lymphocytic leukemia P388 concentration of agent required to reduce cell viability by 50%
    		[PMID: 10377219]
    P388 IC50
    0.3 3
    Compound: 6 (VP-16)
    In vitro cytotoxicity against P388 murine leukemia cells in culture in a clonogenic assay after 1 hour exposure to drug
    In vitro cytotoxicity against P388 murine leukemia cells in culture in a clonogenic assay after 1 hour exposure to drug
    		[PMID: 8410993]
    P388 IC50
    0.3 3
    Compound: VP-16
    In vitro cytotoxicity was evaluated following 1 hour transient exposure of P388 mouse leukemia cells to the compound
    In vitro cytotoxicity was evaluated following 1 hour transient exposure of P388 mouse leukemia cells to the compound
    		10.1016/0960-894X(95)00044-T
    P388 IC50
    0.3 3
    Compound: VP-16
    In vitro cytotoxicity against P388 mouse leukemia cells
    In vitro cytotoxicity against P388 mouse leukemia cells
    		10.1016/0960-894X(95)00160-U
    P388 IC50
    1.3 3
    Compound: Etoposide
    Cytotoxicity against mouse P388 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against mouse P388 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 26920801]
    P388 IC50
    150 1
    Compound: Etoposide
    Growth inhibitory activity against murine P388 leukemia cells
    Growth inhibitory activity against murine P388 leukemia cells
    		[PMID: 12620081]
    P388 IC50
    170 1
    Compound: 1a
    In vitro cytotoxicity against the P-388 (from DBA/2 mouse) neoplastic cell line
    In vitro cytotoxicity against the P-388 (from DBA/2 mouse) neoplastic cell line
    		[PMID: 14980682]
    P388 IC50
    2.62 6
    Compound: Etoposide
    Cytotoxicity against mouse P388 cells
    Cytotoxicity against mouse P388 cells
    		[PMID: 9214732]
    P388 IC50
    29.8 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against P388 cell line
    In vivo antiproliferative activity against P388 cell line
    		[PMID: 15084135]
    P388 IC50
    1.0 x 10-8 41
    Compound: VP-16
    Cytotoxicity against P388 leukemia
    Cytotoxicity against P388 leukemia
    		[PMID: 8389875]
    PAM IC50
    180 3
    Compound: Etoposide
    Inhibitory activity against PAM cell line
    Inhibitory activity against PAM cell line
    		[PMID: 9554873]
    PANC-1 IC50
    1.6 6
    Compound: Etoposide
    Cytotoxic activity against human tumor PANC-1 pancreas cells
    Cytotoxic activity against human tumor PANC-1 pancreas cells
    		[PMID: 15056007]
    PANC-1 IC50
    18.26 3
    Compound: Etoposide
    Cytotoxicity against human PANC-1 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Cytotoxicity against human PANC-1 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 39151060]
    PANC-1 IC50
    24.35 3
    Compound: Etoposide
    Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability by MTT assay
    Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability by MTT assay
    		[PMID: 35694689]
    PANC-1 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
    Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    PC-12 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human PC12 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human PC12 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    PC-3 ED50
    > 100 3
    Compound: 1
    Dose required for reduction in human prostate PC-3 cancer cells after 3 days incubation
    Dose required for reduction in human prostate PC-3 cancer cells after 3 days incubation
    		[PMID: 15456257]
    PC-3 GI50
    0.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 25792142]
    PC-3 GI50
    0.6 3
    Compound: Etoposide
    Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 30071406]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 21115210]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    PC-3 GI50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
    		[PMID: 29670691]
    PC-3 GI50
    11.1 3
    Compound: etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    Cytotoxicity against human PC3 cells after 72 hrs by Cell Titer 96 Aqueous Non-Radioactive assay
    		[PMID: 18321710]
    PC-3 GI50
    12.5 3
    Compound: etoposide
    Growth inhibition of human PC3 cells
    Growth inhibition of human PC3 cells
    		[PMID: 18502124]
    PC-3 GI50
    2.6 3
    Compound: 2, VP-16
    Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    PC-3 IC50
    1 3
    Compound: VP16
    Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
    Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
    		[PMID: 26291037]
    PC-3 IC50
    1.1 3
    Compound: Etoposide
    Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    PC-3 IC50
    1.59 3
    Compound: 3; Etop
    Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    PC-3 IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs
    Cytotoxicity against human PC3 cells after 48 hrs
    		[PMID: 19115839]
    PC-3 IC50
    13.18 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    PC-3 IC50
    13.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by WST-8 assay
    Cytotoxicity against human PC3 cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    PC-3 IC50
    13.6 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by SRB method
    Cytotoxicity against human PC3 cells after 48 hrs by SRB method
    		[PMID: 19425589]
    PC-3 IC50
    13.9 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 28068602]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 24487188]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
    		[PMID: 24953027]
    PC-3 IC50
    14.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 25453799]
    PC-3 IC50
    15.8 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human PC3 cells incubated for 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells incubated for 72 hrs by MTT assay
    		[PMID: 32992133]
    PC-3 IC50
    17.4 3
    Compound: 2
    Cytotoxicity against human PC-3 cells by sulforhodamine B assay
    Cytotoxicity against human PC-3 cells by sulforhodamine B assay
    		[PMID: 17988764]
    PC-3 IC50
    17.5 3
    Compound: 2
    Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    PC-3 IC50
    18.2 3
    Compound: Eto
    Cytotoxicity against human PC3 cells assessed as growth inhibition by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition by MTT assay
    		[PMID: 23920485]
    PC-3 IC50
    2 3
    Compound: Etoposide
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    PC-3 IC50
    2.39 3
    Compound: Etoposide
    Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    		[PMID: 38784476]
    PC-3 IC50
    2.6 3
    Compound: Etoposide
    Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
    Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
    		[PMID: 21074444]
    PC-3 IC50
    2.7 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    PC-3 IC50
    2300 1
    Compound: VP16
    Antiproliferative activity measured against PC-3 human prostate adenocarcinoma
    Antiproliferative activity measured against PC-3 human prostate adenocarcinoma
    		[PMID: 9876111]
    PC-3 IC50
    3 3
    Compound: VP-16
    Antiproliferative activity against human PC-3 cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human PC-3 cells incubated for 72 hrs by CCK8 assay
    		[PMID: 36063665]
    PC-3 IC50
    30 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    		[PMID: 32199733]
    PC-3 IC50
    31.5 3
    Compound: Etoposide
    Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth
    Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth
    		[PMID: 33722739]
    PC-3 IC50
    4.33 3
    Compound: VP-16
    Antiproliferative activity against human PC3 cells assessed as cell viability incubated for 72 hrs by MTT assay
    Antiproliferative activity against human PC3 cells assessed as cell viability incubated for 72 hrs by MTT assay
    		[PMID: 25799376]
    PC-3 IC50
    5.4 3
    Compound: Etoposide
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
    		[PMID: 29525336]
    PC-3 IC50
    5.73 3
    Compound: VP-16
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 29335211]
    PC-3 IC50
    69.54 3
    Compound: etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		[PMID: 20405844]
    PC-3 IC50
    7.2 6
    Compound: Etoposide
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    		10.1039/C4MD00525B
    PC-3 IC50
    7.8 3
    Compound: etoposide
    Antiproliferative activity against human PC3 cell line
    Antiproliferative activity against human PC3 cell line
    		[PMID: 16686539]
    PC-3 IC50
    8 3
    Compound: Etoposide
    Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human PC-3 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    PC-3 IC50
    > 100 3
    Compound: Etoposide
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    Growth inhibition of human PC3 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    PC-9 IC50
    2.22 3
    Compound: 3; Etop
    Antiproliferative activity against human PC-9 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    Antiproliferative activity against human PC-9 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT based ELISA
    		[PMID: 39106476]
    Panel NCI-60 (60 carcinoma cell lines) GI50
    12 3
    Compound: 1
    Antiproliferative activity against human NCI60 cells after 48 hrs by SRB assay
    Antiproliferative activity against human NCI60 cells after 48 hrs by SRB assay
    		[PMID: 29870668]
    RAW264.7 IC50
    0.82 3
    Compound: Etoposide
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    RKO IC50
    1.9 3
    Compound: Etoposide
    Antiproliferative activity against human RKO cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human RKO cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    RKO IC50
    1.96 3
    Compound: Etoposide
    Antiproliferative activity against human RKO cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human RKO cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    RKO IC50
    > 150 3
    Compound: vp16
    Antiproliferative activity against human RKO cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human RKO cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    RPMI-8226 IC50
    0.14 3
    Compound: 2, VP-16
    Cytotoxicity against human RPMI8226 cells after 48 hrs
    Cytotoxicity against human RPMI8226 cells after 48 hrs
    		[PMID: 20053564]
    RPMI-8226 IC50
    0.7 3
    Compound: VP-16
    Cytotoxicity against human RPMI8226 cells after 72 hrs by CCK8 method
    Cytotoxicity against human RPMI8226 cells after 72 hrs by CCK8 method
    		[PMID: 20071056]
    RPMI-8226 IC50
    4.8 3
    Compound: Etoposide
    Cytotoxicity against human RPMI8226 cells after 72 hrs by MTT assay
    Cytotoxicity against human RPMI8226 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    RT-112 IC50
    0.22 3
    Compound: Etoposide
    Growth inhibition against human RT-112 cell lines
    Growth inhibition against human RT-112 cell lines
    		[PMID: 15189040]
    RT-4 IC50
    1.33 3
    Compound: Etoposide
    Growth inhibition against human RT-4 cell lines
    Growth inhibition against human RT-4 cell lines
    		[PMID: 15189040]
    RWPE-1 GI50
    0.9 3
    Compound: Etoposide
    Cytotoxicity against human RWPE1 cells after 72 hrs by MTT assay relative to untreated control
    Cytotoxicity against human RWPE1 cells after 72 hrs by MTT assay relative to untreated control
    		[PMID: 24389510]
    RWPE-1 IC50
    27.64 3
    Compound: Etoposide
    Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay
    Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay
    		[PMID: 26292628]
    Raji IC50
    1.21 3
    Compound: Etoposide
    Cytotoxicity against human Raji cells after 48 hrs by MTT assay
    Cytotoxicity against human Raji cells after 48 hrs by MTT assay
    		[PMID: 30109008]
    Raji IC50
    1.68 3
    Compound: Etoposide
    Antiproliferative activity against human Raji cells after 48 hrs by MTT assay
    Antiproliferative activity against human Raji cells after 48 hrs by MTT assay
    		[PMID: 26649766]
    Renca IC50
    2.9 3
    Compound: etoposide
    Antiproliferative activity against mouse Renca cell line
    Antiproliferative activity against mouse Renca cell line
    		[PMID: 16686539]
    SBC-3 ED50
    1.6 6
    Compound: VP-16
    Inhibition of growth of lung small cell carcinoma SBC-3 cell line
    Inhibition of growth of lung small cell carcinoma SBC-3 cell line
    		[PMID: 8389875]
    SBC-3 IC50
    0.0676 6
    Compound: Etoposide
    Cytotoxic activity against human tumor SBC-3 lung cells
    Cytotoxic activity against human tumor SBC-3 lung cells
    		[PMID: 15056007]
    SCLC IC50
    1.3 3
    Compound: VP-16 (Etoposide)
    Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP)
    Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP)
    		[PMID: 8258835]
    SCaBER IC50
    0.276 6
    Compound: Etoposide
    Cytotoxic activity against human tumor SCaBER bladder cells
    Cytotoxic activity against human tumor SCaBER bladder cells
    		[PMID: 15056007]
    SCaBER IC50
    0.31 6
    Compound: Etoposide
    Cytotoxic activity of compound against SCaBER bladder squamous human tumor cell line
    Cytotoxic activity of compound against SCaBER bladder squamous human tumor cell line
    		[PMID: 12459024]
    SF-268 GI50
    4.21 3
    Compound: ETO
    Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
    Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
    		10.1007/s00044-013-0798-7
    SF-268 IC50
    3.25 3
    Compound: VP-16
    Antiproliferative activity against human SF-268 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SF-268 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    SF-295 IC50
    13.3 3
    Compound: 2
    Cytotoxicity against human SF295 cells by sulforhodamine B assay
    Cytotoxicity against human SF295 cells by sulforhodamine B assay
    		[PMID: 17988764]
    SF-295 IC50
    13.5 3
    Compound: 2
    Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21477899]
    SGC-7901 IC50
    0.08 3
    Compound: etoposide
    Cytotoxicity against human SGC7901 cells
    Cytotoxicity against human SGC7901 cells
    		[PMID: 23092389]
    SGC-7901 IC50
    12.09 3
    Compound: 2
    Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
    Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    SGC-7901 IC50
    5.26 3
    Compound: vp16
    Antiproliferative activity against human SGC-7901 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human SGC-7901 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    SGC-7901 IC50
    6.56 3
    Compound: Vp-16
    Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		10.1039/C4MD00209A
    SH-SY5Y IC50
    0.89 3
    Compound: VP-16
    Cytotoxicity against human SH-SY5Y cells expressing low level of topoisomerase I/II measured after 72 hrs by MTT assay
    Cytotoxicity against human SH-SY5Y cells expressing low level of topoisomerase I/II measured after 72 hrs by MTT assay
    		[PMID: 35612499]
    SH-SY5Y IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by WST-8 assay
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by WST-8 assay
    		[PMID: 19072209]
    SH-SY5Y IC50
    1.7 3
    Compound: Etoposide
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by SRB method
    Cytotoxicity against human SH-SY5Y cells after 48 hrs by SRB method
    		[PMID: 19425589]
    SH-SY5Y IC50
    5.37 3
    Compound: 2
    Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
    Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    SISO IC50
    0.15 3
    Compound: Etoposide
    Growth inhibition against human SISO cell lines
    Growth inhibition against human SISO cell lines
    		[PMID: 15189040]
    SK-BR-3 IC50
    0.3 3
    Compound: Etoposide
    Inhibitory activity against SKBR-3 cell line using MTT assay (ER-amplified erB2,mutant p53)
    Inhibitory activity against SKBR-3 cell line using MTT assay (ER-amplified erB2,mutant p53)
    		[PMID: 10780913]
    SK-HEP1 IC50
    0.22 3
    Compound: Etoposide
    Antiproliferative activity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    SK-HEP1 IC50
    0.25 3
    Compound: Etoposide
    Cytotoxicity in human SK-HEP1 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human SK-HEP1 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    SK-HEP1 IC50
    0.38 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    SK-HEP1 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    SK-HEP1 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human SK-HEP1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    SK-HEP1 IC50
    0.41 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by SRB assay
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    SK-HEP1 IC50
    0.63 3
    Compound: Etoposide
    Growth inhibition of human SKHEP1 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human SKHEP1 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    SK-HEP1 IC50
    0.63 3
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human SKHEP1 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    SK-HEP1 IC50
    0.7 3
    Compound: Etoposide
    Antiproliferative activity against human SK-HEP1 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human SK-HEP1 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    SK-HEP1 IC50
    0.78 3
    Compound: Etoposide
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    SK-HEP1 IC50
    0.93 3
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    SK-HEP1 IC50
    1.1 3
    Compound: etoposide
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    SK-HEP1 IC50
    1.1 3
    Compound: etoposide
    Antiproliferative activity against human SKHEP1 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human SKHEP1 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    SK-HEP1 IC50
    2.8 3
    Compound: etoposide
    Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    SK-HEP1 IC50
    49.6 3
    Compound: etoposide
    Cytotoxicity against human SK-Hep1 cells by MTT assay
    Cytotoxicity against human SK-Hep1 cells by MTT assay
    		[PMID: 18637688]
    SK-HEP1 IC50
    62 1
    Compound: Etoposide
    Cytotoxicity against human SKHEP1 cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human SKHEP1 cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    SK-MEL-1 IC50
    8 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human SK-MEL-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 29032930]
    SK-MEL-1 IC50
    > 30 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SK-MEL-1 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    SK-MEL-2 ED50
    0.08 6
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB method
    Cytotoxicity against human SK-MEL-2 cells by SRB method
    		[PMID: 16252909]
    SK-MEL-2 IC50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    SK-MEL-2 IC50
    0.3 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    SK-MEL-2 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB method
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    SK-MEL-2 IC50
    0.41 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by sulforhodamine B assay
    Cytotoxicity against human SK-MEL-2 cells by sulforhodamine B assay
    		[PMID: 21936523]
    SK-MEL-2 IC50
    0.79 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    SK-MEL-2 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 21182258]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Anticancer activity against human SK-MEL-2 cells by SRB assay
    Anticancer activity against human SK-MEL-2 cells by SRB assay
    		[PMID: 21420296]
    SK-MEL-2 IC50
    1.17 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 26988298]
    SK-MEL-2 IC50
    1.33 3
    Compound: Etoposide
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    SK-MEL-2 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity in human SK-MEL-2 cells by SRB assay
    Cytotoxicity in human SK-MEL-2 cells by SRB assay
    		[PMID: 26812172]
    SK-MEL-2 IC50
    4.13 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human melanoma tumor cell line SK-MEL-2 by 50% after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human melanoma tumor cell line SK-MEL-2 by 50% after 72 hr of incubation was determined
    		[PMID: 15482917]
    SK-MEL-2 IC50
    5.72 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    Cytotoxicity against human SK-MEL-2 cells by SRB assay
    		[PMID: 17194596]
    SK-MEL-2 IC50
    5.72 3
    Compound: etoposide
    Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
    		[PMID: 18321715]
    SK-MEL-28 CC50
    1.2 3
    Compound: Etoposide
    Antiproliferative activity against human SK-MEL-28 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SK-MEL-28 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    SK-MEL-28 GI50
    3.2 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    SK-MEL-28 IC50
    1 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    SK-MEL-28 IC50
    1.1 3
    Compound: VP-16
    Antiproliferative activity against human SKMEL-28 cells assessed as cell viability measured after 4 days by MTT assay
    Antiproliferative activity against human SKMEL-28 cells assessed as cell viability measured after 4 days by MTT assay
    		[PMID: 31869654]
    SK-MEL-28 IC50
    3 3
    Compound: Etoposide
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    Growth inhibition of human SK-MEL-28 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    SK-MEL-28 IC50
    850 1
    Compound: 1a
    In vitro cytotoxicity against MEL-28 (human malign melanoma) neoplastic cell line
    In vitro cytotoxicity against MEL-28 (human malign melanoma) neoplastic cell line
    		[PMID: 14980682]
    SK-MES-1 CC50
    0.3 3
    Compound: Etoposide
    Antiproliferative activity against human SKMES1 cells after 96 hrs by MTT assay
    Antiproliferative activity against human SKMES1 cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    SK-MES-1 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells
    Cytotoxicity against human SKMES1 cells
    		[PMID: 25440884]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SK-MES-1 cells after 3 days by MTT assay
    Cytotoxicity against human SK-MES-1 cells after 3 days by MTT assay
    		[PMID: 19013074]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    		[PMID: 19269832]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells after 72 hrs by MTT assay
    		[PMID: 20828890]
    SK-MES-1 IC50
    2.5 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
    		[PMID: 23454511]
    SK-MES-1 IC50
    2.5 3
    Compound: etoposide
    Antitumor against human SK-MES1 cells after 72 hrs by MTT assay
    Antitumor against human SK-MES1 cells after 72 hrs by MTT assay
    		[PMID: 18299197]
    SK-MES-1 IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human SKMES1 cells after 3 days by MTT assay
    Cytotoxicity against human SKMES1 cells after 3 days by MTT assay
    		[PMID: 19419803]
    SK-MES-1 IC50
    2.8 3
    Compound: Etoposide
    Anticancer activity against human SKMES1 cells after 3 days by MTT assay
    Anticancer activity against human SKMES1 cells after 3 days by MTT assay
    		[PMID: 21621882]
    SK-N-MC IC50
    14.04 6
    Compound: Etoposide
    Cytotoxicity against human SK-N-MC cells by MTT assay
    Cytotoxicity against human SK-N-MC cells by MTT assay
    		[PMID: 22341788]
    SK-N-MC IC50
    275 1
    Compound: 1 (VP16)
    In vivo antiproliferative activity against SK-N-MC cell line
    In vivo antiproliferative activity against SK-N-MC cell line
    		[PMID: 15084135]
    SK-N-SH IC50
    9.03 3
    Compound: Etoposide
    Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    SK-N-SH IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human SK-N-SH cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human SK-N-SH cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    SK-OV-3 ED50
    2.7 6
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells by SRB method
    Cytotoxicity against human SKOV3 cells by SRB method
    		[PMID: 16252909]
    SK-OV-3 GI50
    < 0.01 3
    Compound: 2
    In vitro cytotoxic activity against Ovarian (SK-OV3) cell line.
    In vitro cytotoxic activity against Ovarian (SK-OV3) cell line.
    		[PMID: 10465531]
    SK-OV-3 IC50
    0.84 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by SRB assay
    Cytotoxicity against human SKOV3 cells by SRB assay
    		[PMID: 26988298]
    SK-OV-3 IC50
    0.95 6
    Compound: Etoposide
    Cytotoxic activity of compound against SK-OV-3 ovary human tumor cell line
    Cytotoxic activity of compound against SK-OV-3 ovary human tumor cell line
    		[PMID: 12459024]
    SK-OV-3 IC50
    1.06 6
    Compound: Etoposide
    Cytotoxic activity against human tumor SK-OV-3 ovary cells
    Cytotoxic activity against human tumor SK-OV-3 ovary cells
    		[PMID: 15056007]
    SK-OV-3 IC50
    1.31 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by sulforhodamine B assay
    Cytotoxicity against human SKOV3 cells by sulforhodamine B assay
    		[PMID: 21936523]
    SK-OV-3 IC50
    1.72 3
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB method
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB method
    		[PMID: 17493824]
    SK-OV-3 IC50
    1.8 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 31082231]
    SK-OV-3 IC50
    1.81 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells by SRB assay
    Cytotoxicity against human SKOV3 cells by SRB assay
    		[PMID: 21182258]
    SK-OV-3 IC50
    1.81 3
    Compound: Etoposide
    Anticancer activity against human SKOV3 cells by SRB assay
    Anticancer activity against human SKOV3 cells by SRB assay
    		[PMID: 21420296]
    SK-OV-3 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 72 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 72 hrs by SRB assay
    		[PMID: 30776236]
    SK-OV-3 IC50
    1.95 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 28165740]
    SK-OV-3 IC50
    1.96 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 26706168]
    SK-OV-3 IC50
    14.8 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SKOV3 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SKOV3 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SK-OV-3 IC50
    2.39 3
    Compound: VP-16
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth measured after 48 hrs by sulforhodamine B assay
    		[PMID: 31239178]
    SK-OV-3 IC50
    2.6 3
    Compound: Etoposide
    Cytotoxicity in human SKOV3 cells by SRB assay
    Cytotoxicity in human SKOV3 cells by SRB assay
    		[PMID: 26812172]
    SK-OV-3 IC50
    2.9 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 28841320]
    SK-OV-3 IC50
    3.46 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human ovarian tumor cell line SK-OV-3 after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human ovarian tumor cell line SK-OV-3 after 72 hr of incubation was determined
    		[PMID: 15482917]
    SK-OV-3 IC50
    3.84 6
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    SK-OV-3 IC50
    4.28 3
    Compound: etoposide
    Cytotoxicity against human SK-OV-3 cells by SRB assay
    Cytotoxicity against human SK-OV-3 cells by SRB assay
    		[PMID: 17194596]
    SK-OV-3 IC50
    4.28 3
    Compound: etoposide
    Cytotoxicity against human SKOV3 cells after 3 days by SRB assay
    Cytotoxicity against human SKOV3 cells after 3 days by SRB assay
    		[PMID: 18321715]
    SK-OV-3 IC50
    4.9 3
    Compound: VP-16
    Antiproliferative activity against human SKOV-3 ovarian cell line
    Antiproliferative activity against human SKOV-3 ovarian cell line
    		[PMID: 10498216]
    SK-OV-3 IC50
    9.2 3
    Compound: Etoposide
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31669850]
    SK-OV-3 IC50
    >= 2.91 3
    Compound: Etoposide
    Anticancer activity against human SKOV3 cells after 48 hrs by SRB assay
    Anticancer activity against human SKOV3 cells after 48 hrs by SRB assay
    		[PMID: 30660827]
    SK-OV-3 IC50
    >= 6.94 3
    Compound: Etoposide
    Antiproliferative activity against human SKOV3 cells by SRB assay
    Antiproliferative activity against human SKOV3 cells by SRB assay
    		[PMID: 31546197]
    SMMC-7721 IC50
    0.15 3
    Compound: Etoposide
    Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 28169166]
    SMMC-7721 IC50
    0.31 3
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SMMC-7721 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SMMC-7721 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SMMC-7721 IC50
    21.03 3
    Compound: Etoposide
    Cytotoxic activity against human SMMC7721 cells after 72 hrs by MTT assay
    Cytotoxic activity against human SMMC7721 cells after 72 hrs by MTT assay
    		[PMID: 28733083]
    SMMC-7721 IC50
    23.2 3
    Compound: Etoposide
    Cytotoxicity against human SMMC-7721 cells assessed as inhibition of cell growth incubated for 68 hrs by MTT assay
    Cytotoxicity against human SMMC-7721 cells assessed as inhibition of cell growth incubated for 68 hrs by MTT assay
    		[PMID: 37267043]
    SMMC-7721 IC50
    40.44 3
    Compound: Etoposide
    Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
    Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
    		[PMID: 28431878]
    SMMC-7721 IC50
    8.12 3
    Compound: 2
    Anticancer activity against human SMMC7721 cells after 48 hrs by MTT assay
    Anticancer activity against human SMMC7721 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    SNU-638 IC50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability by SRB assay
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability by SRB assay
    		[PMID: 33636429]
    SNU-638 IC50
    0.23 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells by SRB assay
    Cytotoxicity against human SNU638 cells by SRB assay
    		[PMID: 17194596]
    SNU-638 IC50
    0.23 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells after 3 days by SRB assay
    Cytotoxicity against human SNU638 cells after 3 days by SRB assay
    		[PMID: 18321715]
    SNU-638 IC50
    0.3 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay
    		[PMID: 26010585]
    SNU-638 IC50
    0.34 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay
    Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay
    		[PMID: 30755350]
    SNU-638 IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    Antiproliferative activity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hr by SRB assay
    		[PMID: 34931849]
    SNU-638 IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human SNU-638 cells measured after 72 hrs by SRB assay
    Antiproliferative activity against human SNU-638 cells measured after 72 hrs by SRB assay
    		[PMID: 35362983]
    SNU-638 IC50
    0.4 3
    Compound: Etoposide
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Cytotoxicity against human SNU-638 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 37672645]
    SNU-638 IC50
    0.43 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 29893558]
    SNU-638 IC50
    0.5 3
    Compound: etoposide
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Cytotoxicity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 25495422]
    SNU-638 IC50
    0.5 3
    Compound: etoposide
    Antiproliferative activity against human SNU638 cells after 3 days by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells after 3 days by sulforhodamine B assay
    		[PMID: 25700232]
    SNU-638 IC50
    0.52 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells assessed as reduction in cell viability by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells assessed as reduction in cell viability by sulforhodamine B assay
    		[PMID: 32073848]
    SNU-638 IC50
    0.56 3
    Compound: Etoposide
    Cytotoxicity in human SNU-638 cells by sulforhodamine B colorimetric assay
    Cytotoxicity in human SNU-638 cells by sulforhodamine B colorimetric assay
    		[PMID: 27933890]
    SNU-638 IC50
    0.82 3
    Compound: Etoposide
    Antiproliferative activity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    Antiproliferative activity against human SNU638 cells after 72 hrs by sulforhodamine B assay
    		[PMID: 31894983]
    SNU-638 IC50
    1.05 3
    Compound: Etoposide
    Growth inhibition of human SNU638 cells incubated for 72 hrs by sulforhodamine B assay
    Growth inhibition of human SNU638 cells incubated for 72 hrs by sulforhodamine B assay
    		[PMID: 28625715]
    SNU-638 IC50
    1.05 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells assessed as growth inhibition after 72 hrs by SRB assay
    Cytotoxicity against human SNU638 cells assessed as growth inhibition after 72 hrs by SRB assay
    		[PMID: 30041947]
    SNU-638 IC50
    2.57 3
    Compound: Etoposide
    Cytotoxicity against human SNU638 cells by MTT assay
    Cytotoxicity against human SNU638 cells by MTT assay
    		[PMID: 23608763]
    SU-DHL-2 IC50
    2.1 3
    Compound: Etoposide
    Cytotoxicity against human SUDHL2 cells assessed as cell growth inhibition by MTT assay
    Cytotoxicity against human SUDHL2 cells assessed as cell growth inhibition by MTT assay
    		[PMID: 37676247]
    SW-620 GI50
    90 3
    Compound: 2
    In vitro cytotoxic activity against colon (SW 620) cancer cell line.
    In vitro cytotoxic activity against colon (SW 620) cancer cell line.
    		[PMID: 10465531]
    SW-620 IC50
    13.24 3
    Compound: Etoposide
    Cytotoxicity against human SW620 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SW620 cells assessed as growth inhibition after 48 hrs by SRB assay
    		10.1039/C4MD00325J
    SW-620 IC50
    20 3
    Compound: Eto
    Antitumor activity against human SW620 cells after 72 hrs by MTT assay
    Antitumor activity against human SW620 cells after 72 hrs by MTT assay
    		[PMID: 17935309]
    SW-620 IC50
    20 3
    Compound: etoposide
    Growth inhibition of human SW620 cells by MTT assay
    Growth inhibition of human SW620 cells by MTT assay
    		[PMID: 17482821]
    SW1573 GI50
    14 3
    Compound: Etoposide
    Antiproliferative activity against human SW1573 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human SW1573 cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    		[PMID: 37531922]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Growth inhibition of human SW1573 cells
    Growth inhibition of human SW1573 cells
    		[PMID: 21986585]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Growth inhibition of human SW1573 cells after 48 hrs by SRB assay
    Growth inhibition of human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    SW1573 GI50
    15 3
    Compound: Etoposide
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    SW1573 GI50
    15 3
    Compound: VP-16
    Cytotoxicity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    SW1573 GI50
    15 3
    Compound: VP-16
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    SW1573 GI50
    3 3
    Compound: VP-16
    Antiproliferative activity against human SW1573 cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human SW1573 cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    SW480 IC50
    0.07 3
    Compound: Etoposide
    Cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    0.08 3
    Compound: Etoposide
    Additive cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU55933 by SRB assay
    Additive cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    0.31 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 31546197]
    SW480 IC50
    0.6 3
    Compound: VP16
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
    		[PMID: 33191085]
    SW480 IC50
    0.8 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells harboring wild type beta-catenin assessed as reduction in cell viability measured after 72 hrs by SRB assay
    		[PMID: 35544614]
    SW480 IC50
    1.11 3
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
    		[PMID: 33398999]
    SW480 IC50
    17.11 3
    Compound: 2
    Anticancer activity against human SW480 cells after 48 hrs by MTT assay
    Anticancer activity against human SW480 cells after 48 hrs by MTT assay
    		[PMID: 25744190]
    SW480 IC50
    3.5 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU55933 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU55933 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.6 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM 2(((24(2,4-dichlorobenzyl)oxy)naphthalen-1-yl)methyl)amino)ethan-1-ol by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.6 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 50 nM AZD0156 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    3.8 3
    Compound: Etoposide
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU60019 by SRB assay
    Antagonistic cytotoxicity against human SW480 cells measured after 3 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    50 3
    Compound: 1
    Tested for cytotoxicity against Colon adenocarcinoma resistant type SW480 cell line expressing MDR-1 (+) gene; ~50% cells affected by drug
    Tested for cytotoxicity against Colon adenocarcinoma resistant type SW480 cell line expressing MDR-1 (+) gene; ~50% cells affected by drug
    		[PMID: 11844671]
    SW480 IC50
    6.4 3
    Compound: Etoposide
    Cytotoxicity against Homo sapiens (human) SW480 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) SW480 cells after 72 hr by MTT assay
    		10.1007/s00044-011-9937-1
    SW480 IC50
    6.4 3
    Compound: Etoposide
    Anticancer activity against Homo sapiens (human) SW480 cells assessed as decrease in cell growth after 3 days by MTT assay
    Anticancer activity against Homo sapiens (human) SW480 cells assessed as decrease in cell growth after 3 days by MTT assay
    		10.1007/s00044-012-0245-1
    SW480 IC50
    7.7 6
    Compound: Etoposide
    Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
    		[PMID: 29335206]
    SW480 IC50
    7.7 6
    Compound: Etoposide
    Cytotoxicity against human SW480 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    Cytotoxicity against human SW480 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
    		[PMID: 29908441]
    SW480 IC50
    764 1
    Compound: Ref 34, Cpd 2
    Antiproliferative activity against human SW480 cells incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SW480 cells incubated for 48 hrs by MTT assay
    		[PMID: 32992133]
    SW480 IC50
    < 0.01 3
    Compound: Etoposide
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU60019 by SRB assay
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 5 uM KU60019 by SRB assay
    		[PMID: 35231830]
    SW480 IC50
    < 0.01 3
    Compound: Etoposide
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 50 nM AZD0156 by SRB assay
    Synergistic cytotoxicity against human SW480 cells measured after 9 days in presence of 50 nM AZD0156 by SRB assay
    		[PMID: 35231830]
    SW948 IC50
    1.3 3
    Compound: etoposide
    Antiproliferative activity against human SW948 cells after 3 days by XTT assay
    Antiproliferative activity against human SW948 cells after 3 days by XTT assay
    		[PMID: 19691293]
    SiHa GI50
    3.1 3
    Compound: 2, VP-16
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    SiHa GI50
    3.11 3
    Compound: 2, Eto
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    SiHa IC50
    2.76 3
    Compound: 2, VP-16
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    		[PMID: 22244588]
    SiHa IC50
    30.7 3
    Compound: VP-16
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
    		[PMID: 21733601]
    SiHa IC50
    40.4 3
    Compound: 5, VP-16
    Cytotoxicity against human SiHa cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human SiHa cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 22041063]
    T47D GI50
    15 3
    Compound: VP-16
    Antiproliferative activity against human T47D cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    T47D GI50
    22 3
    Compound: Etoposide
    Growth inhibition of human T47D cells
    Growth inhibition of human T47D cells
    		[PMID: 21986585]
    T47D GI50
    22 3
    Compound: Etoposide
    Growth inhibition of human T47D cells after 48 hrs by SRB assay
    Growth inhibition of human T47D cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    T47D GI50
    22 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    T47D GI50
    22 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    T47D GI50
    22 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    Antiproliferative activity against human T47D cells assessed as inhibition of culture growth incubated for 48 hrs by SRB assay
    		[PMID: 37531922]
    T47D GI50
    22 3
    Compound: VP-16
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    T47D GI50
    7.9 6
    Compound: Etoposide
    Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 31546197]
    T47D IC50
    0.05 6
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 3 days by MTT assay
    Cytotoxicity against human T47D cells after 3 days by MTT assay
    		[PMID: 21216051]
    T47D IC50
    0.1 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells
    Cytotoxicity against human T47D cells
    		[PMID: 19788270]
    T47D IC50
    0.16 3
    Compound: Etoposide
    Inhibitory activity against T47D cell line using MTT assay (ER+,mutant p53)
    Inhibitory activity against T47D cell line using MTT assay (ER+,mutant p53)
    		[PMID: 10780913]
    T47D IC50
    0.32 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK-8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK-8 assay
    		[PMID: 29510948]
    T47D IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells incubated for 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells incubated for 72 hrs by CCK8 assay
    		[PMID: 29402741]
    T47D IC50
    0.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-CYTOX reagent based assay
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-CYTOX reagent based assay
    		[PMID: 30262132]
    T47D IC50
    0.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells incubated from day 2 to day 4 by CCK8 assay
    Cytotoxicity against human T47D cells incubated from day 2 to day 4 by CCK8 assay
    		[PMID: 26022080]
    T47D IC50
    0.88 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation incubated for 72 hrs by WST assay
    		[PMID: 36493620]
    T47D IC50
    0.94 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by CCK8 assay
    Cytotoxicity against human T47D cells after 2 days by CCK8 assay
    		[PMID: 26361737]
    T47D IC50
    0.97 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells incubated for 72 hrs by microplate reader analysis
    Antiproliferative activity against human T47D cells incubated for 72 hrs by microplate reader analysis
    		[PMID: 37418826]
    T47D IC50
    1.21 3
    Compound: ETO
    Cytotoxicity against human T47D cells after 72 hrs by MTT assay
    Cytotoxicity against human T47D cells after 72 hrs by MTT assay
    		[PMID: 22819942]
    T47D IC50
    1.64 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells measured after 72 hrs by EZ-Cytox assay
    Antiproliferative activity against human T47D cells measured after 72 hrs by EZ-Cytox assay
    		[PMID: 31398033]
    T47D IC50
    1.84 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 3 days by CCK8 assay
    Cytotoxicity against human T47D cells after 3 days by CCK8 assay
    		[PMID: 26927425]
    T47D IC50
    1.84 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 27643560]
    T47D IC50
    1.96 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    Cytotoxicity against human T47D cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay
    		[PMID: 27707625]
    T47D IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    		[PMID: 26890115]
    T47D IC50
    11.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 48 hrs by MTT assay
    		[PMID: 30660827]
    T47D IC50
    13.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells measured on day 4 by CCK8 assay
    Cytotoxicity against human T47D cells measured on day 4 by CCK8 assay
    		[PMID: 25936262]
    T47D IC50
    13.7 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by CCK8 assay
    Cytotoxicity against human T47D cells after 48 hrs by CCK8 assay
    		[PMID: 26945111]
    T47D IC50
    2.39 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by cell counting kit-8 analysis
    Cytotoxicity against human T47D cells after 2 days by cell counting kit-8 analysis
    		[PMID: 22503656]
    T47D IC50
    2.57 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days
    Cytotoxicity against human T47D cells after 2 days
    		[PMID: 24904965]
    T47D IC50
    2.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    Cytotoxicity against human T47D cells assessed as reduction in cell growth after 72 hrs by CCK8 assay
    		[PMID: 27484510]
    T47D IC50
    3.25 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28384547]
    T47D IC50
    3.42 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 2 days by CCK-8 assay
    Cytotoxicity against human T47D cells after 2 days by CCK-8 assay
    		[PMID: 24013413]
    T47D IC50
    4.85 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells measured after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells measured after 72 hrs by CCK8 assay
    		[PMID: 27654394]
    T47D IC50
    4.98 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells by MTT assay
    Cytotoxicity against human T47D cells by MTT assay
    		[PMID: 23608763]
    T47D IC50
    5.58 3
    Compound: Etopo
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-Cytox colorimetric assay
    Antiproliferative activity against human T47D cells after 72 hrs by EZ-Cytox colorimetric assay
    		[PMID: 34678573]
    T47D IC50
    5.82 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation
    Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation
    		[PMID: 35123005]
    T47D IC50
    6.4 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 26988802]
    T47D IC50
    7 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28068603]
    T47D IC50
    8.2 6
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells after 48 hrs by MTT assay
    		[PMID: 24219991]
    T47D IC50
    8.74 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells after 4 days by CCK-8 assay
    Cytotoxicity against human T47D cells after 4 days by CCK-8 assay
    		[PMID: 25062006]
    T47D IC50
    8.81 3
    Compound: Etoposide
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay
    		[PMID: 28633898]
    T47D IC50
    8.9 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells by MTT assay
    Cytotoxicity against human T47D cells by MTT assay
    		[PMID: 25847767]
    T47D IC50
    9.28 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells measured after 2 days by MTT assay
    Cytotoxicity against human T47D cells measured after 2 days by MTT assay
    		[PMID: 26334499]
    T47D IC50
    9.8 3
    Compound: Etoposide
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 27863370]
    T84 IC50
    3 3
    Compound: Etoposide
    Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
    		[PMID: 26731300]
    T98G IC50
    460 1
    Compound: Etoposide
    Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay
    Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay
    		[PMID: 22564383]
    TERT-RPE1 IC50
    0.09 3
    Compound: Etoposide
    Compound was tested for growth inhibition against human h-TERTRPE1 cell lines
    Compound was tested for growth inhibition against human h-TERTRPE1 cell lines
    		[PMID: 15189040]
    TERT-RPE1 IC50
    0.23 3
    Compound: Etoposide
    Cytostatic activity against human hTERT-RPE1 cells
    Cytostatic activity against human hTERT-RPE1 cells
    		[PMID: 30738653]
    THP-1 IC50
    1 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    		[PMID: 30447888]
    THP-1 IC50
    1.27 6
    Compound: Etoposide
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    THP-1 IC50
    1.82 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    THP-1 IC50
    1.82 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    THP-1 IC50
    1.83 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells by MTT assay
    Cytotoxicity against human THP1 cells by MTT assay
    		[PMID: 19782567]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells by MTT assay
    Cytotoxicity against human THP1 cells by MTT assay
    		[PMID: 19036584]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 2 days by MTT assay
    Cytotoxicity against human THP1 cells after 2 days by MTT assay
    		[PMID: 22325897]
    THP-1 IC50
    2.16 3
    Compound: Etoposide
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    Antiproliferative activity against human THP1 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    THP-1 IC50
    2.16 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    THP-1 IC50
    2.16 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    THP-1 IC50
    3.66 3
    Compound: Etoposide
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    THP-1 IC50
    4.42 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    THP-1 IC50
    5.02 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    THP-1 IC50
    59 3
    Compound: Etop
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
    		[PMID: 34606997]
    THP-1 IC50
    6.34 6
    Compound: Etoposide
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    THP-1 IC50
    < 6.25 3
    Compound: Etop
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 34606997]
    TK-10 GI50
    5.89 3
    Compound: ET
    Cytotoxicity against human TK10 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human TK10 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    TK-10 GI50
    7.19 3
    Compound: Etoposide
    Antiproliferative activity against human TK10 cells after 48 hrs by SRB assay
    Antiproliferative activity against human TK10 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    TK-10 GI50
    7.19 3
    Compound: Etoposide
    Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    TK-10 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human TK-10 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    Antiproliferative activity against human TK-10 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    		[PMID: 27010926]
    TK-10 IC50
    0.83 3
    Compound: Etoposide
    Anticancer activity against human TK-10 cells
    Anticancer activity against human TK-10 cells
    		[PMID: 31945642]
    TK-10 IC50
    20.4 6
    Compound: Etoposide
    Anticancer activity against human TK10 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human TK10 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    TK-10 IC50
    9952.5 1
    Compound: etoposide
    Cytotoxicity against human TK10 cells after 48 hrs by SRB assay
    Cytotoxicity against human TK10 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    U-251 IC50
    0.5 3
    Compound: Etoposide
    Cytotoxicity against human U251 RCB 0641 cells after 72 hrs by MTT assay
    Cytotoxicity against human U251 RCB 0641 cells after 72 hrs by MTT assay
    		[PMID: 18558490]
    U-373MG ATCC GI50
    24.9 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 28406636]
    U-373MG ATCC IC50
    25 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 24180210]
    U-373MG ATCC IC50
    7 3
    Compound: Etoposide
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    Growth inhibition of human U373 cells after 72 hrs by MTT assay
    		[PMID: 24950030]
    U-373MG ATCC IC50
    8.5 3
    Compound: etoposide
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    U-87MG ATCC ED50
    73.6 3
    Compound: 1
    Dose required for reduction in human glioblastoma U-87-MG cancer cells after 3 days incubation
    Dose required for reduction in human glioblastoma U-87-MG cancer cells after 3 days incubation
    		[PMID: 15456257]
    U-87MG ATCC IC50
    12.4 3
    Compound: Etoposide
    Cytotoxicity against human U87 cells after 72 hrs by MTT assay
    Cytotoxicity against human U87 cells after 72 hrs by MTT assay
    		[PMID: 22342101]
    U-87MG ATCC IC50
    145 1
    Compound: Etoposide
    Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay
    Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay
    		[PMID: 20210346]
    U-87MG ATCC IC50
    27 3
    Compound: Etoposide
    Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
    Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis
    		[PMID: 36857518]
    U-87MG ATCC IC50
    5.09 3
    Compound: vp16
    Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay
    Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay
    		[PMID: 35462164]
    U-87MG ATCC IC50
    620 1
    Compound: Etoposide
    Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay
    Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay
    		[PMID: 22564383]
    U-937 IC50
    0.92 3
    Compound: etoposide
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    		[PMID: 19053514]
    U-937 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT colorimetric assay
    		[PMID: 25644672]
    U-937 IC50
    1.1 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    		[PMID: 28062194]
    U-937 IC50
    1.4 3
    Compound: etoposide
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    Cytotoxicity against human U937 cells after 72 hrs by MTT assay
    		[PMID: 23865778]
    U-937 IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		[PMID: 25800433]
    U-937 IC50
    10.1 3
    Compound: Etoposide
    Anticancer activity against human U937 cells by MTT assay
    Anticancer activity against human U937 cells by MTT assay
    		10.1039/C4MD00279B
    U-937 IC50
    10.43 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		10.1007/s00044-013-0757-3
    U-937 IC50
    10.56 6
    Compound: Etoposide
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 19410455]
    U-937 IC50
    10.56 6
    Compound: etoposide
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    		[PMID: 17689837]
    U-937 IC50
    10.6 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 22704923]
    U-937 IC50
    17.94 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 48 hrs by MTT assay
    Cytotoxicity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 22115593]
    U-937 IC50
    17.94 3
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    Cytotoxicity against human U937 cells after 2 days by MTT assay
    		[PMID: 22325897]
    U-937 IC50
    17.94 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells after 24 hrs by MTT assay
    		[PMID: 21632155]
    U-937 IC50
    17.96 3
    Compound: Etoposide
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
    		[PMID: 22578452]
    U-937 IC50
    2.27 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as decrease in cell number after 24 hrs by MTT assay
    		[PMID: 25978960]
    U-937 IC50
    2.89 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 28351589]
    U-937 IC50
    22.94 3
    Compound: Etoposide
    Antiproliferative activity against human U-937 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    Antiproliferative activity against human U-937 cells assessed as reduction in cell viability measured for 48 hrs by MTT assay
    		[PMID: 36996717]
    U-937 IC50
    6.14 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 25016373]
    U-937 IC50
    6.7 6
    Compound: Etoposide
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    Cytotoxicity against human U937 cells assessed as reduction in cell viability after 24 hrs by MTT assay
    		[PMID: 24424132]
    U-937 IC50
    < 1 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human U937 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human U937 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    UACC-62 GI50
    0.89 3
    Compound: Etoposide
    Antiproliferative activity against human UACC62 cells after 48 hrs by SRB assay
    Antiproliferative activity against human UACC62 cells after 48 hrs by SRB assay
    		[PMID: 22682920]
    UACC-62 GI50
    0.89 3
    Compound: Etoposide
    Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay
    		[PMID: 28041801]
    UACC-62 GI50
    3.41 3
    Compound: ET
    Cytotoxicity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22889556]
    UACC-62 IC50
    0.83 3
    Compound: Etoposide
    Antiproliferative activity against human UACC-62 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    Antiproliferative activity against human UACC-62 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay
    		[PMID: 27010926]
    UACC-62 IC50
    0.83 3
    Compound: Etoposide
    Anticancer activity against human UACC-62 cells
    Anticancer activity against human UACC-62 cells
    		[PMID: 31945642]
    UACC-62 IC50
    1.4 6
    Compound: Etoposide
    Anticancer activity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    Anticancer activity against human UACC62 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21816519]
    UACC-62 IC50
    1130 1
    Compound: etoposide
    Cytotoxicity against human UACC62 cells after 48 hrs by SRB assay
    Cytotoxicity against human UACC62 cells after 48 hrs by SRB assay
    		[PMID: 16309315]
    UACC-62 IC50
    > 50 3
    Compound: Etoposide
    Activation of procaspase-3-mediated human UACC62 cell death after 72 hrs by MTS/PMS assay
    Activation of procaspase-3-mediated human UACC62 cell death after 72 hrs by MTS/PMS assay
    		[PMID: 16936720]
    VCR100 IC50
    15.5 3
    Compound: 1
    Tested for cytotoxicity against T-lymphoblastoide VC resistant type VCR 100 cell line expressing MDR-1 (+) gene
    Tested for cytotoxicity against T-lymphoblastoide VC resistant type VCR 100 cell line expressing MDR-1 (+) gene
    		[PMID: 11844671]
    Vero IC50
    1.5 3
    Compound: Etoposide
    Cytotoxicity against human Vero cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human Vero cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    		[PMID: 27560280]
    Vero IC50
    16 3
    Compound: ET
    Cytotoxicity against African green monkey Vero cells assessed as decrease in cell viability after 72 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as decrease in cell viability after 72 hrs by MTT assay
    		[PMID: 28385594]
    Vero IC50
    31.14 3
    Compound: 2
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    		[PMID: 22687745]
    Vero IC50
    50 3
    Compound: Etoposide
    Cytotoxicity against African green monkey Vero cells assessed as cells growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as cells growth inhibition after 48 hrs by MTT assay
    		[PMID: 27994737]
    Vero IC50
    > 10 3
    Compound: Etoposide
    Antiproliferative activity against African green monkey Vero cells by MTT assay
    Antiproliferative activity against African green monkey Vero cells by MTT assay
    		[PMID: 29072457]
    Vero IC50
    > 25 3
    Compound: Etoposide
    Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    		[PMID: 38784476]
    WI-38 IC50
    17.6 3
    Compound: VP16
    Cytotoxicity against human WI38 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells measured after 48 hrs by MTT assay
    		[PMID: 27517805]
    WI-38 IC50
    25.7 3
    Compound: 2; VP-16
    Cytotoxicity against human WI38 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells assessed as reduction in inhibition of cell growth incubated for 48 hrs by MTT assay
    		[PMID: 29248296]
    WI-38 IC50
    35.8 3
    Compound: VP16; 2
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
    		[PMID: 26873416]
    WI-38 IC50
    46.9 3
    Compound: 2; VP-16
    Cytotoxicity against human WI38 cells after 48 hrs by MTT assay
    Cytotoxicity against human WI38 cells after 48 hrs by MTT assay
    		[PMID: 28512026]
    WIL2-NS CC50
    0.2 3
    Compound: Etoposide
    Antiproliferative activity against human WIL2-NS cells after 96 hrs by MTT assay
    Antiproliferative activity against human WIL2-NS cells after 96 hrs by MTT assay
    		[PMID: 21741130]
    WiDr GI50
    23 3
    Compound: Etoposide
    Growth inhibition of human WiDr cells
    Growth inhibition of human WiDr cells
    		[PMID: 21986585]
    WiDr GI50
    23 3
    Compound: Etoposide
    Growth inhibition of human WiDr cells after 48 hrs by SRB assay
    Growth inhibition of human WiDr cells after 48 hrs by SRB assay
    		[PMID: 24211632]
    WiDr GI50
    23 3
    Compound: Etoposide
    Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
    Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
    		[PMID: 27023255]
    WiDr GI50
    23 3
    Compound: Etoposide
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    		[PMID: 30840453]
    WiDr GI50
    23 3
    Compound: VP-16
    Cytotoxicity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
    Cytotoxicity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
    		[PMID: 27765506]
    WiDr GI50
    23 3
    Compound: VP-16
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
    		[PMID: 29129514]
    WiDr GI50
    26 3
    Compound: VP-16
    Antiproliferative activity against human WiDr cells after 48 hrs incubation by SRB assay
    Antiproliferative activity against human WiDr cells after 48 hrs incubation by SRB assay
    		[PMID: 25899335]
    WiDr IC50
    1.63 6
    Compound: Etoposide
    Cytotoxic activity against human WiDr colon tumor cell line
    Cytotoxic activity against human WiDr colon tumor cell line
    		[PMID: 15149673]
    XF498 ED50
    2.6 6
    Compound: etoposide
    Cytotoxicity against human XF498 cells by SRB method
    Cytotoxicity against human XF498 cells by SRB method
    		[PMID: 16252909]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 21182258]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Anticancer activity against human XF498 cells by SRB assay
    Anticancer activity against human XF498 cells by SRB assay
    		[PMID: 21420296]
    XF498 IC50
    1.72 3
    Compound: Etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 26988298]
    XF498 IC50
    3.14 3
    Compound: Etoposide
    Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 by 50% after 72 hr of incubation was determined
    Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 by 50% after 72 hr of incubation was determined
    		[PMID: 15482917]
    XF498 IC50
    3.45 3
    Compound: VP-16
    Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay
    Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay
    		[PMID: 19053767]
    XF498 IC50
    3.48 3
    Compound: etoposide
    Cytotoxicity against human XF498 cells by SRB assay
    Cytotoxicity against human XF498 cells by SRB assay
    		[PMID: 17194596]
    XF498 IC50
    3.48 3
    Compound: etoposide
    Cytotoxicity against human XF498 cells after 3 days by SRB assay
    Cytotoxicity against human XF498 cells after 3 days by SRB assay
    		[PMID: 18321715]
    XRS6 IC50
    0.14 3
    Compound: etopside
    Cytotoxicity against CHO cell line xrs6
    Cytotoxicity against CHO cell line xrs6
    		[PMID: 7473578]
    YAPC IC50
    1.32 3
    Compound: Etoposide
    Compound was tested for growth inhibition against human YAPC cell lines
    Compound was tested for growth inhibition against human YAPC cell lines
    		[PMID: 15189040]
    Z-138 IC50
    0.85 3
    Compound: Etoposide
    Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
    		[PMID: 37252100]
    Z-138 IC50
    1.06 3
    Compound: Etoposide
    Cytostatic activity against human Z138 cells
    Cytostatic activity against human Z138 cells
    		[PMID: 30738653]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, Eto
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 22364746]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, Eto
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 23849207]
    ZR-75-1 GI50
    0.2 3
    Compound: 2, VP-16
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21489802]
    ZR-75-1 GI50
    0.2 3
    Compound: Etoposide
    Cytotoxicity against human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
    		[PMID: 21737288]
    ZR-75-1 IC50
    0.24 3
    Compound: Etoposide
    Inhibitory activity against ZR-75-1 cell line using MTT assay (ER+,pgr+,mutant p53)
    Inhibitory activity against ZR-75-1 cell line using MTT assay (ER+,pgr+,mutant p53)
    		[PMID: 10780913]
    ZR-75-1 IC50
    3.1 3
    Compound: etoposide
    Cytotoxicity against human ZR751cells by SRB microtiter plate assay
    Cytotoxicity against human ZR751cells by SRB microtiter plate assay
    		[PMID: 17585747]
    ZR-75-30 IC50
    1.5 3
    Compound: Eto
    Antiproliferative activity against human ZR-7530 cells after 72 hrs by MTT assay
    Antiproliferative activity against human ZR-7530 cells after 72 hrs by MTT assay
    		[PMID: 30109001]
    ZR-75-30 IC50
    2.5 3
    Compound: etoposide
    Cytotoxicity against human ZR-7530 cells after 72 hrs by MTT assay
    Cytotoxicity against human ZR-7530 cells after 72 hrs by MTT assay
    		[PMID: 25402632]
    In Vitro

    Etoposide is capable of causing cytotoxicity on pancreatic β-cells by inducing apoptosis through the JNK/ERK-mediated GSK-3 downstream-triggered mitochondria-dependent signaling pathway in RIN-m5F cells[1].
    Etoposide and Anti-Human VEGF significantly abolish P1 sphere-forming ability, an effect associated with apoptosis of this subset of cells[2].
    Etoposide phosphate (0-1μM; 72 hours) inhibits HCT116 FBXW+/+, FBXW-/- and p53-/- as a dose-dependent manner, exhibits IC50s of 0.945 μM; 0.375 μM; and 1.437 μM, respectively[5].
    Etoposide (25 μM; 6 hours) delays p53 recover in FBXW7-deficient cells. In addition, FBXW7 expression is disappeared in FBXW7-/- cells[5].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Etoposide Related Antibodies

    Cell Viability Assay[5]

    Cell Line: HCT116 FBXW+/+, FBXW-/- and p53-/- cells
    Concentration: 0.025 μM, 0.05 μM, 0.075 μM, 0.1 μM, 0.2 μM, 0.4 μM, 0.6 μM, 0.8 μM, 1 μM
    Incubation Time: 72 hours
    Result: Inhibits HCT116 FBXW+/+p>, FBXW-/- and p53-/- cell growth as a concentration manner.

    Western Blot Analysis[5]

    Cell Line: HCT116 FBXW7+/+ or FBXW7-/- cells
    Concentration: 25 μM
    Incubation Time: 6 hours
    Result: Exhibited that the recovery of p53 levels after DNA damage is mediated by FBXW7.
    In Vivo

    Etoposide (50 μM) and Anti-Human VEGF-treated hypoxic cells injected intravenously into immunodeficient mice reveals a reduced capacity to induce lung colonies, which also appear with a longer latency period[2]. Etoposide (10 mg/kg/day, i.v.) with NSC 109724 and NSC 241240, reduces the tumor volume in the hepatoblastoma cell injected NMRI nude mice[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
    Clinical Trial
    Molecular Weight

    588.56

    Formula

    C29H32O13
    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]4O[C@H](C)OC[C@H]4O3)O)O)C5=C(C=C6OCOC6=C5)[C@@H](C7=CC(OC)=C(O)C(OC)=C7)[C@]21[H]
    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 39 mg/mL (66.26 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.6991 mL 8.4953 mL 16.9906 mL
    5 mM 0.3398 mL 1.6991 mL 3.3981 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    % 
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.93%

    SDS (420 KB)

    COA (266 KB) HNMR (322 KB) RP-HPLC (245 KB) LCMS (106 KB)

    Handling Instructions (2659 KB)
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.6991 mL 8.4953 mL 16.9906 mL 42.4766 mL
    5 mM 0.3398 mL 1.6991 mL 3.3981 mL 8.4953 mL
    10 mM 0.1699 mL 0.8495 mL 1.6991 mL 4.2477 mL
    15 mM 0.1133 mL 0.5664 mL 1.1327 mL 2.8318 mL
    20 mM 0.0850 mL 0.4248 mL 0.8495 mL 2.1238 mL
    25 mM 0.0680 mL 0.3398 mL 0.6796 mL 1.6991 mL
    30 mM 0.0566 mL 0.2832 mL 0.5664 mL 1.4159 mL
    40 mM 0.0425 mL 0.2124 mL 0.4248 mL 1.0619 mL
    50 mM 0.0340 mL 0.1699 mL 0.3398 mL 0.8495 mL
    60 mM 0.0283 mL 0.1416 mL 0.2832 mL 0.7079 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Etoposide Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Etoposide33419-42-0VP-16 VP-16-213VP16VP 16TopoisomeraseAutophagyMitophagyBacterialApoptosisAntibioticMitochondrial AutophagyHCT116prodrugFBXWp53anti-cancerchemotherapyapoptosisP388leukemiaInhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Etoposide
    Cat. No.:
    HY-13629
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (420 KB) Français - FR (420 KB) Deutsch - DE (420 KB) Norwegian - NO (420 KB) Español - ES (420 KB) Swedish - SV (420 KB) Italian - IT (420 KB) Korean - KR (420 KB) Portuguese - PT (420 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.